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INHIBITION OF THE HOST 5’-3’ RNA DECAY PATHWAY IS A NOVEL MECHANISM BY 
WHICH FLAVIVIRUSES INFLUENCE CELLULAR GENE EXPRESSION  
 
 Host gene expression is an intricate process that requires many levels of regulation to 
allow the cell to react properly to a given stimulus or maintain homeostasis. One mechanism by 
which RNA viruses perturb host gene expression and potentially favor the allocation of host cell 
resources for viral proliferation is through interfering with cellular post-transcriptional processes. 
Furthermore, because viral RNAs must persist in the host cell cytoplasm to allow translation of 
viral proteins and ultimately viral replication, the same post-transcriptional processes that 
regulate host messenger RNAs (mRNAs) likely act on viral RNAs as well. The general RNA 
decay machinery in the cell serves as an important regulatory step for proper gene expression 
at the post-transcriptional level. Many RNA viruses have evolved unique mechanisms for 
dealing with the cellular RNA decay machinery to preserve their transcripts and ensure a 
productive infection. Viruses in the Flaviviridae contain positive-sense, single-stranded RNA 
genomes that are not polyadenylated. Therefore, these viral RNAs are likely recognized by the 
host cell as deadenylated, incongruous mRNAs and are likely substrates for the general cellular 
RNA decay machinery. Remarkably, members of the Flavivirus genus including the dengue 
viruses (DENV) and West Nile virus (WNV) produce an abundant non-coding subgenomic RNA 
(sfRNA) during infection that is generated through incomplete degradation of the viral genome 
by the host 5’-3’ exoribonuclease 1 (XRN1). We demonstrate that human and mosquito XRN1 
stalls on highly structured, conserved elements in the 3’ untranslated region of flaviviral RNAs, 
resulting in sfRNA formation. Furthermore, we determined that these sfRNAs act as competitive, 
reversible inhibitors of XRN1. Infected cells display several signs of sfRNA-dependent XRN1 
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dysfunction, including the accumulation of uncapped transcripts and an overall stabilization of 
host mRNAs. Additionally, sfRNA acts as a weak inhibitor of the host cell RNA interference 
(RNAi) pathway. We propose that sfRNA likely acts as a sponge for Argonaute-2 (AGO2) and 
DICER, and have determined that siRNA-mediated decay is suppressed in an sfRNA-
dependent fashion in flavivirus-infected human cells. This suppression of the RNAi pathway 
appears to alter host gene expression to a limited extent, and may be especially important for 
viral replication in the mosquito vector. Other members of the Flaviviridae, including hepatitis C 
virus (HCV) and bovine viral diarrhea virus (BVDV) do not form an sfRNA from their 3’ 
untranslated regions, but they do contain highly structured 5’ untranslated regions. Herein we 
show that aside from acting as internal ribosome entry sites, the 5’ UTRs of HCV and BVDV 
also stall and inhibit XRN1. Therefore, members of the Flavivirus, Pestivirus, and Hepacivirus 
genera appear to inhibit a major mRNA decay pathway by suppressing XRN1 activity via highly 
structured viral RNAs. Consequences of XRN1 suppression during viral infection include the 
stabilization and upregulation of short-lived transcripts including those encoding oncogenes, 
angiogenic factors, and pro-inflammatory factors. Furthermore, we present evidence that WNV 
sfRNA may dysregulate the coordination between mRNA stability and transcription. Therefore, 
the suppression of XRN1 may potentially act as an important mechanism by which diverse 
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 The molecular mechanisms by which viruses interact with their hosts coupled with how 
the host responds to infection form the basis for virus-induced pathology. Viruses with RNA 
genomes lack the genetic space necessary to encode all protein factors required for viral 
replication and gene expression, and therefore rely on the host cell for many aspects of viral 
propagation. Viral mRNAs must access the cellular translation machinery in the cytoplasm for 
gene expression. Furthermore, because viral mRNAs mimic cellular mRNAs, they are likely to 
interact with cytoplasmic RNA-binding proteins and mRNA decay factors. One important but 
under-studied aspect of host-virus interactions is how viral transcripts evade or suppress the 
cellular RNA decay machinery. We have identified a unique mechanism by which all members 
of the Flaviviridae family appear to suppress a major aspect of cellular RNA decay.  We posit 
that major changes in host gene expression occur as a consequence of this inhibition of RNA 
decay by members of the Flaviviridae. Furthermore, pathways by which virus-induced changes 
in mRNA stability could contribute to pathology as a result of mis-regulated gene expression will 
be discussed herein. This introduction seeks to contextualize the following studies and is 
separated into two major sections. Section I will give an overview of the molecular aspects of 
flavivirus propagation and viral pathogenesis. Section II will discuss the major pathways by 
which cellular mRNAs are degraded and will provide background on how RNA viruses are 
known to interact with the RNA decay machinery. 
 
Section I: Introduction to the Flaviviridae family   
 
 The following studies are focused on a particular group of viruses that as a whole are 
endemic around the globe and affect humans and animals. The Flaviviridae family includes 
three genera: the Flaviviruses, Hepaciviruses, and Pestiviruses (Quan et al. 2013; Stapleton et 
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al. 2011). Colloquially, all members of the Flaviviridae family (and the Flavivirus genus) are 
referred to as ‘flaviviruses’. The overall goal of this section is to provide the reader with a 
literature review on the known mechanisms of flaviviral propagation and the innate immune 
response to flavivirus infections. We hypothesize that one mechanism by which diverse 
flaviviruses cause disease is by the suppression of normal cellular RNA decay pathways that 
are essential for the coordinated regulation of gene expression in the cell. Therefore, the known 
mechanisms by which these viruses propagate and cause disease will be important to provide 
background for the following studies presented herein. 
 The Flavivirus genus includes many vector-borne viruses transmitted by mosquitoes or 
ticks to mammalian or avian hosts (Burke and Monath 2001). Members of this genus, Yellow 
Fever virus (YFV), DENV, WNV, and Japanese encephalitis virus (JEV) cause significant 
morbidity and mortality worldwide. The dengue viruses are four closely related flaviviruses that 
are known as dengue virus type 1-4, and the following studies utilized dengue virus type 2 
(DENV-2). Dengue viruses are the cause of the most common vector-transmitted disease 
globally (Centers for Disease Control and Prevention (CDC) 2012) and JEV is the most 
common cause of mosquito-borne pathogen-induced encephalitis worldwide (Sips et al. 2012). 
Of particiular importance in discussing the threat of arthropod-borne flaviviruses to human and 
animal health is the fact that these viruses can rapidly spread to new geographic regions. For 
example, WNV was introduced into North America in 1999 and is now endemic in the United 
States (Jia et al. 1999). Alarmingly, DENV is now likely circulating in the southern United States 
(CDC 2010; Shin et al. 2013). Vaccines against some flaviviruses and some mosquito control 
approaches have been effective in mitigating disease in certain populations, although we still 
lack effective vaccines and vector control strategies for many of these viruses (Heinz and 
Stiasny 2012; Gubler 2011). Therefore there is a profound need to develop effective anti-viral 
treatments and/or vaccines to combat these viruses, particularly with the threat of further 
geographic expansion of mosquito-borne flaviviruses.  
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 Members of the Hepacivirus genus currently include HCV and the GB viruses (GBV; 
named after the surgeon with the initials G.B. that GB viruses were initially derived from). This 
taxon is expanding, as several HCV and GBV genome-like RNA sequences have been detected 
in samples from dogs, rodents, bats and horses (Kapoor et al. 2013; Drexler et al. 2013; 
Chandriani et al. 2013; Burbelo et al. 2012; Kapoor et al. 2011; Epstein et al. 2010). Intriguingly, 
a recent survey of serum samples collected from 58 species of bats identified several new GB- 
and HCV- like viral RNA sequences, indicating that bats may be a major reservoir for these viral 
pathogens (Quan et al. 2013). Furthermore, these recent studies have revealed that the GB 
viruses have likely diverged significantly from the hepaciviruses and should be classified in their 
own taxonomic group, the Pegiviruses (Stapleton et al. 2011; Quan et al. 2013). Importantly, 
HCV is the most common blood-borne pathogen in the United States and is a leading cause of 
hepatocellular carcinoma (HCC) and liver disease worldwide (Wise et al. 2010; Armstrong et al. 
2006). Although the incidence of HCV is decreasing in the U.S., the overall incidence and costs 
associated with chronic disease associated with HCV infection are predicted to continue to rise 
(Razavi et al. 2013). Risk factors for acquiring HCV include infection with human 
immunodeficiency virus (HIV-1), use of injected drugs, receipt of an organ transplant or blood 
transfusions before 1992, and being born during the period from 1945-1965 (Smith et al. 2012). 
There are no vaccines available to protect against HCV, but several anti-viral drugs are in use 
or in development (Scheel and Rice 2013). However, identifying patients infected with HCV and 
providing adequate therapy to infected individuals around the globe remain significant 
challenges (Scheel and Rice 2013). Therefore, further research into the mechanisms of viral 
propagation and host response to infection is vital for the discovery and application of novel 
diagnostics, treatments and vaccines. 
 The pestiviruses include several pathogens of livestock, including BVDV, Border 
Disease virus (BDV) and Classic Swine Fever virus (CSFV; also known as hog cholera virus; 
Becher et al. 2003). Pestiviruses generally infect animals in the order Artiodactyla (the even-
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toed ungulates) (Peterhans et al. 2010). The economic burden of BVDV infections worldwide in 
the dairy and beef industries is substantial (Lanyon et al. 2014). For example, Heuer et al. 
(2007) found that in New Zealand, BVDV infection of cattle was associated with decreased milk 
production, increased time to conception, increased abortions, and loss of calves due to 
persistent infection or abortion. The resulting cost due to BVDV infection was thus estimated to 
be 73 dollars (US) per cow per year (Heuer et al. 2007). Commercially available vaccines 
against BVDV and CSFV have been used to limit disease prevalence in livestock, but one major 
limitation to this strategy to eradicate disease is the ability of these viruses to be transmitted 
vertically from mother to offspring in utero (Newcomer and Givens 2013). Several anti-viral 
compounds including nucleoside analogs that target the activity of the pestiviral RNA-dependent 
RNA polymerase (RdRp) have been efficacious in laboratory settings (Hoover and Striker 2008; 
Dukhan et al. 2005; Angusti et al. 2008; Newcomber and Givens 2013). However, these viruses 
are known to mutate frequently and are likely to evolve to resist anti-viral agents, particularly if 
applied individually (Newcomer and Givens 2013). Therefore, the eradication of BVDV will likely 
require the development and use of effective vaccines, diagnostics, and novel therapeutics 
targeting several viral and/or host factors. 
 
Overview of the flaviviral ‘life’ cycle 
 
 All members of the Flaviviridae are enveloped, contain single stranded positive-sense 
RNA genomes, and replicate exclusively in the cytoplasm of host cells. The replication cycle of 
flaviviruses can be broken into eight important steps (Figure 1). First, the virus enters the cell by 
receptor-mediated endocytosis mediated by the viral envelope glycoproteins (Box 1, Figure 1) 
(Smit et al. 2011) and a slew of cellular factors including the glycosaminoglycans (Chen et al. 
1997; Hilgard and Stockert 2000; Mandl et al. 2001; Germi et al. 2002). These low-affinity 
interactions are thought to concentrate the virus in certain regions of the cell surface to permit 
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entry by more specific viral receptors that remain unidentified (Lecoin et al. 2014). Once viral 
particles adhere to the cell surface they are permitted entry into the cell via clathrin-mediated 
endocytosis (Chu et al. 2006; Acosta et al. 2008; Suksanpaisan et al. 2009; Yang et al. 2013).  
 
 
Figure 1. Flaviviruses, hepaciviruses, and pestiviruses replicate exclusively in the 
cytoplasm.The eight major steps in the replication cycle are highlighted in orange boxes. 
 
 Unlike the flaviviruses, hepaciviruses and pestiviruses encode at least two envelope 
proteins that likely mediate entry into the cell and subsequent fusion of the viral and cellular 
membranes (Kim and Chang 2013; Lindenbach and Rice 2001). Hepatitis C virus appears to 
enter cells by interacting with several receptors including CD81, occludin, scavenger receptor 
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type B class 1, and claudin 1 (Ploss et al. 2009; Evans et al. 2007; Scarselli et al. 2002). 
Interestingly, the expression of human CD81 and human occludin alone was sufficient to permit 
HCV infection in a mouse model (Dorner et al. 2011). The CD46 protein may act as a common 
receptor for the pestivirus E2 protein (Hulst and Moormann 1997; Flores et al. 1996; Maurer et 
al. 2004); although the pestivirus E(rns) protein may mediate non-specific interactions between 
the virus and glycosaminoglycans on the surface of the cell (Iqbal et at 2000). Like the 
flaviviruses, HCV and BVDV appear to enter the cell by clathrin-mediated endocytosis 
(Grummer et al. 2004; Mathapati et al. 2009; Blanchard et al. 2006; van der Schaar et al. 2008). 
Therefore, flavivirus entry into the cell appears to require several steps: initial association of the 
virus with low-affinity receptors (e.g. glycosaminoglycans), recognition of virus-specific 
receptors, and initiation of clathrin-mediated endocytosis. 
 Following receptor-mediated entry into the cell, pH-dependent fusion of viral and cellular 
membranes takes place in pre-lysosomal endocytic vesicles (Box 2, Figure 1) (Gollins and 
Porterfield 1985; Tscherne et al. 2006; Chu and Ng 2004; van der Schaar et al. 2008; Pierson 
and Kielian 2013). Interestingly, the flavivirus E protein appears to undergo an irreversible 
conformational change in the low pH environment of pre-lysosomal vesicles that facilitates 
membrane fusion (Stiasny et al. 2002; Modis et al. 2003; Li et al. 2008; Yu et al. 2008). 
However, the mechanisms by which envelope proteins mediate hepacivirus and pestivirus 
membrane fusion are slightly different (Lindenbach and Rice 2001). Studies of HCV and BVDV 
cell entry have revealed that low pH alone is not sufficient for membrane fusion and HCV and 
BVDV maintain their infectivity after exposure to low pH (Depner et al. 1992; Krey et al. 2005; 
Tscherne et al. 2006). These studies indicate that either an additional factor is required for HCV 
and BVDV fusion (aside from low pH alone) or that conformational changes of the envelope 
proteins of the virions at low pH are reversible (Tscherne et al. 2006). Ultimately, fusion of the 
viral and endocytic membrane causes extrusion of the viral core protein in complex with the 
RNA genome into the cytoplasmic membrane (Lindenbach and Rice 2001).  
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 The next stage of the flavivirus replication cycle is the uncoating of the viral genome, or 
the dissociation of the core protein from the viral RNA (Box 3, Figure 1). Importantly, this occurs 
in the cytoplasm of infected cells where the viral RNA can be translated to produce non-
structural and structural proteins for replication and nascent virion production (Box 4, Figure 1) 
(Lindenbach and Rice 2001). Therefore, these viral RNAs are likely exposed to constitutively 
expressed cellular ribonucleases that function in normal host mRNA turnover and/or quality 
control functions (and will be discussed in Section II of this Introduction). All flaviviruses encode 
a single polyprotein that is co- and post-translationally cleaved by cellular and viral proteases to 
generate distinct proteins as discussed in further detail below. Because viral translation is 
required for subsequent genome replication to take place (Brinton 2013), the flaviviral RNA must 
remain intact and protected from nucleases to permit viral propagation. 
 Replication of flavivirus genomes then takes place in induced membranous 
compartments that are derived from the endoplasmic reticulum (ER) as depicted in Box 5, 
Figure 1 (Ng 1987; Egger et al. 2002; Weiskircher et al. 2009; Romero-Brey et al. 2012; Miorin 
et al. 2013; Kaufusi et al. 2014). The resulting compartmentalization of the cell is thought to 
serve three important functions: (1) to segregate the distinct processes of translation, viral 
particle assembly, and RNA replication for proper virion production, (2) to concentrate cellular 
factors necessary for viral RNA replication and construction of nascent virions, and (3) to shield 
newly made viral genomic RNAs and viral proteins from cellular ribonucleases and proteases 
(Paul and Bartenschlager 2013). Replication of flavivirus RNAs in these membranous 
compartments is thought to require the activity of all seven viral non-structural (NS) proteins 
(Brinton 2013). The four membrane associated proteins NS2A, NS2B, NS4A, and NS4B are 
thought to anchor the flaviviral protein-RNA replication complexes to induced membranous 
compartments for localized genome replication (Mackenzie et al. 1998; Westaway et al. 2002; 
Miller et al. 2006; Miller et al. 2007; Kaufusi et al. 2014). Recent studies have implicated the 
activity of NS4B in the formation of these ER-derived membranous sites of viral RNA replication 
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in flavivirus (Kaufusi et al. 2014), pestivirus (Weiskircher et al. 2009), and hepacivirus (Egger et 
al. 2002; Gouttenoire et al. 2010; Paul et al. 2011) infected cells.  
 Upon the formation of replication complexes in these membranous compartments, viral 
RNA replication ensues (Box 5, Figure 1). The Flaviviral RNA-dependent RNA polymerase NS5 
(or the hepaciviral or pestiviral NS5B) synthesizes nascent viral RNAs. Interestingly, the 
flavivirus NS3 protein possesses a helicase activity and a triphosphatase activity that is 
responsible for dephosphorylation of the 5’ ends of newly transcribed viral RNAs (Luo et al. 
2008; Wang et al. 2009). This permits the addition of a methylated 5’ cap on flaviviral RNAs 
(discussed in more detail in the next below) (Issur et al. 2009; Yap et al. 2010). The NS5 and 
NS5B proteins are anchored to the ER-derived membranes via hydrophobic trans-membrane 
domains to cause the localized, protected replication of viral RNAs (Gu and Rice 2013; Caillet-
Saguy et al. 2014). Newly transcribed viral RNAs are excreted from these membranous 
replication complexes into the cytoplasm, and can then either be packaged into nascent virions, 
undergo translation or serve as templates for further genome replication (Brinton 2013; Miorin et 
al. 2013). 
 For viral assembly, nascent viral RNA genomes form a complex with the basic core or 
capsid proteins and these ribonucleoproteins (RNPs) assemble with viral structural proteins to 
form immature virions (Box 6, Figure 1). Similar to the flavivirus capsid protein, the HCV and 
BVDV core proteins are enriched in basic amino acid residues to facilitate their tight association 
during viral RNA packaging in the ER (Lindenbach and Rice 2001). These newly constructed 
viral particles then bud through ER-associated membranes to create mature enveloped viruses. 
 Finally, fully formed, immature viral particles are trafficked through the trans-Golgi 
network in large vesicles (Box 7, Figure 1). Flavivirus particles undergo furin-mediated 
proteolytic cleavage of the structural prM protein to liberate the pr peptide from the mature M 
protein. The maturation of M on nascent viral particles is important for subsequent infections to 
be initiated (Guirakhoo et al. 1992; Elshuber et al. 2003; Junjhon et al. 2010; Zhang et al. 2003). 
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Although other viral proteins are proteolytically processed during or shortly after translation, 
delaying the cleavage of the pr peptide from M until viruses are in the trans-Golgi network likely 
protects the virus from undergoing pre-mature fusion with cellular membranes (Yu et al. 2008; Li 
et al. 2008). The flavivirus pr peptide therefore protects the viral E protein from undergoing 
irreversible conformational changes in the low pH of the trans-Golgi network (Yu et al. 2008; Li 
et al. 2008). Interestingly, pestiviruses and hepaciviruses appear to actively modulate the pH in 
these vesicular compartments via the p7 protein, which is known to oligomerize to form pore-like 
structures in membranes that selectively allow cations (e.g. protons) to cross the membrane 
(Griffin et al. 2003; Pavlovic et al. 2003; Premkumar et al. 2004; Wozniak et al. 2010). The p7 
protein was shown to be essential for HCV propagation in a non-human primate model of 
infection (Sakai et al. 2003), and further studies demonstrated that p7 is required for HCV and 
BVDV assembly and egress from the cell (Harada et al. 2000; Jones et al. 2007). Finally, virus-
laden vesicles ultimately fuse with the cellular membrane for release of the virions into the 
extracellular environment (Box 8, Figure 1). To summarize, flaviviruses, hepaciviruses, and 
pestiviruses undergo ‘life’ cycles exclusively in the cytoplasm of the cell and require both host 
and viral factors for successful propagation. 
 
Overview of flavivirus genome structure and gene expression strategy 
 
 Flaviviral genomic RNAs are approximately 10-12 kilobases in length and contain a 
single open reading frame flanked by 5’ and 3’ untranslated regions. In general, viral structural 
proteins are encoded at the 5’ end and non-structural proteins at the 3’ end of the open reading 
frame. Viruses of all three genera use a similar gene expression strategy, in which the viral RNA 
is translated into one long polypeptide that is proteolytically cleaved by viral or cellular proteases 
to generate distinct gene products. The genome structure, organization and gene expression 
strategy of flaviviruses will be discussed below. 
10 
 
Conserved elements in the flavivirus genomic RNA 
 
 The flavivirus genome is ~11 kb in length and contains a 5’ 7-methylguanosine cap but 
no poly(A) tail (Thurner et al. 2004; Brinton and Dispoto 1988; Chambers et al. 1990). Like 
many mammalian cells (Furuichi et al. 1975; Werner et al. 2011; Smietanski et al. 2014), the 5’ 
caps of flavivirus RNAs contain an additional 2’ O ribose methylation (Daffis et al. 2010; Zust et 
al. 2011; Szretter et al. 2012). The flavivirus NS5 protein mediates the methylation of the 5’ cap 
via a guanine N7 methyltransferase activity and a nucleoside 2’ O-ribose methyltransferase 
activity (Issur et al. 2009; Yap et al. 2010; Caillet-Saguy et al. 2014). This cap structure is 
required for cap-dependent translation of the flavivirus genome. 
 The 5’ and 3’ untranslated regions (~100 nt and 400-700 nt, respectively) have 
conserved sequence and structural elements that facilitate viral RNA replication, genome 
packaging, and translation (Lindenbach and Rice 2001). In general, the overall sequence 
composition of the 3’ and 5’ UTRs are not especially well conserved among all flaviviruses, but 
several structural motifs and short sequence elements that facilitate viral translation and 
replication are conserved (Thurner et al. 2004; Brinton and Dispoto 1988; Brinton et al. 1986). 
The short conserved sequence elements in the 5’ and 3’ UTRs are thought permit viral genome 
cyclization through long range RNA-RNA interactions, resulting in the formation of a complex 
tertiary structure necessary for genome replication (Hahn et al. 1987; Khromykh et al. 2001; 
Alvarez et al. 2005; Polacek et al. 2009; Friebe and Harris 2010). The specific RNA-RNA 
interactions between the viral RNA 5’ and 3’ UTRs are thought to position the viral RdRp 
appropriately for viral transcription initiation (Filomatori et al. 2006; Filomatori et al. 2011). The 
conserved structural motifs present in the 5’ UTRs and 3’ UTRs of flavivirus genomes will be 
discussed in more detail below and are diagrammed in Figure 2.  
 The 5’ UTRs of flaviviral RNAs are ~100 nucleotides long and contain a conserved stem-
loop structure (SLA) of ~70 nucleotides in length (Figure 2A; Liu et al. 2009(a)). This stem-loop 
is thought to function as a promoter for negative strand viral RNA synthesis in conjunction with a 
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short conserved U-rich region adjacent to SLA (Liu et al. 2009(a); Lodeiro et al. 2009). Two 
additional stem-loops are conserved in flavivirus RNAs downstream from SLA, stem-loop B 
(SLB) and a hairpin in the capsid-coading region of the open reading frame (cHP; Figure 2A). 
The SLB moiety contains a conserved sequence motif that mediates genome cyclization (Liu et 
al. 2009(a)). Finally, cHP is thought to be important for viral RNA replication and translation 
initiation (Liu et al. 2009(a); Clyde and Harris 2006; Clyde et al. 2008). Unlike the hepaciviruses 
and pestiviruses, the 5’ UTR of the flavivirus RNA does not harbor an IRES element. The 
flaviviral 5’ UTR therefore contains essential sequence and structural elements for viral RNA 
synthesis and cap-dependent translation initiation.  
 
Figure 2. Conserved structural elements in flaviviral RNAs. (A) The conserved 
structures in the 5’ capped RNA of dengue viruses (representative of the Flavivirus 
genus) with 5’ and 3’ UTRs flanked by structural (S) and non-structural (NS) protein-
coding regions. The three conserved stem-loops, SLA, SLB, and cHP (capsid-coding 
region hairpin) are indicated. (B) Conserved structures in the triphosphorylated HCV RNA 
(a representative of the Hepacivirus genus). The 5’ UTR contains four conserved 
structural domains numbered as 5’I-IV and two additional conserved stem-loops are 
present in the core-coding region (5’V and 5’VI). The seven conserved stem-loops at the 
3’ end of the viral RNA (3’I-VII) are found in the non-structural protein coding region and 
the 3’ UTR. The 3’ UTR contains a variable region (VR), a poly(U/UC) tract, and a 3’ X 
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tail. (C) The conserved structural motifs in the triphosphorylated BVDV RNA (a 
representative of the Pestivirus genus). As in the HCV RNA, the BVDV 5’ UTR contains 
four major structural elements labeled I-IV. The 3’ UTR contains three stem-loops (I-III), 
two of which are in the variable region (VR). Adapted from Liu et al. (2009(a)). 
 
 The 3’ UTRs of most flaviviruses encompass three conserved domains containing 
unique conserved structural and sequence elements (Figure 2A; Liu et al. 2009(a)). Domain I is 
adjacent to the open reading frame and is variable in sequence, but contains at least two 
conserved stem-loop structures (Liu et al. 2009(a); Ward et al. 2011). Directly 3’ to Domain I, 
Domain II has two dumbbell structures, each containing conserved sequence motifs (Liu et al. 
2009(a); Ward et al. 2011). Domain III encompasses the 3’ end of the viral RNA and contains 
two conserved sequence elements that are complementary to regions in the 5’ UTR (facilitating 
genome cyclization) plus a large stem-loop (3’SL) at the RNA terminus (Liu et al. 2009(a); 
Rauscher et al. 1997; Romero et al. 2006).  
 All flaviviruses tested to date generate distinct subgenomic RNAs (sfRNAs) of ~500 nt in 
length that contain the majority of the viral 3’ UTR (Urosevic et al. 1997; Lin et al. 2004; Pijlman 
et al. 2008). Intriguingly, higher-ordered pseudoknot-like structures formed from interactions 
between the conserved stem-loops and dumbbell motifs in Domains I and II in the 3’ UTR are 
implicated in sfRNA formation (Pijlman et al. 2008; Funk et al. 2010; Silva et al. 2010; Chapman 
et al. 2014). These viral RNAs are particularly interesting because they appear to be formed as 
a result of incomplete digestion of the viral genome by the major cellular exoribonuclease XRN1 
(Pijlman et al. 2008; Silva et al. 2010). We have therefore focused our studies on the 
interactions between the cellular RNA decay machinery and flaviviruses by studying the 






Hepacivirus and pestivirus genome structure  
 
 Although there are many similarities in the genome organization of the flaviviruses and 
viruses in the other two genera in the Flaviviridae family, the 3’ and 5’ UTRs of hepacivirus and 
pestivirus RNAs are more similar to one another than they are to flavivirus RNAs. Hepatitis C 
virus (the proto-typical hepacivirus) has a ~9.6 kb genome and pestivirus genomes are ~12.3 kb 
in length (Lindenbach and Rice 2001). Viruses in both genera have highly structured 5’ UTRs 
and several conserved sequence and structural elements in their 3’ UTRs that are diagrammed 
in Figure 2B (Bukh et al. 1992; Lindenbach and Rice 2001; Liu et al. 2009(a)). Two pieces of 
evidence indicate that hepacivirus and pestivirus genomes likely possess a 5’ triphosphate in 
lieu of a methylated cap structure: (1) they are translated by a cap-independent mechanism, 
and (2) their RNA dependent RNA polymerases do not harbor methyltransferase activities (Li et 
al. 2013(a); Lindenbach and Rice 2001; Caillet-Saguy et al. 2014; Le et al. 1996; Wang et al. 
1993). Both viruses use internal ribosome entry sites (IRES) that have similar structural 
elements to undergo cap-independent translation (Le et al. 1996; Wang et al. 1993; Pestova et 
al. 1998).  
 Similar to what is observed in flaviviruses, hepacivirus and pestiviruses genomes may 
circularize for efficient viral RNA replication and/or translation. In HCV, genome cyclization is 
thought to occur via long-range RNA-RNA interactions and/or by interactions between the 
cellular RNA binding proteins (RBPs) including poly(C) binding protein 2 (PCBP2) and a group 
of normally nuclear NFAR proteins with the viral 5’ and 3’ UTRs (Wang et al. 2011; Romero-
Lopez and Berzal-Herranz 2009; Isken et al. 2007). Studies in BVDV replication revealed that 
these NFAR proteins likely form a complex on the viral 3’ UTR and bridge the interaction with 
the viral 5’ UTR to promote viral translation and/or replication (Isken et al. 2003; Isken et al. 
2007). Therefore, in contrast to what is known about flavivirus genome cyclization, it appears 
that hepaciviruses and pestiviruses rely on cellular RBPs to mediate these long range RNA-
RNA interactions.   
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 In further contrast to the flavivirus genome structure, the 5’ UTRs of hepacivirus and 
pestivirus RNAs contain structural motifs that facilitate cap-independent translation. These viral 
5’ UTRs have four distinct conserved structural domains that are numbered I-IV from the 5’ end 
of the genome as depicted in Figure 2B and C (Liu et al. 2009(a); Brown et al. 1992; Fletcher 
and Jackson 2002). Additionally, there are four predicted conserved stem-loops in the open 
reading frame of HCV in the region encoding the core protein adjacent to the IRES element as 
depicted in Figure 2B (Vassilaki et al. 2008). In contrast, pestivirus genomic RNAs appear to 
contain only two highly conserved, short (~20-30 nt) stem-loops in the NS4A- and NS5B-coding 
regions of the open reading frame, quite distant from the IRES element (and therefore not 
depicted in Figure 2) (Thurner et al. 2004). 
 Interestingly, stem-loops I and II in the HCV and BVDV genomes were shown to be 
essential for viral RNA replication (Yu et al. 2000; Kim et al. 2002). The pestivirus and 
hepacivirus IRES elements encompass Domains II, III and IV, all of which were shown to be 
required for viral translation (Liu et al. 2009(a); Lukavsky 2009; Fletcher and Jackson 2002). 
The eukaryotic initiation factor 3 (eIF3) and 40S ribosomal subunits were shown to specifically 
interact with these IRES elements to facilitate translation (Pestova et al. 1998; Sizova et al. 
1998; Kieft et al. 2001). Interestingly, the IRES elements contain a complex pseudoknot-like 
structure in Domain IV that positions the 40S ribosomal subunit appropriately for translation 
initiation (Fletcher and Jackson 2002; Berry et al. 2010; Moes and Wirth 2007). Two of the 
stem-loops in the HCV ORF (5’V and 5’VI in Figure 2B) were shown to be important for viral 
translation and replication in both cell culture and non-human primate models of infection 
(McMullan et al. 2007). Therefore, the 5’ UTRs of hepacivirus and pestivirus RNAs contain 
several highly conserved structural elements that are primarily thought to facilitate cap-
independent translation and mediate viral RNA synthesis. 
 Not only does the HCV 5’ UTR harbor the essential structural elements necessary for 
viral replication and translation, but it uniquely contains two conserved binding sites for a host 
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microRNA, miR-122 (Jopling et al. 2005). A region containing the first 50 nucleotides in the HCV 
5’ UTR has two sites complementary to 2nd – 8th or 2nd-7th nucleotides of miR-122 (Jopling et al. 
2008). This cellular microRNA is highly specific to human hepatocytes, and was shown to be 
essential for HCV propagation in tissue culture cells and in a non-human primate model of 
infection (Jopling et al. 2005; Jopling et al. 2008; Lanford et al. 2010).  Furthermore, miR-122 
was shown to bind the HCV genome in complex with Argonaute-2 (AGO2) to promote efficient 
viral replication, possibly by enhancing viral translation and/or by stabilizing the viral RNA 
(Jopling et al. 2005; Jangra et al. 2010; Li et al. 2013(b); Conrad et al. 2013). Recent evidence 
indicates that miR-122 may mask the 5’ terminus of the HCV genome from exonucleolytic 
decay, potentially stabilizing the RNA as a replacement for the 5’ methylguanosine cap that 
these viruses lack (Machlin et al. 2011; Li et al. 2013(b)). It will be interesting to determine 
whether or not pestiviruses commandeer microRNAs to similarly facilitate viral propagation. 
However, in contrast to HCV, the BVDV 5’ UTR contains a conserved stem-loop at the exact 5’ 
terminus (Yu et al. 2000) that could potentially serve a similar function in protecting the 5’ end of 
the viral RNA from exonucleolytic decay (Figure 2C). Therefore, although the exact mechanism 
by which miR-122 enhances HCV replication and/or translation has yet to be fully elucidated, 
this viral RNA-miRNA interaction is important for mediating viral propagation. 
 The 3’ untranslated regions of hepaciviruses and pestiviruses share several sequence 
and structural elements (Thurner et al. 2004). Both viral 3’ UTRs contain a variable region 
adjacent to the open reading frame, an AU- or UC-rich region, and a conserved region at the 3’ 
terminus (Figure 1B and C). The HCV 3’ UTR variable region is ~50 nt long and is adjacent to a 
conserved poly(U/UC) stretch of ~30-80 nt in length, and the ~100 nt highly conserved 
sequence element called the X-tail is at the 3’ terminus of the viral RNA (Kolykhalov et al. 1996; 
Tanaka et al. 1996; Yamada et al. 1996; Tsuchihara et al. 1997; Thurner et al. 2004). Similarly, 
the 5’ end of the pestivirus 3’ UTR is known to contain a short region of variable sequence and 
length (~50-120 nt), an AU-rich region (of variable location and size), and a ~100 nt highly 
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conserved region at the 3’ terminus (Deng and Brock 1993; Becher et al. 1998; Yu et al. 1999; 
Vilcek et al. 1999). The hepacivirus variable region is not absolutely required for viral replication, 
but deletion of this region was shown to significantly reduce viral RNA replication in one study 
(Friebe and Bartenschlager 2002). The pestivirus variable region contains several conserved 
stem-loop structures and was also shown to be required for efficient BVDV replication in 
addition to translation termination (Isken et al. 2004). Interestingly, the conserved U-rich regions 
in hepacivirus and pestivirus 3’ UTRs are quite important for viral propagation. The HCV 
poly(U/UC) tract was shown to be required for viral replication (Friebe and Bartenschlager 2002; 
Yi and Lemon 2003; You and Rice 2008) and for mediating viral translation (Song et al. 2006; 
Bradrick et al. 2006). Similarly, all pestivirus 3’ UTR sequences compared in one study 
(including BDV, BVDV, and CSFV) harbor conserved AU-rich regions, although these sequence 
motifs are variable in location and size in the viral RNA (Vilcek et al. 1999). The X-tail, or the 3’ 
terminus of the HCV 3’ UTR harbors three highly conserved stem-loops (SL I, II, and III) that are 
also required for HCV replication (Yi and Lemon 2003; Friebe and Bartenschlager 2002). Stem-
loop II was shown to interact with a cruciform RNA structure in the NS5B coding region in a 
long-range RNA-RNA interaction that appears to be required for viral replication (You and Rice 
2002; You et al. 2004; Friebe et al. 2005; You and Rice 2008). The 3’ conserved region of the 
pestivirus RNA has a short conserved sequence element (ACAGCACUUUA) in addition to a 
conserved stem-loop at the 3’ terminus of the RNA that is required for efficient viral replication 
(Deng and Brock 1993; Isken et al. 2004). It is important to note that hepaciviruses and 
pestiviruses do not generate sfRNA-like subgenomic RNAs from their 3’ UTRs. However, as 






Flavivirus gene expression strategy 
 
 Flaviviruses use an elegant post-translational processing scheme to generate multiple 
distinct protein products from a single translated polyprotein precursor. A schematic of the 
organization and pre-/post-translational processing of the flaviviral polyprotein is provided in 
Figure 3. As described above, the structural proteins are generally encoded at the 5’ end of the 
viral open reading frame (ORF) and the non-structural proteins are grouped at the 3’ end of the 
viral ORF. A brief description of the flavivirus, hepacivirus, and pestivirus genome organization 




Figure 3. Post- and co-translational processing of gene products in viruses of the 
Flaviviridae family. (A) Flaviviruses have 5’ methylguanosine caps and 5’ and 3’ 
untranslated regions flanking a single open reading frame that is processed by cellular 
and viral proteases to generate distinct protein products. Three structural proteins and 
seven non-structural proteins are made. (B) The hepacivirus genome contains a 5’ 
triphosphate instead of a methylated cap, and is translated via an internal ribosome entry 
site (IRES) that makes up the 5’ untranslated region. Four structural and six non-
structural proteins are generated. (C) Pestiviruses generate up to five structural and 
seven non-structure proteins through cap-independent translation via an IRES element 
and genomes are also likely 5’ triphosphorylated (Linderbach and Rice 2001).  
 
 
 As diagrammed in Figure 3A, the flavivirus RNA encodes three structural proteins, C 
(capsid), M (membrane; the precursor protein is prM), and E (envelope) and seven non-
structural proteins, NS1, NS2A, NS2B, NS3, NS4A, NS4B, and NS5 (Lindenbach and Rice 
2001; Chambers et al. 1990). As the viral polyprotein is translated, the C protein first undergoes 
several proteolytic processing events by both cellular and viral proteases (Boege et al. 1983; 
Trent 1977; Lindenbach and Rice 2001). Next, the prM protein is generated by distinct 
proteolytic cleavage events mediated by both cellular and viral proteases. Interestingly, the prM 
protein undergoes proteolysis by the cellular protease furin long after translation is terminated, 
when nascent virions are trafficked through trans-Golgi network (Yamshchikov and Compans 
1994; Stadler et al. 1997). The final structural protein, E, is generated by cellular signal 
peptidase cleavage of the viral polyprotein (Markoff et al. 1994). In contrast, the flaviviral non-
structural proteins are mostly liberated from the polyprotein by the protease activity of the viral 
NS3 protein (Yamshchikov et al. 1997). Importantly, as discussed above, the sequential 
proteolytic cleavage of viral proteins is essential for proper viral gene expression (Lindenbach 
and Rice 2001; Lee et al. 2000).  
 The hepaciviruses and pestiviruses also generate a single polyprotein that is co-and 
post-translationally processed by cellular and viral proteases to generate distinct protein 
products (Figure 3B and C). As occurs in flaviviruses, the three structural proteins core (C), E1 
and E2 of HCV encoded at the 5’ end of the viral open reading frame (ORF) are proteolytically 
cleaved by cellular signal peptidases (Lindenbach and Rice 2001). The E2 envelope protein 
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then undergoes a second proteolytic cleavage event by a signal peptidase to liberate the non-
structural p7 peptide on the surface of the ER membrane (Lin et al. 1994).  Seven non-structural 
proteins are encoded in the rest of the ORF: a small polypeptide cleaved from the E2 protein 
(p7), NS2, NS3, NS4A, NS4B, NS5A, and NS5B. As is observed in flavivirus polyprotein 
maturation, viral proteases are mostly responsible for processing the HCV non-structural 
proteins. The NS2-NS3 polypeptide acts as an autoprotease, and the liberated NS3 protein 
retains protease activity when directly interacting with NS4A, which acts as a co-factor for this 
process (Bartenschlager et al. 1994; Lin et al. 1994; Failla et al. 1994; Tanji et al. 1994).  
 The pestiviruses are slightly more complex in that they harbor four structural proteins 
and seven non-structural proteins (Figure 3C). Uniquely, the pestiviruses encode a non-
structural protein, N(pro), at the 5’ terminus of the single open reading frame. The N(pro) protein 
acts as an autoprotease, liberating itself from the adjacent C protein during translation (Stark et 
al. 1993; Wiskerchen et al. 1991; Lindenbach and Rice 2001). The four structural proteins that 
are next translated are the core (C) protein and three envelope proteins E(rns), E1, and E2; 
these are mostly processed by cellular proteases (Lindenbach and Rice 2001). The other non-
structural proteins located at the 3’ end of the pestivirus genome from 5’ to 3’ are NS2, NS3, 
NS4A, NS4B, NS5A, and NS5B. In contrast to the hepaciviruses, NS2-NS3 and NS5A-NS5B 
are generated through an initial proteolytic cleavage event, and can then be liberated to form 
distinct protein products or remain covalently linked (Lindenbach and Rice 2001). Interestingly, 
not all pestivirus isolates generate NS2 and NS3 from cleavage of the NS2-NS3 precursor. 
Furthermore, all non-cytopathic BVDV isolates tested to date generate the unprocessed NS2-
NS3 precursor only, but cytopathic BVDV (and CSFV) both generate distinct NS2 and NS3 
products (Donis and Dubovi 1987; Greiser-Wilke et al. 1992; Meyers and Thiel 1996). There is 
some evidence that insertion of host RNA sequences into the pestivirus RNA directly 
contributes to proteolytic processing of the NS2-NS3 precursor. Therefore, pestiviruses are 
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unique in that they normally maintain the NS2-NS3 and NS5A-NS5B as single protein products, 
and cleavage of NS2-NS3 is strongly associated with pathogenicity. 
  To summarize, all members of the Flaviviridae use both cellular and viral proteases to 
generate distinct gene products from a single translated polyprotein. Furthermore, the genome 
organization of these viruses is generally conserved, in which structural and non-structural 
proteins are grouped together. Because flaviviral gene expression relies on translation of a 
single viral mRNA, it is very important for these viruses to evade cellular nucleases to permit 
viral propagation. Furthermore, because RNA-RNA recombination events can influence the 
pathogenicity of pestivirus infections by facilitating the formation of distinct NS2 and NS3 
proteins, the ability of cellular exonucleases to degrade viral RNAs before they can recombine 
could ultimately influence viral pathogenesis. 
 
General host anti-flaviviral innate immune mechanisms 
 A general discussion of the immune mechanisms that are important for anti-flaviviral 
host response is relevant to this discussion, as aberrant or over-active immune responses (e.g. 
inflammation) are known to play important roles in mediating the pathology of flavivirus 
infections (Paton and Greiser-Wilke 2004; Guidotti and Chisari 2006; King et al. 2007; Rossini et 
al. 2013; Yacoub et al. 2013). The rates at which viral and cellular mRNAs are degraded in the 
cell could theoretically influence the innate immune response to viral infection in two ways. First, 
flaviviral RNAs are known to activate host innate immune pathways by triggering cytosolic 
pathogen recognition receptors (PRRs). Therefore, viral RNAs that are resistant to degradation 
would theoretically be available for a longer period of time to stimulate PRRs. Second, the 
expression of pro-inflammatory factors is often heavily regulated at the post-transcriptional level, 
and virus-induced changes in post-transcriptional gene regulatory mechanisms could therefore 
alter the immune response to infection (Anderson 2009; Hao and Baltimore 2009). This 
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discussion will be focused on intrinsic innate anti-flaviviral immune mechanisms including the 
activation of cellular nucleases that are induced as a result of the cellular recognition of viral 
RNAs. 
 Flaviviral RNAs contain several specific motifs, considered pathogen associated 
molecular patterns (PAMPs) that can stimulate PRRs. Importantly, all flaviviruses generate 
double stranded RNA (dsRNA) replication intermediates in the cytoplasmic membranous 
compartments of the host cell that appear to be immunogenic (Errett et al. 2013). Furthermore, 
higher-order RNA structures present in flaviviral RNAs can also be recognized as PAMPs 
(Pichlmair et al. 2009). The 5’ terminal triphosphate of hepacivirus or pestivirus RNAs stimulate 
PRRs, and uniquely, a ~36 nt highly conserved poly(U/UC) tract in the HCV 3’ UTR also 
appears to be immunogenic (Sumpter et al. 2005; Schnell et al. 2012). The PRRs that sense 
these viral RNA motifs include the interferon-induced proteins with tetratricopeptide repeats 
(IFITs), retinoic acid-inducible gene-I (RIG-I) like receptors (RLRs), Toll-like receptors (TLRs) 
the NOD, LRR and pyrin domain containing 3 (NLRP3) inflammasome, oligoadenylate synthase 
(OAS) and the interferon-induced protein kinase R (Samuel et al. 2006; Gilfoy and Mason 2007; 
Li et al. 2011(a); Kaushik et al. 2012; Schnell et al. 2012; Suthar et al. 2013). In general, the 
outcome of PRR stimulation is the activation of intracellular signaling cascades that ultimately 
induce transcription of pro-inflammatory cytokines, chemokines, and/or interferon α or β (the 
type I interferons; IFN) which can exert anti-viral and/or pro-inflammatory effects (Jensen and 
Thomsen 2012). IFNβ is ultimately secreted from the cell and binds to the IFNα and IFNβ 
receptor complex 1 (IFNAR1) located on the same cell or a neighboring cell (Suthar et al. 2013). 
The activation of IFNAR1 ultimately results in activation of a complex containing interferon 
regulatory factor 9 (IRF9), the signal transducer and activator of transcription 1 (STAT1) and 
STAT2 (Horvath 2004). These transcription factors then enter the nucleus and induce the 
expression of distinct interferon stimulated genes (ISGs) and interferon α (Horvath 2004; 
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Tenoever et al. 2007). The recognition of flavivirus RNAs by IFITs, RLRs, TLRs, and OAS, and 
the outcome of PRR stimulation will be discussed further below. 
 
IFIT proteins in flavivirus infections 
 
 Viral transcripts that contain non-methylated cap structures (e.g. hepaciviruses and 
pestiviruses) are recognized by down-stream effectors of the type I interferon pathway called 
IFITs (Daffis et al. 2010; Hyde et al. 2014). Because mammalian IFIT1 (also known as P56)  
has been shown to suppress translation initiation by sequestering subunits of the eiF3 complex, 
inhibition of viral translation was thought to be the mechanism by which IFIT1-mediated virus 
restriction occurred (Guo et al. 2000; Hui et al. 2005; Daffis et al. 2010). Indeed, one study 
demonstrated that IFIT1 likely suppressed IRES-mediated translation of HCV through this 
mechanism (Wang et al. 2003). However, it was later demonstrated that susceptibility of 
flaviviruses to IFIT-mediated restriction largely depended on the presence or absence of the 2’ 
O-methyl group on the 5’ cap of viral RNAs. Although members of the Flavivirus genus normally 
have 5’ methylated cap structures that resemble cellular mRNAs, mutant RNA viruses (including 
WNV) that were incapable of adding the 2’ O-methyl group to the 5’ cap were shown to be much 
more sensitive to IFIT-mediated restriction (Daffis et al. 2010; Szretter et al. 2012). Furthermore, 
it was recently demonstrated that IFIT1 binds directly to 5’ triphosphorylated RNAs, limiting their 
ability to be translated by sequestering these RNAs away from the translation machinery 
(Pichlmair et al. 2011). Therefore, triphosphorylated RNAs generated in HCV and BVDV 
infections are likely recognized directly by IFIT proteins that are induced as a result of the type I 





The RIG-I like receptors in flavivirus infections 
 
 The RIG-I like receptors are present in most mammalian cells where they serve as the 
major sensors of viral RNAs and essential activators of the type I interferon response (Kato et 
al. 2005; Jensen and Thomsen 2012). These proteins include RIG-1 and melanoma 
differentiation antigen 5 (MDA5). Both RIG-I and MDA5 also contain caspase recruitment 
domains essential for signal transduction (Yoneyama et al. 2004; Jensen and Thomsen 2012). 
MDA5 appears to have some specificity for RNAs longer than 2,000 nucleotides in length, and 
RIG-I can recognize shorter RNAs (Kato et al. 2005; Triantafilou et al. 2012; Feng et al. 2012). 
Furthermore, MDA5 is stimulated by higher-order RNA structures that contain both single 
stranded and double stranded regions (Pichlmair et al. 2009). Importantly, the stimulation of 
RIG-I by triphosphorylated viral RNAs containing dsRNA-like panhandle structures can occur 
immediately following viral infection upon disassociation of the viral RNA from the capsid protein 
(Weber et al. 2013). In addition to dsRNA recognition, both RIG-I and MDA5 may also recognize 
foreign mRNA 5’ cap structures. Viral RNAs with 5’ triphosphates (e.g. Hepatitis C virus) can 
activate RIG-I (Saito et al. 2008; Kato et al. 2008) and a recent study demonstrated that MDA5 
may recognize viral RNAs lacking the 2’ O methyl group normally present on viral and cellular 
mRNAs (Zust et al. 2011). Upon stimulation, RLRs undergo a conformational change leading to 
oligomerization and re-localize to cellular membranes where they bind the cellular mitochondrial 
antiviral signaling (MAVS) protein, also known as IPS-1 (Loo and Gale 2011; Suthar et al. 2013; 
Horner 2014). This complex then causes interferon regulatory factor 3 (IRF3) and/or nuclear 
factor κ B (NFκB) to re-localize to the nucleus and promote the transcription of interferon β and 
other genes to induce a type I interferon response (Loo and Gale 2011; Suthar et al. 2013). 
 Flaviviruses including WNV, DENV, JEV, and HCV are known to trigger type I IFN 
responses as a result of RIG-I and/or MDA5 stimulation (Li et al. 2011(a); Sumpter et al. 2005; 
Kato et al. 2006; Loo et al. 2008; Fredericksen et al. 2008; Kawai and Akira 2008; Suthar et al. 
2010; Schnell et al. 2012). The pestiviruses also trigger RIG-I and MDA5-mediated signaling 
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pathways, leading to enhanced production of pro-inflammatory cytokines (including IL-1β, IL-6, 
and TNFα) and type I IFN (Smirnova et al. 2012; Dong et al. 2013). Both cytopathic and non-
cytopathic BVDV strains are capable of stimulating type I IFN gene expression in animal and 
cell culture models of infection (Rossi and Kiesel 1980; Smirnova et al. 2008; Palomares et al. 
2013).  
 Several studies have demonstrated that RLR-mediated signaling is essential for an 
effective immune response to flaviviral infection. Mice deficient in MDA5 or RIG-I had decreased 
survival upon WNV infection, and WNV infections in animals lacking both MDA5 and RIG-I or 
the essential downstream signaling molecule IPS-1 were invariably fatal (Errett et al. 2013). 
Furthermore, WNV RNA accumulated to significantly greater levels in mouse embryonic 
fibroblasts lacking both MDA5 and RIG-I in association with dramatic reductions in IFNβ, 
IFNα2a, IL-6, and other RLR-stimulated genes (Errett et al. 2013). However, WNV infection of 
mice lacking the signaling protein IPS-1 displayed enhanced inflammation and early virus entry 
into the CNS (Suthar et al. 2010). Specifically, RLR signaling was shown to be important for 
promoting the survival of CD8+ T cells during WNV infection and facilitating the expansion of 
these cells in the CNS to limit viral spread (Suthar et al. 2012). RLRs are therefore important for 
coordinating adaptive and immune responses in flavivirus infections (Suthar et al. 2010). 
Furthermore, defects in IFN stimulated gene expression in non-cytopathic BVDV infection of 
fetuses can contribute to the establishment of a persistent pestivirus infection (Adler et al. 1997; 
Charleston et al. 2001). Therefore, diverse flaviviruses activate RLR signaling and these 
pathways are likely important for survival, mitigating neuropathology, and eradicating the virus 






Toll-like receptors in flavivirus infections 
 
  Several endosome-associated Toll-like receptors (TLR3, TLR7, and TLR8) also 
recognize foreign RNAs and signal through two proteins, myeloid differentiation 88 (MYD88) 
and TIR domain-containing adaptor inducing IFNβ (TRIF), ultimately leading to NFκB-, IRF3-, or 
interferon regulatory factor 7 (IRF7)-mediated transcription of pro-inflammatory chemokines, 
cytokines, and interferon stimulated genes (Akira et al. 2006; Li et al. 2011(a); Suthar et al. 
2013). DENV has been shown to activate TLR3 following acidification of the endosomal 
compartment and viral uncoating, leading to the induction of IFN and activation of the 
transcription factors NFκB, AP-1, and IRF3 (Lee et al. 2012(a); Green et al. 2014). HCV also 
induces IFN expression through TLR3-mediated sensing of viral dsRNAs (Wang et al. 2009; 
Eksioglu et al. 2011; Li et al. 2012). Stimulation of TLR3 during HCV infection induces activation 
and translocation of both NFκB and IRF3 into the nucleus, leading to the transcription of 
cytokines and chemokines including CCL5, CXCL10, and CCL4 (Li and Lemon 2013). The 
Pestivirus BVDV is similarly known to induce the expression of TLR3 and TLR7 during infection 
of monocytes, regardless of whether the strain used is cytopathic or non-cytopathic (Lee et al. 
2008). TLR3 and/or TLR7 are likely activated in general in various flavivirus infections and 
probably contribute to the up-regulation of pro-inflammatory immune mediators observed in 
these systems. 
 In addition to the RLRs, TLRs are important for stopping the spread of WNV in the 
central nervous system and may be particularly important for mediating antiviral immunity in 
neurons (Szretter et al. 2010). Mice lacking the signaling protein MYD88 succumbed to WNV 
infection more rapidly than wild-type mice and displayed increased WNV titers in the brain 
(Szretter et al. 2010). Importantly, defects in chemokine induction due to MYD88 depletion likely 
contributed to reduced recruitment of leukocytes into the CNS upon WNV infection (Szretter et 
al. 2010). Therefore, TLR-mediated signaling events are likely very important for facilitating anti-
viral leukocyte recruitment into the brain for WNV clearance.  
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 Interestingly, the CCCH-type zinc finger nuclease 12A (ZC3H112A or MCPIP1) is 
induced upon stimulation of Toll-like receptors (TLR) or expression of the pro-inflammatory 
factors chemokine (C-C motif) ligand 2 (MCP-1) or interleukin-1β (Uehata and Akira 2013; Lin et 
al. 2013). Several RNA viruses including DENV, JEV, and Influenza virus are restricted by 
MCPIP1 expression, likely as a result of the decay of viral RNAs and cellular RNAs by MCPIP1 
(Liu et al. 2013(a); Lin et al. 2013). Upon resolution of an infection, MCPIP1 expression may 
mediate the rapid suppression of pro-inflammatory gene expression to reduce tissue damage 
(Matsushita et al. 2009; Uehata et al. 2013). Of interest, MCPIP1 knockout mice were shown to 
have severe immune disease characterized by enlarged spleens and lymph nodes, widespread 
inflammation, and hypergammaglobulinemia (Matsushita et al. 2009). Therefore, MCPIP1 likely 
serves two roles during viral infection by directly degrading both viral and cellular mRNAs. 
 
The OAS/RNase L pathway 
 
 Another important flaviviral dsRNA PRR is 2’,5’ OAS. The association of OAS with 
dsRNAs activates OAS to convert adenosine triphosphate to 2’,5’ oligoadenylate. 2’,5’ 
oligoadenylate then induces the dimerization of ribonuclease L (RNase L) monomers, resulting 
in the formation of a functional endonuclease (Floyd-Smith et al. 1981; Li et al. 2011; Huang et 
al. 2014). Both OAS and RNase L are constitutively expressed in the cytoplasm and nucleus in 
monomeric, inactive forms, although they are also transcriptionally up-regulated by type I 
interferon signaling (Li et al. 2011(a)). Importantly, RNase L cleaves viral and cellular RNAs, 
including ribosomal RNAs, the U6 small nuclear RNA, and diverse mRNAs (Hovanessian et al. 
1979; Cooper et al. 2014). Similarly to MCPIP1, the activation of RNase L is thought to serve as 
a mechanism by which the cell can limit interferon-mediated gene expression to minimize 
inflammation following viral clearance (Bisbal and Silverman 2007). Accordingly, RNase L can 
degrade the transcripts encoding the RNA stability factor tristetraprolin and several interferon 
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stimulated genes (Li et al. 2000; Khabar et al. 2003; Bisbal and Silverman 2007; Al-Haj et al. 
2012). Another important consequence of RNase L activation is the induction of apoptosis, 
which ultimately results in the death of infected cells to limit viral growth (Castelli et al. 1997; 
Zhou et al. 1998; Bisbal and Silverman 2007). Therefore, RNase L activity can suppress viral 
proliferation by actively degrading viral RNAs and also by altering cellular gene expression to 
induce apoptosis and minimize damaging inflammation. 
 RNase L is induced during HCV infection and cleaves the viral open reading frame when 
it encounters UA and UU dinucleotides in single stranded RNA sequences (Han and Barton 
2002; Washenberger et al. 2007). Furthermore, the generation of endonucleolytic cleavage 
products from the HCV RNA can stimulate RLRs to further amplify the innate immune response 
to infection (Malathi et al. 2007; Malathi et al. 2010). The activation of RNase L also plays an 
important role in limiting WNV replication (Scherbik et al. 2006). Furthermore, the murine 
homolog of OAS (Oas1b) is known to be very important for restricting flavivirus infections 
(Brinton and Perelygin 2003; Courtney et al. 2012). RNase L therefore provides an interesting 
example of an induced cellular nuclease that can suppress viral propagation and influence viral 
pathogenicity. 
 
Viral subversion of the type I interferon response 
 Several flaviviral gene products including subgenomic flavivirus RNA have been 
implicated in viral inhibition of type I IFN signaling. Two recent studies evaluated the ability of 
sfRNA in KUNV and JEV infections to counteract the mammalian type I interferon response. It 
was initially demonstrated that KUNV mutants deficient in sfRNA formation grew to lower titers 
in certain cell lines, including the non-human primate Vero cell line and mosquito C6/36 cells 
(Pijlman et al. 2008). However, growth of an sfRNA-deficient KUNV mutant could be partially 
rescued in mice lacking the type I interferon α/β receptor (IFNAR) and in cell culture when viral 
growth in wild-type mouse embryonic fibroblasts (MEFs) were compared with that in IRF3-/- 
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IRF7-/- MEFs (Schuessler et al. 2012). Furthermore, survival dramatically decreased when mice 
that lacked IRF3, IRF7, or IFNAR were infected with the sfRNA-deficient KUNV, although on 
average the mice died later than mice infected with wild-type virus (Schuessler et al. 2012). 
Pathogenicity due to sfRNA deficient KUNV was therefore partially restored when the type I 
interferon pathway was abrogated, although the mechanism by which this occurs is unknown. 
Recently, JEV sfRNA was shown to play a role in blocking IRF3 phosphorylation and 
subsequent nuclear translocation of this important innate immune transcription factor, although 
the mechanism by which this occurs is also not yet known (Chang et al. 2013). Therefore, 
sfRNA formation directly or indirectly promotes viral evasion of the type I interferon pathway in 
mammalian cells. 
Many viruses have evolved unique mechanisms for suppressing RNase L activation 
directly (reviewed in Bisbal and Silverman 2007; Zhang et al. 2013). Of particular relevance to 
this discussion however is the ability of several viral RNAs to inhibit RNase L direction. A 
conserved element in the group C enterovirus (e.g. poliovirus) RNA inhibits the endonuclease 
activity of RNase L by acting as a competitive inhibitor (Han et al. 2007; Townsend et al. 2008). 
The abundant WNV sfRNA could potentially inhibit RNase L in a similar fashion, as sfRNA-
deficient KUNV growth was partially rescued in cells that lacked RNase L (Schuessler et al. 
2012). However, the exact mechanism by which sfRNA aids in viral evasion of RNase L-
mediated viral restriction remains to be determined.  
 Flaviviral proteins are also implicated in the evasion of type I interferon responses. The 
WNV, YFV, and DENV nonstructural protein 4B was shown to block IFN signaling in one study 
(Munoz-Jordan et al. 2005). Similarly, the NS5 protein of DENV was shown to induce the 
proteolytic degradation of STAT2, leading to decreased activity of the TLR-mediated innate 
immune pathway (Ashour et al. 2009; Morrison et al. 2013). The HCV NS5A has also been 
implicated in the suppression of type I IFN signaling, potentially by blocking STAT1 
phosphorylation, to ultimately suppress the formation of the STAT1-STAT2 heterodimer in the 
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TLR3 pathway (Kumthip et al. 2012). Furthermore, a recent study also demonstrated that HCV 
may impede TLR-mediated signaling by inducing the expression of a host microRNA, miR-21, 
that targets the mRNA of MYD88 (Chen et al. 2013(a)). Pestiviruses appear to take a more 
active approach in shutting down host innate immune responses. The pestivirus N(pro) protease 
has been shown to trigger the degradation of the signaling molecule IRF3 by the cellular 
proteasome during CSFV and BVDV infections (Ruggli et al. 2003; Gil et al. 2006; Chen et al. 
2007; Seago et al. 2007; Bauhofer et al. 2007; Gottipati et al. 2013). Pestiviruses may also limit 
the abundance of immunogenic dsRNAs generated during viral infection by expressing a 
ribonuclease, E(rns). The E(rns) protein has ribonuclease activity and is thought to mediate 
degradation of intracellular and extracellular dsRNAs generated by BVDV during replication 
before they can stimulate cellular PRRs to induce a type I interferon response (Meyers et al. 
2007; Magkouras et al. 2008; Matzener et al. 2009). Therefore, members of the Flavivirus and 
Hepacivirus genera likely impede host innate immune responses by targeting essential 
components of the cytoplasmic signaling pathways that ultimately trigger transcriptional up-
regulation of chemokines and other antiviral immune factors. Because innate immune pathways 
have been shown to be important clearance of flavivirus infections and can also contribute to 
immunopathology, the ability of diverse flaviviruses to modulate type I IFN responses in the host 
can likely dramatically alter the pathogenesis of an infection. 
 
On the role of inflammation in flavivirus-mediated pathology 
 
 Although the previous section discussed how innate immunity is important for protecting 
the host from pathology due to flavivirus infections, excessive inflammation can cause 
pathogenesis in and of itself. Furthermore, because flaviviruses have evolved mechanisms to 
escape some innate immune responses, the host innate immune response to infection may fail 
to clear the virus but still cause damage to the surrounding tissue (i.e. bystander damage). This 
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section discusses some of the ways that excessive inflammatory responses are known to 
contribute to flavivirus-induced pathology. 
 Flaviviruses can cause a range of clinical outcomes, the most serious of which are 
encephalitis (e.g. JEV or WNV) or hemorrhagic fever (e.g. DENV or YFV).  Interestingly, 
Flavivirus infections that generally lead to hemorrhagic fever in humans oftentimes cause 
encephalitis in mouse models of infection (Burke and Monath 2001). Furthermore, studies have 
revealed that in some instances up to 21% of patients with Dengue fever also display 
neurological abnormalities (Domingues et al. 2008; Carod-Artal et al. 2013). It is therefore 
possible that there are common molecular mechanisms that lead to either hemorrhagic fever or 
encephalitis (or both). A further discussion on the pathogenesis of Flavivirus infections follows 
below with emphasis on the neuropathogenesis of WNV as a representative Flavivirus. 
 Over-zealous immune responses are considered to be a major contributor to DENV-
induced hemorrhagic fever/shock syndrome (Costa et al. 2013, Rothman 2011; Basu and 
Chaturvedi 2008). Furthermore, the encephalitic flaviviruses JEV and WNV are thought to cause 
neuropathology by two mechanisms: indirect immune-mediated processes or direct virus-
mediated cell death (Ghoshal et al. 2007; Rossini et al. 2013). Inflammation is thought to 
contribute to WNV-mediated neurologic disease by contributing to the break-down of the blood 
brain barrier (Wang et al. 2004). Stimulation of TLR3 during WNV infection was shown to induce 
TNF–α production by infected monocytes, leading to increased entry of WNV and immune cells 
into the CNS of mice (Wang et al. 2004). TLR3 depletion lead to less neuropathology, 
inflammation, and viral proliferation and this was correlated with decreased production of the 
pro-inflammatory factors TNF-α, IL-6, IFN-α, and IL-12 (Wang et al. 2004). Importantly 
enhanced permeability of the blood brain barrier is a precursor of WNV neuroinvasive disease 
(Sips et al. 2012; Suthar et al. 2013; Wang et al. 2004). Neuropathogenesis of the related 
Japanese Encephalitis virus is also enhanced by aberrant expression of pro-inflammatory 
factors in neural tissues, ultimately leading to immune-mediated cell death in the central 
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nervous system (Bhattacharyya et al. 2014; Ghoshal et al. 2007; Swarup et al. 2007). Because 
immunopathology/excessive inflammatory responses are known to play major roles in disease 
due to various flavivirus infections, it is possible that a common viral factor contributes to this 
effect in the host by modulating fundamental gene regulatory mechanisms. 
 In contrast to the neuropathology and/or hemorrhagic syndromes caused by many 
Flaviviruses, Hepatitis C virus causes a very different spectrum of disease, oftentimes due to 
persistent infections that can last decades. One of the most serious outcomes of HCV infections 
is hepatocellular carcinoma (HCC). The underlying molecular mechanisms by which HCV 
causes HCC remain unknown, and whether or not the virus directly (or indirectly) causes HCC 
has yet to be elucidated (Lemon and McGivern, 2012). However, the onset of cancer in HCV 
infected patients takes place on average 29 years after infection, and therefore subtle changes 
in cell homeostasis and gene expression that occur over time as a consequence of infection are 
thought to contribute to hepatocellular transformation (Kiyosawa 1998). The HCV core protein or 
non-structural protein 3 have been implicated in HCV-induced carcinogenesis and are known to 
alter host gene expression in several models of infection, but the exact cause of HCV induced 
HCC remains unknown (Marusawa 1999; Moriya 1998; Banerjee et al. 2010; Ray et al. 1997; 
Ray et al. 1998; Bergqvist and Rice 2001; Sakamuro 1995; Thoren et al. 2004). However, pro-
inflammatory factors are up-regulated in human patients and cell culture models of HCV 
infection (Nishitsuji et al. 2013), and there is evidence that excessive production of pro-
inflammatory factors during HCV infections can contribute to HCC in human patients (Matsuzaki 
et al. 2007). Furthermore, it is thought that bystander tissue damage due to chronic 
inflammation in the infected liver is an important contributing factor to the onset of HCC (Flecken 
et al. 2012; Brownell and Polyak 2013).  
 Another mechanism by which HCV-induced carcinogenesis may occur is by 
dysregulation of oncogenes and angiogenic factors in infected cells, some of which are also 
induced during the process of inflammation and/or act as transcription factors for pro-
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inflammatory gene expression. For example, the AP-1 transcription factor complex is comprised 
of c-FOS and JUN family members, and is known to play important roles in transcription of pro-
inflammatory cytokines, cell proliferation, bone development, and oncogenesis (reviewed in 
Zenz et al. 2008; Lee et al. 2012(a); Green 2014). Intriguingly, HCV has been shown to benefit 
from increased abundance of c-FOS (Kang et al. 2011(a)) and c-JUN overexpression can 
contribute to hepatocellular carcinogenesis (Machida et al. 2010). The oncogene c-myc is also 
upregulated in HCV patients that have HCC and this protein has been shown to alter cell cycle 
progression (Higgs et al. 2013). Furthermore, inflammation has long been accepted to 
contribute to the progression of cancer (Coussens et al. 2002; Romagnani et al. 2004; Benelli et 
al. 2006; Porta et al. 2009). Importantly, several angiogenic factors known to be involved in both 
cancer progression and inflammation (Romagnani et al. 2004; Goel and Mercurio 2013) are 
implicated in HCV-induced HCC. Anti-angiogenic therapies have recently extensively 
investigated as systemic treatments for HCC although it is interesting to note that hypoxia 
caused by these agents may lead to metastases (Coulon et al. 2010; Ebos et al. 2009). 
Secretion of vascular endothelial growth factor A (VEGFA) can induce angiogenesis by 
activation of endothelial cells and stimulate the production of hepatic growth factor, which in turn 
causes hepatocyte proliferation (Chiang et al. 2008; Shimizu et al. 2001; LeCouter et al. 2003; 
Hao et al. 2006). Hypoxia inducible growth factor 1α (HIF1A) has been shown to both enhance 
HCV propagation and stimulate migration and altered polarity of hepatic cells in a cell culture 
model of metastasis (Wilson et al. 2012; Mee et al. 2010). Furthermore, HIF1A induces NFκB 
expression, which in turn promotes CXCL2 expression (Scortegagna et al. 2008). The 
chemokine CXCL2 (also known as the Gro2 oncogene or macrophage inflammatory protein-2) 
has been implicated in a variety of cancers (Doll et al. 2010; Kavandi et al. 2012; Dong et al. 
2011; Oue et al. 2012), hepatic and extrahepatic tumor metastasis (Kollmar et al. 2008; Kollmar 
et al. 2006), liver inflammation (Krohn et al. 2009) and has been shown to be upregulated in a 
Tupaia belangeri chinensis hepatocyte culture model of HCV infection (Guitart et al. 2005). 
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Therefore, the pro-inflammatory response to HCV infection could potentially contribute to the 
onset of hepatocellular carcinoma. 
 Intriguingly, pestiviruses can cause persistent infections in their hosts through a unique 
mechanism that allows the virus to evade adaptive immune responses by infecting their hosts in 
utero early in the gestation period (Peterhans and Schweizer 2010; Hansen et al. 2010). 
Infected calves can shed BVDV in all excretions/secretions and cytopathic BVDV can cause 
mild or lethal mucosal disease (the appearance of ulcers in the gastrointestinal tract) in cattle 
with acute, transient, or persistent infections (Tautz et al. 1998; Fulton et al. 2005). Three 
important potential outcomes of BVDV infections in cattle are (1) defects in fertility, (2) 
conception or development of fetuses of infected pregnant heifers, and (3) mucosal disease. 
Cattle infected with BVDV have decreased conception rates and infection can result in abortion 
and a variety of congenital defects (Collins et al. 2009). Calves persistently infected with BVDV 
can develop a lethal mucosal disease, defined as bloody diarrhea and ulcerations in the mucosa 
including the mouth and intestines (particularly in Peyer’s patches; Peterhans et al. 2010; 
Brownlie et al. 1984). Pregnant heifers that are persistently infected by non-cytopathic BVDV 
can pass the virus on to the fetus early in the gestational period, leading to a persistent infection 
in the calf (Hansen et al. 2010). Intriguingly, BVDV infection in utero results in the breakdown of 
self: non-self-recognition leading to immune tolerance; this ultimately inhibits the calf from 
clearing the virus (Hansen et al. 2010). Furthermore, when a pregnant heifer passes BVDV on 
to the fetus later in the gestation period, defects in fetal growth including bone and nervous 
system abnormalities or abortion can result (Hansen et al. 2010). Importantly, these persistently 
infected calves continue to shed infectious virus throughout their lives, and can die upon super-
infection with a cytopathic BVDV (or if the non-cytopathic BVDV mutates into a cytopathic form; 
Peterhans et al. 2010). In contrast, cytopathic BVDV infections are usually cleared by the host 
through innate and adaptive immune responses that can protect the animal from future 
infections (Brackenbury et al. 2003; Ridpath 2013).  
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 Dysregulation of immune responses or inflammation could contribute to the 
pathogenesis of BVDV. First, there is evidence that cattle infected with BVDV display an anti-
viral immune response. Heifers acutely infected with BVDV show a large increase in the 
abundance of interferon stimulated gene 15 kD (ISG15) which is considered a marker of a 
robust type I interferon-mediated innate immune response (Hansen et al. 2010). A later study 
demonstrated that upon infection with a non-cytopathic strain of BVDV, peripheral blood 
monocytes induce the expression of the chemokines CXCL4 and CXCL12, and several 
interferon stimulated genes (Weiner et al. 2012). Importantly, fetuses and steers with persistent 
BVDV infections also have increased expression of innate immune factors and over-exposure to 
type I interferon may contribute to intrauterine growth restriction in fetuses persistently infected 
with BVDV (Hansen et al. 2010). Furthermore, the trafficking of BVDV into the central nervous 
system of the fetuses of infected cattle was shown to coincide with vasculopathy including 
hypertrophy of endothelial cells and perivascular edema associated with microglial cells that 
stained positive for BVDV antigen in the surrounding tissues. One type I interferon stimulated 
gene, ISG15, was shown to be elevated at the protein and mRNA levels in the brains of infected 
fetuses early in BVDV infection, especially in the vascular endothelial cells of the 
microvasculature of the developing brain (Bielefeldt-Ohmann et al. 2012). The authors 
speculate that type I interferon responses early during infection may enhance virus spread to 
the central nervous system by the extravasation of microglial precursor cells carrying BVDV 
(Bielefeldt-Ohmann et al. 2012). Lesions consistent with destruction of microvasculature due to 
excessive type I interferon-induced gene expression were also observed. Therefore, the ability 
of Pestiviruses to stimulate type I interferon responses through the activation of cellular PRRs 
can potentially contribute to both viral persistence and trafficking to the central nervous system. 
Importantly, cattle that are persistently infected with BVDV show defects in growth and 
development including decreased calve weight at cesarean section and malformation of the 
long bones (Hansen et al. 2010). The exact molecular mechanisms by which these defects in 
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growth and development occur remain unknown, but dysregulated immune responses likely 
contribute to disease symptoms observed in BVDV infected cattle. 
 
A role for aberrant post-transcriptional gene regulation in flavivirus-induced pathology 
 
 From the moment a virus deposits its RNA genome into the cytoplasm of an infected 
cell, the virus must evade or suppress constitutively expressed nucleases that normally degrade 
cellular RNAs to preserve their transcripts and ensure viral gene expression. Therefore, the 
general cellular RNA decay machinery may act in part as an intrinsic anti-viral mechanism, as 
viral RNAs may be rapidly destroyed early in an infection if they do not contain the proper 
stability elements (reviewed in Moon and Wilusz 2013). Understanding how host mRNAs are 
normally turned over in the cytoplasm provides us with a starting framework for how viral RNAs 
may be degraded in the cell. Furthermore, changes in post-transcriptional gene regulatory 
mechanisms due to viral infection could dramatically alter the way the host cell responds to the 
virus. 
 As discussed above, pathology induced by flavivirus infections can oftentimes be directly 
associated with uncontrolled inflammation leading to tissue damage (Ghoshal et al. 2007; 
Rossini et al. 2013), oncogenesis in HCV infections (Iliopoulos et al. 2009; Stauffer et al. 2012), 
and developmental defects in BVDV infections (Bielefeldt-Ohmann et al. 2012). Although 
transcriptional responses are clearly important for inducing a pro-inflammatory response in the 
host when viral PAMPs are detected by PRRs, the post-transcriptional regulation of cytokines, 
chemokines, and other pro-inflammatory factors is also likely very important for modulating this 
response. Many studies on the post-transcriptional regulation of mRNAs containing AU-rich 
elements (AREs) in their 3’ UTRs demonstrate how defects in this important regulatory 
mechanism can lead to pathology. Importantly, many immune factors contain AREs in their 
mRNAs (Caput et al. 1986), and AREs were shown to function as cis-acting destabilizing factors 
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(Shaw and Kamen 1986). Importantly, a later study demonstrated that hundreds of short-lived 
ARE-containing transcripts are induced upon activation of human T cells, and changes in mRNA 
decay rates were thought to therefore be an important mechanism by which T cells respond to a 
given stimulus and become activated (Raghavan et al. 2002). Interestingly, mice lacking 
tristetraprolin (TTP), an RNA binding protein that destabilizes ARE-containing transcripts, 
develop an inflammatory autoimmune syndrome (Taylor et al. 1996). Tristetraprolin was later 
shown to target the ARE-containing mRNA of TNF-α and other pro-inflammatory cytokines 
induced by TLR stimulation for decay, allowing the cell to rapidly modulate the abundance of 
this potent pro-inflammatory factor through post-transcriptional mechanisms (Carballo et al. 
1998; Lai et al. 1999; Carballo et al. 2000; Kang et al. 2011(b); Van Tubergen et al. 2011; Molle 
et al. 2013). These studies demonstrate the importance of adequate post-transcriptional 
regulatory mechanisms to ensure that inflammatory factors can be quickly induced and then 
degraded to perform an effector function without damaging the surrounding tissue. 
 Importantly, some viral infections have been demonstrated to dramatically alter the post-
transcriptional regulation of certain pro-inflammatory immune factors. The rate of degradation of 
TNFα mRNA in human monocytes infected with Measles virus was shown to increase 
substantially in one study, leading to a decrease in the overall abundance of TNF-α mRNA and 
likely dysregulating the normal response to infection (Leopardi et al. 1992). In contrast, the 
stability of the transcript encoding chemokine CXCL8 was shown to be substantially increased 
in several cell lines harboring HCV replicons (Green et al. 2006). Finally, many viruses interact 
directly with the cellular mRNA decay machinery and therefore likely alter the post-
transcriptional regulation of cellular transcripts. Considering the importance of post-
transcriptional regulatory mechanisms in modulating the host immune response to infection, The 
following section aims to describe the major mechanisms by which mRNAs are degraded in the 
cell to provide a framework for how viral manipulation of cellular post-transcriptional regulatory 
mechanisms could contribute to pathology. 
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Section II: Viral interactions with the general mRNA decay machinery 
 
 General mRNA decay mechanisms in the cell serve two important functions. They serve 
as a quality control mechanism to ensure that aberrant transcripts are quickly removed from the 
translatable pool of mRNAs, and they permit the normal turnover of transcripts. Because viral 
RNAs must enter the cytoplasm to undergo translation, they are also likely to encounter cellular 
nucleases that normally degrade cellular mRNAs. Additionally, cellular RNA decay factors may 
recognize viral RNAs as foreign, as they often lack a nuclear experience (and therefore are not 
complexed with ribonucleoproteins that normally associate with cellular mRNAs) and can also 
lack 5’ methylated caps and/or poly(A) tails (e.g. hepacivirus RNAs). Furthermore, mRNA decay 
pathways are likely integral to the rapid host response to viral infection, as transcripts of many 
immune factors are heavily regulated at the post-transcriptional level. The rate at which a 
transcript is degraded can dramatically influence gene expression. Indeed, changes in mRNA 
decay rates can account for up to 50% of all changes in mRNA abundances (Cheadle et al. 
2005(a)). By regulating the stability of a transcript in addition to the rate at which the transcript is 
generated, the cell can fine-tune gene expression and rapidly alter the transcriptome in 
response to any given stimulus. Otherwise, the cellular response to a stimulus would likely be 
much slower, as mRNA synthesis, processing (e.g. splicing), and transport of the mRNA from 
the cytoplasm into the nucleus would have to take place before any changes in gene expression 
could occur. Intriguingly, several recent studies propose that cytoplasmic mRNA decay is 
coordinated with mRNA synthesis, and this will be discussed further below. Therefore, viral 
RNAs may interact with the RNA decay machinery in such a way as to protect their transcripts 
from decay or to alter the cellular response to infection. The following section will outline the 
major mechanisms by which cellular mRNAs are degraded to provide context for a discussion 





 The initial step in the degradation of most mRNAs is deadenylation, the removal of the 
poly(A) tail (Figure 4). Deadenylation is thought to be the rate-limiting step in the degradation of 
many transcripts in yeast and mammalian cells, and the poly(A) tail is an important stabilizing  
element for mRNAs (Wilson and Treisman 1988; Muhlrad and Parker 1992; Shyu et al. 1991).  
 
 
Figure 4. Deadenylation-dependent exonucleolytic decay pathways in the 
cytoplasm of mammalian cells. Transcripts are first deadenylated by members of the 
CCR4-NOT complex, the PAN2-PAN3 complex, or PARN. Following removal of the 
poly(A) tail, the transcript may undergo 3’-5’ decay by the exosome complex (bottom) or it 
may be decapped by DCP1 and DCP2 and degraded in the 5’-3’ direction by XRN1 (top).  
 
The ~150-200 nt poly(A) tail of mammalian mRNAs (Brawerman 1974; Brawerman et al. 1972; 
Nakazato et al. 1973) is removed by deadenylases, proteins that shuttle between nucleus and 
cytoplasm (Yan 2014; Yamashita et al. 2005). In mammalian cells, the major deadenylases 
include homologs of the yeast proteins PAN2, CCR4, CAF1, Nocturnin and the poly(A)-specific 
ribonuclease (PARN) which has no known yeast homolog (Yan 2014; Yamashita et al. 2005). 
Each of these deadenylases forms a complex or homodimer to be functional. The catalytic 
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activity of the PAN2 deadenylase requires a protein co-factor, PAN3 (Brown et al. 1996). PAN3 
recruits PAN2 to the target mRNA by interacting with the poly(A) binding protein PABP (Mangus 
et al. 2004; Siddiqui et al. 2007; Uchida et al. 2004). In mammalian cells, the CCR4-NOT protein 
family is made up of CAF1, Nocturnin, and CCR4 homologs. Interestingly, CAF1 proteins are 
the major deadenylases in human cells, as knockdown of the two human isoforms of CAF1 
resulted in increased poly(A) tail length and delayed deadenylation of cellular transcripts 
(Schwede et al. 2008). Furthermore, depletion of CAF1 proteins was shown to result in 
differential abundance of more transcripts than depletion of CCR4 proteins in human cells 
(Mittal et al. 2011). This study revealed that CCR4 proteins may degrade a set of transcripts that 
is distinct from that targeted by CAF1 proteins (Mittal et al. 2011). Similarly, PARN was recently 
shown to regulate the stability and abundance of a discrete set of mRNAs in mouse myoblasts 
that encode proteins known to be important for mediating cell migration (Lee et al. 2012(b)). 
Instead of forming a heterogeneous multi-protein complex, PARN must form a homodimer to 
bind to target mRNAs and exhibit catalytic activity (Yan 2014; Yamashita et al. 2005; Wu et al. 
2005). Interestingly, it is possible that several deadenylase complexes work in concert to 
degrade target transcripts. One study indicated that in mammalian cells, transcripts could be 
deadenylated through a biphasic process in which the PAN2-PAN3 complex slowly degrades 
the poly(A) tail until ~100 nt remain, followed by a more rapid removal of the rest of the poly(A) 
tail by the CCR4-NOT complex (Yamashita et al. 2005). Regardless of which deadenylase 
specifically acts on the transcript, the end result is a truncated RNA that contains a short 
oligo(A) tract at the 3’ end (Chowdhury et al. 2007). 
 Upon removal of the poly(A) tail, the majority of mRNAs undergo decapping and 5’-3’ 
decay in eukaryotes (Decker and Parker 1993; Muhlrad et al. 1994; Beelman et al. 1996; 
Anderson and Parker 1998). This occurs when the short oligoadenylate tract (< 20 nt) remaining 
at the 3’ end of the deadenylated transcript is bound by the LSm1-7 complex (Chowdhury et al. 
2007).  The LSm1-7 complex is comprised of seven Sm-like proteins and was shown to interact 
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with the PAT1 homolog PAT1b to promote mRNA decay in yeast (Totaro et al. 2011; Bouveret 
et al. 2000; Chowdhury et al. 2007; Wu et al. 2014). Mutations or deletion of members of the 
LSm1-7-PAT1 complex causes increased mRNA stability and the accumulation of capped and 
oligoadenylated mRNAs in yeast (Tharun et al. 2000). Furthermore, LSm1 protein was shown to 
be essential for the degradation of a reporter RNA containing an AU-rich element in mammalian 
cells (Stoecklin et al. 2006). Therefore, the LSm1-7 complex normally recruits the mRNA 
decapping factors DCP1-DCP2 to promote 5’-3’ decay of mRNAs. 
  Once a transcript is targeted for 5’-3 decay by interacting with the LSm1-7 complex, it 
undergoes decapping, or the removal of the 7-methylguanosine cap at the 5’ end of the mRNA. 
Decapping factors also form a complex in yeast and mammalian cells to facilitate efficient and 
specific hydrolysis of the 5’ methylated caps from transcripts. The decapping factors DCP1 and 
DCP2 were first shown to be required for efficient mRNA decapping in yeast (Beelman et al. 
1996; Dunckley and Parker 1999). Later, EDC1 and EDC2, two additional protein factors 
required for decapping, were identified in yeast (Dunckley et al. 2001). These EDC proteins 
were shown to have the ability to bind RNA, but not decap it directly (Schwartz et al. 2003). It 
was later determined that DCP2 was the major decapping activity in yeast, and its activity was 
enhanced by interactions with DCP1, EDC1, and EDC2 (Steiger et al. 2003). In yeast, DCP1 
and DCP2 directly interact, likely stabilizing the conformation of the DCP2 protein to facilitate 
the decapping reaction (She et al. 2008). Importantly, Wang et al. (2002) demonstrated that the 
yeast homolog of DCP2 was a functional decapping enzyme in mammalian cells. Furthermore, 
in mammalian cells it appears that rather than directly interacting with one another, DCP1 and 
DCP2 are bridged by the EDC4 protein (Fenger-Gron et al. 2005). Structural analyses revealed 
that EDC4 indeed functions as a scaffold for the decapping complex in Drosophila and 
mammalian cells (Braun et al. 2012; Chang et al. 2014). Interestingly, recent studies indicate 
that additional decapping enzymes (NUDT proteins) exist in mammalian cells (Song et al. 2010; 
Song et al. 2013). The decapping factor NUDT16 appears to share some mRNA targets with 
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DCP2 and have some target specificity (Song et al. 2010; Li et al. 2011(b)), but the exact 
specificities and contributions of DCP2 and NUDT16 to overall mRNA decay in mammalian cells 
remains to be fully characterized. 
 Hydrolysis of the 5’ methylguanosine cap from the deadenylated transcript exposes the 
RNA to rapid degradation by the major cytoplasmic exonuclease 1 (XRN1). The highly 
processive exoribonuclease 1 was first described as an important 5’-3’ mRNA decay factor in 
yeast, as cells lacking XRN1 displayed increased levels of uncapped and deadenylated mRNAs 
(Hsu and Stevens 1993; Stevens 1980). The cytoplasmic XRN1 protein is highly similar to the 
major nuclear 5’-3’ exoribonuclease 2 (XRN2). The N-terminal regions of XRN1 and XRN2 
contain a highly conserved nuclease domain (an alignment of the amino acid sequences of 
XRN1 homologs is presented in Appendix 2). XRN1 contains five additional conserved regions 
adjacent to the the nuclease domain: a PAZ/Tudor domain, a KOW domain, a winged helix 
domain, and an SH3-like domain (Jinek et al. 2011). The PAZ/Tudor domain and the SH3 
domain are thought to stabilize the conformation of XRN1 to allow nuclease activity (Jinek et al. 
2011; Nagarajan et al. 2013). The winged-helix domain is thought to have several functions. It 
exists in close proximity to the nuclease domain and was postulated to shield the entry site 
during nucleolytic decay, it may mediate protein-protein interactions, and it also contains a 
positively charged region that likely interacts with RNA strands to further stabilize the RNA-
protein complex (Jinek et al. 2011). In contrast, the amino acid sequence of the C-terminal 
region of XRN1 is not well conserved and is also quite unstructured (Jones et al. 2012; 
Nagarajan et al. 2013). However, the C-terminus of Drosophila and human XRN1 harbors a 
proline-rich region that mediates the interaction between XRN1 and decapping factors (Braun et 
al. 2012; Chang et al. 2014). Interestingly, the nuclear XRN2 protein does not contain these 
conserved protein domains, and instead associates with protein partners that stabilize the 
nuclease domain (Stevens and Poole 1995; Xue et al. 2000; Nagarajan et al. 2013; Xiang et al. 
2009; Miki et al. 2014). In this manner, the activity of the yeast XRN2 homolog Rat1 is activated 
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by the Rai1 protein (Xiang et al. 2009). A recent study identified a unique XRN2-binding domain 
in the PAXT-1 protein in Caenorhabditis elegans that is also present in the human CDKN2AIP 
(cyclin-dependent kinase inhibitor 2 A interacting protein) and NKRF (NF kappa B repressing 
factor) (Miki et al. 2014). 
 Recently, the crystal structure of the N-terminus of Drosophila XRN1 (pacman) in 
complex with an RNA substrate was solved (Jinek et al. 2011). This structure revealed that 
XRN1 likely sterically blocks the insertion of RNAs with 5’ methylguanosine caps or 
triphosphorylated ends in favor of smaller 5’ monophosphorylated RNAs to permit specific 
decay of uncapped transcripts (Jinek et al. 2011). The nuclear XRN2 protein likely has similar 
specificity to monophosphorylated transcripts, as the nuclease domain is very similar to that of 
XRN1 (Nagarajan et al. 2013). In cell-free assays, yeast XRN1 has been shown to stall on 
stable stem-loop structures and poly(G) tracts. However, yeast XRN1 can degrade highly 
structured ribosomal RNAs (rRNAs); indeed it is routinely used to deplete rRNAs from total RNA 
pools to purify mRNAs. Furthermore, Drosophila XRN1 can effectively degrade RNA duplexes 
in vitro if there is a >5 nt single stranded region at the 5’ end to allow the RNA to enter the active 
site (Jinek et al. 2011). Therefore, viral RNAs that resist XRN1-mediated decay (e.g. the 3’ 
UTRs of flavivirus RNAs) likely contain unique structural or sequence elements that have not 
been previously characterized. 
 Both XRN1 and XRN2 serve important roles in degrading mRNAs (or pre-mRNAs in the 
nucleus in the case of XRN2) and non-coding RNAs that have a 5’ monophosphate as a result 
of decapping or endonucleolytic cleavage (Hsu and Stevens 1993; Muhlrad et al. 1994; Lejeune 
et al. 2003). Furthermore, XRN2 trims the 5’ ends of ribosomal RNA precursors during rRNA 
maturation (Stevens et al. 1991; Henry et al. 1994; Geerlings et al. 2000). Although XRN1 is 
primarily localized to the cytoplasm, recent evidence indicates that it can translocate to the 
nucleus to influence transcription in yeast (Sun et al. 2013(b); Haimovich et al. 2013), and this 
will be discussed in more detail below. The yeast XRN2 homolog serves an important function 
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in mediating transcription termination, and was recently shown to influence the phosphorylation 
state of the C-terminal domain of RNA polymerase II (Kim et al. 2004; Jimeno-Gonzalez et al. 
2014). Therefore, these 5’-3’ exoribonucleases are important for regulating gene expression by 
mediating transcription and post-transcriptional processes. 
 Intriguingly, XRN-deficient organisms exhibit defects in several important biological 
processes (reviewed in Nagarajan et al. 2013 and Jones et al. 2012). Yeast deficient in a 
functional XRN1 enzyme exhibit defects in cell growth, proliferation, and sporulation (Larimer 
and Stevens 1990; Tishkoff et al. 1991; Kim and Kim 2002). More complex organisms (including 
fruit flies) show developmental defects and reduced fertility in the absence of a functional XRN1 
protein (Newbury and Woollard 2004; Grima et al. 2008; Lin et al. 2008; Zabolotskaya et al. 
2008). Defects in XRN2 activity have been shown to reduce cell survival and sporulation in 
yeast and reduce fertility and survival in plants (Amberg et al. 1992; Kenna et al. 1993; Gy et al. 
2007). Therefore, the 5’-3’ exoribonucleases are important for many essential aspects of 
organismic growth and development.   
 How are the seemingly distinct processes of deadenylation, decapping, and 5’-3’ decay 
coordinated? Intriguingly, many of these mRNA decay factors contain disordered domains that 
likely facilitate the assembly of these large multi-protein complexes (Jonas and Izaurralde 
2013).The LSm1-7 complex physically interacts with the decapping complex component DCP1 
in yeast (Tharun et al. 2000) and was later shown to co-localize with decapping factors DCP1, 
DCP2, and the 5’-3’ exoribonuclease XRN1 in discrete cytoplasmic foci in mammalian cells 
(Ingelfinger et al. 2002). Importantly, XRN1 has been shown to interact with EDC4 in 
mammalian and Drosophila cells, coordinating decapping and 5’-3’ decay (Braun et al. 2012; 
Chang et al. 2014). Furthermore, another scaffolding protein, PAT1b, was shown to physically 
associate with the CCR4-NOT deadenylation complex, the DCP1-DCP2 decapping factors, and 
LSm1 protein in human cells (Ozgur et al. 2010). A recent study also demonstrated that XRN1 
activity can be modulated by the decapping scavenger DCS1 in yeast (Sinturel et al. 2012; 
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described below), indicating that coordination between 3’-5’ and 5’-3’ decay may allow fine-
tuning of mRNA decay and cellular gene expression. Therefore, physical interactions between 
distinct RNA decay factors mediated by scaffolding proteins likely facilitate the coordination of 
these unique events. 
 Alternatively, the deadenylated transcript may undergo 3’-5’ decay by the cytoplasmic 
exosome complex comprised of 10 subunits (Januszyk and Lima 2014) or the newly described 
Dis3L2 (Malecki et al. 2013; Lubas et al. 2013). The Dis3L2 exonuclease appears to specifically 
degrade deadenylated RNAs or pre-miRNAs that were oligouridylated by TUTases (Malecki et 
al. 2013; Lubas et al. 2013). In contrast, the interaction of various co-factors in yeast with the 
exosome has been demonstrated to impact the RNA substrates degraded by the exosome 
(Januszyk and Lima 2014). Following 3’-5’ decay of deadenylated transcripts, the scavenger 
decapping enzyme DCPS then hydrolyses the m7GpppG 5’ cap. Interestingly, DCPS (also 
known as DCS1) has been shown to physically associate with members of the exosome 
complex in mammalian cells, and it can mediate decapping of RNAs less than 10 nucleotides in 
length, although it is more efficient at hydrolyzing free cap moieties (Wang and Kiledjian 2001; 
Liu et al. 2002).  
 Although deadenylation-mediated decay is an important mechanism by which many 
cellular mRNAs are degraded in the cell, some mRNAs are degraded via endonucleolytic decay 
pathways. Three such pathways that serve quality control functions in the cell will be discussed 
below. Furthermore, small RNAs also mediate degradation of some transcripts, and these 
pathways serve important functions in regulating both normal gene expression and serving as 
an important anti-viral immune mechanism. Importantly, factors that participate in 
deadenylation-mediated decay pathways are also essential for endonucleolytic and small RNA-




Quality control mRNA decay pathways 
 
 Several deadenylation-independent quality control pathways exist that begin with the 
endonucleolytic cleavage of aberrant transcripts and end with exonucleolytic decay of the 3’ and 
5’ mRNA fragments by XRN1 or the exosome. Nonsense-mediated decay (NMD), no-go decay, 
and non-stop decay are three such quality control pathways that are particularly relevant in the 
context of viral infection. Transcripts that contain multiple termination codons and long 3’ 
untranslated regions are targets for NMD, and a major trigger for NMD is the absence of the 
exon junction complex on unspliced RNAs. Importantly, viral RNAs often have one or more of 
these characteristics.  
 Cellular RNAs can be targeted for NMD due to mistakes made during pre-mRNA 
splicing, transposon-containing RNAs, and transcripts that contain mutations from inaccurate 
transcription are all subject to NMD (Maquat and Gong 2009). When a transcript is targeted for 
NMD, UPF1 assembles with other translation factors and upon ribosome stalling upstream of 
the premature termination codon, UPF1 is phosphorylated and recruits SMG6, SMG5, and 
SMG7 (Maquat and Gong, 2009; Eberle et al. 2009; Loh et al. 2013). UPF1 causes translational 
repression and eventual decay of the target transcript through SMG6-dependent 
endonucleolytic cleavage and/or by SMG5- SMG7-mediated recruitment of exonucleolytic decay 
factors (e.g. XRN1) and/or deadenylases (Yamashita et al. 2005; Eberle et al. 2009; Franks et 
al. 2010; Loh et al. 2013). 
  Transcripts that do not contain termination codons (e.g. due to premature 
polyadenylation or mutation) undergo non-stop decay. This process is triggered when the 
translating ribosome becomes vacant as the ribosome falls off the poly(A) tail of the transcript in 
the absence of proper termination (van Hoof et al. 2002; Vasudevan et al. 2002; Frischmeyer et 
al. 2002). The Ski7 protein then recruits the cytoplasmic exosome complex to the mRNA 
(Vasudevan et al. 2002; van Hoof et al. 2002; Klauer and van Hoof 2012). Finally, aside from 
improper translation termination, stalling of the ribosome on mRNAs can also trigger a quality 
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control pathway called no-go decay (Harigaya and Parker 2010). The ribosome can stall on 
stable stem-loop structures in the open reading frame of an RNA, allowing Dom34p and Hbs1p 
to bind to the ribosome, triggering endonucleolytic cleavage of the RNA (Doma and Parker 
2006; Harigaya and Parker 2010). Importantly, the resulting fragments are degraded by XRN1 
and the exosome complex (Harigaya and Parker 2010). 
 
MicroRNA mediated decay 
 
 MicroRNAs (miRNAs) are ~22 nt RNAs that are derived from endogenous precursor 
RNAs that form long hairpin structures and in mammals are post-transcriptionally cleaved by 
Drosha in the nucleus to form a pre-miRNA and exported to the cytoplasm where the mature 
miRNA duplex is formed by DICER (Bartel 2004). This duplex miRNA is then loaded onto AGO2 
and a helicase activity facilitates the unwinding of the duplex to allow the guide strand to bind its 
target mRNA (Bartel 2004). Interestingly, the stability of the AGO2 protein is enhanced upon 
miRNA binding (Smibert et al. 2013; Martinez and Gregory 2013).  
 MicroRNAs contain a 2-7 nt seed sequence that guides AGO2 to target mRNAs by 
Watson-Crick base pairing with the target (Bartel 2009). Target sites are mostly found in the 3’ 
UTR, possibly because the translation machinery would disrupt RNA induced silencing complex 
(RISC) associated with the target mRNA during translation elongation (Bartel 2009). Transcripts 
targeted by microRNAs may be translationally repressed and/or degraded by a deadenylation-
dependent mechanism (Huntzinger et al. 2013). Several mammalian proteins have been 
identified that mediate the interaction of AGO2 with target transcripts and cause the RISC to 
localize to distinct cytoplasmic granules in the cell (processing bodies; Eystathioy et al. 2003): 
TNRC6A (also called TNRC6A) and the related TNRC6B and TNRC6C proteins (Baillat and 
Shiekhattar 2009; Takimoto et al. 2009). TNRC6A/TNRC6 proteins recruit the CCR4-NOT 
complex (Fabian et al. 2011; Chekulaeva et al. 2011) and the PAN2-PAN3 complex (Christie et 
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al. 2013) to AGO2-bound target mRNAs to facilitate both translational repression and 
deadenylation-dependent decay (Huntzinger et al. 2013; Takimoto et al. 2009; Chen et al. 
2009). Following deadenylation, transcripts then undergo DCP1-DCP2-mediated decapping and 
5’-3’ decay by XRN1 (Rehwinkel et al. 2005; Chen et al. 2009). Therefore, miRNA-mediated 
decay is an important mechanism by which transcripts are targeted for decay pathway in 
mammalian cells. 
 
Small interfering RNA mediated decay 
 
 Small interfering RNAs (siRNAs) are 21-27 nt RNAs generated from dsRNAs, such as 
viral replication intermediates that accumulate in infected cells (Ma et al. 2008). Unlike miRNAs, 
siRNA-mediated decay of target transcripts does not induce deadenylation, but rather results in 
endonucleolytic cleavage of the mRNA by AGO2 followed by exonucleolytic decay of the 
resulting mRNA fragments by XRN1 and the exosome complex (Orban and Izaurralde 2005). 
Recent work has demonstrated that mammalian cells have a functional anti-viral RNAi response 
(Maillard et al. 2013; Li et al. 2013(c)), although there is some debate about whether this is 
significant (Cullen et al. 2013). Although most somatic mammalian cells rely on PRRs and the 
induction of a type I IFN responses that oftentimes result in the expression of induced nucleases 
to combat RNA virus infections, the current literature supports the hypothesis that mammalian 
cells are capable of generating siRNAs from viral dsRNAs that may have anti-viral activity (Li et 
al. 2013(c)). The ability of a mammalian cell to process dsRNAs into siRNAs depends on 
DICER activity, and it was recently shown that an N-terminal truncated isoform of DICER that is 
preferentially expressed in mouse oocytes can dice dsRNAs into siRNAs but the isoform that is 
expressed in differentiated cells does not have this activity (Flemr et al. 2013). Human DICER 
can cleave dsRNAs with perfect complementarity but this process is less efficient than pre-
miRNA cleavage because the N-terminus of the protein serves as an autoinhibitor of DICER 
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activity (Ma et al. 2008). However, siRNA-mediated gene silencing in human cells is effective 
and therefore human cells contain the necessary dicing and slicing activities for RNAi to take 
place (Caplen et al. 2001). Although RNAi may not be a major anti-viral mechanism in human 
cells, it is very important for anti-viral immunity in mosquito cells which express two unique 
DICER proteins that function in either the miRNA or siRNA pathway (Blair 2011; Sanchez-
Vargas et al. 2009; Campbell et al. 2008). Therefore, arthropod-borne viruses could benefit 
greatly from impaired RNA interference pathways to facilitate efficient viral transmission to the 
next host.  
 
Coordination between mRNA synthesis and decay 
 
 Changes in mRNA stability and synthesis rates are important for the regulation of 
cellular gene expression. Studies using an in vitro model of T cell activation demonstrated that 
up to 50% of changes in polyadenylated mRNA abundance may be due to changes in mRNA 
stability, as nuclear run on experiments demonstrated that altered transcription rates do not 
account for all observed changes in mRNA abundance (Cheadle et al. 2005(a); Cheadle et al. 
2005(b)). A more recent study of gene expression in mouse myoblasts demonstrated that 
coordination between mRNA decay and synthesis may buffer gene expression, as many 
stabilized transcripts were also less abundant (Lee et al. 2012b). This may allow the cell to fine-
tune gene expression through coordination of mRNA synthesis and decay.  
 How could the disparate processes of cytoplasmic mRNA decay and transcription be 
coordinated? Intriguingly, protein factors that mediate transcription may pass between the 
nucleus and the cytoplasm to link these two processes. For example, the RNA polymerase II 
Rpb4/7 complex was shown to shuttle from the nucleus to the cytoplasm and influence the 
stability of mRNAs in yeast (Goler-Baron et al. 2008). The Rpb4/7 complex was later shown to 
associate with cytoplasmic mRNA decay factors in Saccharomyces cerevisiae, and depletion of 
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decapping activators Pat1 and Dhh1 conferred a similar decrease in yeast life span comparable 
to Rpb4-deficient cells (Duan et al. 2013). The nuclear Rpb4 protein was shown to shuttle out of 
the nucleus into the cytoplasm upon shifting cultures of the pathogenic fungus Cryptococcus 
neoformans to 37oC, and Rpb4-deficient organisms had defects in deadenylation (Bloom et al. 
2013). Intriguingly, Rpb4/7 may also coordinate mRNA synthesis and decay with translation in 
yeast (Harel-Sharvit et al. 2010). Therefore, protein factors that facilitate transcription can also 
alter mRNA decay. 
Factors required for mRNA decay in the cytoplasm may also enter the nucleus to 
potentially influence transcription. The CCR4-NOT complex can be observed in the cytoplasm in 
processing bodies, associated with ribosomes, or in the nucleus in yeast (Collart et al. 2013; 
Collart 2003). CCR4-NOT has also been shown to interact with the mRNA export machinery, 
indicating that it could couple the processes of mRNA decay and export to coordinate post-
transcriptional gene regulatory mechanisms in yeast (Kerr et al. 2011). Yeast deficient in the 
Ccr4-NOT complex were shown to have decreased rates of both mRNA decay and mRNA 
synthesis (Sun et al. 2012). The 5’-3’ exoribonuclease XRN1 was also recently shown to shuttle 
between the cytoplasm and the nucleus in yeast and could therefore influence mRNA synthesis 
(Haimovich et al. 2013; Sun et al. 2013b). Several studies have demonstrated that yeast cells 
lacking XRN1 have lower or unchanged mRNA abundances and increased mRNA half-lives (He 
et al. 2003; Haimovich et al. 2013; Sun et al. 2013; Medina et al. 2014) and although Drosophila 
expressing a mutant XRN1 homolog allele displayed phenotypic changes, very few mRNAs 
were differentially expressed compared to wild-type organisms (Jones et al. 2013). However, 
changes in mRNA stability in these flies were not assessed. In general, these studies support 
the hypothesis that gene expression is buffered such that stabilization of a transcript may cause 
decreased transcription (or vice versa) to allow coordination between early and late stages of 
gene expression.  Therefore, interactions between viruses and the mRNA decay machinery 
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could alter both the degradation and synthesis of mRNAs, and potentially cause dramatic 
changes in cellular gene expression. 
 
Sites of mRNA decay in the cytoplasm 
 
 Another important aspect of cellular gene expression that contributes to the stability of 
messenger RNAs and the likelihood that they will be translated is the subcellular localization of 
transcripts in large ribonucleoprotein complexes (e.g. P-bodies or stress granules) that are 
dynamically regulated in the cytoplasm. In general, transcripts exist in RNP complexes that 
facilitate export from the nucleus, translation, and ultimately degradation (Wilusz and Wilusz 
2010). Processing bodies often contain many mRNA decay factors including XRN1, DCP1a, 
and AGO2 (Sheth and Parker 2003). Using an MS2 reporter construct containing a poly(G) tract 
resistant to yeast XRN1-mediated decay, Sheth and Parker (2003) showed that 5’-3’ mRNA 
decay intermediates accumulate in P-bodies, supporting the hypothesis that 5’-3’ decay can 
take place in these discrete RNP granules. It was later shown in both yeast and mammalian 
systems that RNAs may be stored in P-bodies and eventually exit these distinct cytoplasmic foci 
and associate with polysomes to undergo translation (Brengues et al. 2005; Bhattacharyya et al. 
2006). Interestingly, treating human or yeast cells with cyclohexamide to inhibit translation 
elongation results in P-body dispersal, indicating that P-body formation may be seeded by 
mRNAs that have undergone translation and are targeted for decay (Sheth and Parker 2003; 
Cougot et al. 2004). Transcripts targeted for miRNA-mediated decay are guided to P-bodies in 
human cells (Bhattacharyya et al. 2006). Processing bodies therefore may function as discrete 
pseudo-organelles where the fate of an mRNA is decided (Buchan and Parker 2009).  
 Yeast and mammalian cells also form stress granules (SG), which are induced upon 
inhibition of translation initiation by a variety of stressors (Buchan and Parker 2009; Kedersha et 
al. 1999). Puromycin treatment, which causes mRNA-ribosome complexes to disassemble, 
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causes formation of SG in mammalian and yeast systems (Buchan and Parker 2009; Kedersha 
et al. 2000; Buchan et al. 2008). Stress granules and P-bodies likely interact and mRNPs may 
be shuttled between them (Buchan and Parker 2009). Indeed, stress granule assembly in yeast 
depends on P-body formation and may be seeded by mRNP complexes assembled in P-bodies 
(Buchan et al. 2008). Therefore the subcellular localization and mRNP context is likely a major 
contributing factor for the regulation of cellular gene expression.  
 In summary, eukaryotic cells harbor several constitutively expressed nucleases that can 
potentially act on viral RNAs during an infection. These pathways normally allow for the post-
transcriptional regulation of cellular mRNAs and likely play important roles in mediating the 
proper host response to infection by facilitating the rapid induction and degradation of normally 
short-lived pro-inflammatory immune mediators. Therefore, viruses could benefit from altering 
cellular RNA decay processes by influencing host gene expression and potentially protecting 
their transcripts from decay. The following section will discuss some of the known interactions 
between viruses and the cytoplasmic mRNA decay machinery.  
 
Viral evasion of deadenylation 
 
 Several pieces of evidence indicate that polyadenylated viral RNAs are susceptible to 
deadenylation-dependent decay, and many viruses appear to have evolved mechanisms for 
resisting deadenylation. Viral RNAs are known to evade deadenylation-dependant decay by 
either interacting with cellular RNA binding proteins or by forming stable structures that 
essentially hide the poly(A) tail from deadenylases. 
 The arthropod-borne viruses in the Togaviridae family possess positive sense, single 
stranded RNA genomes that have 5’ methylated caps and poly(A) tails, and in this sense they 
mimic cellular transcripts. Intriguingly, Sindbis virus (SINV; a representative member of the 
Alphavirus genus in the Togaviridae family) encodes a conserved U-rich sequence element in 
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the 3’ UTR of the viral RNA that is essential for inhibiting deadenylation-dependent decay 
(Garneau et al. 2008). The cellular RNA stability factor ELAVL1 (also known as HuR) was 
shown to bind with high affinity to this U-rich region of alphavirus RNAs, thus inhibiting 
deadenylation and promoting viral RNA stability in both mosquito and mammalian systems 
(Garneau et al. 2008; Sokoloski et al. 2010). The interaction between HuR and SINV RNAs was 
shown to be very important for viral proliferation, as cells deficient in HuR protein supported less 
viral growth than normal cells, and viruses lacking the U-rich HuR binding site replicated to 
lower levels than wild-type viruses (Sokoloski et al. 2010). Interestingly, HuR is normally present 
in the nucleus of mammalian cells. However, alphavirus infections specifically induce the re-
localization of HuR from the nucleus to the cytoplasm (Sokoloski et al. 2010; Dickson et al. 
2012). Therefore, alphaviruses cause the selective re-localization of the RNA stability factor 
HuR to protect their transcripts from deadenylation-dependent decay, and this is essential for 
optimal viral propagation in mammalian and mosquito cells.  
 Suppressing the deadenylation-dependent decay of viral transcripts can not only 
enhance viral propagation in general, but could also permit the fine-tuning of viral gene 
expression. Rabies virus (a member of the Rhabdoviridae family) contains a negative sense 
RNA genome from which five capped and polyadenylated transcripts (encoding the N, P, M, G, 
and L proteins) are synthesized by the viral polymerase in the cytoplasm (Schnell et al. 2010). 
The abundance of each viral transcript is dictated by its position in the RNA genome such that 
sequences closest to the 3’ end of the negative sense viral RNA genome are transcribed more 
frequently than those at the 5’ end of the genome (Schnell et al. 2010). However, it was recently 
demonstrated that the viral glycoprotein (G) mRNA was present in greater abundance in human 
cells infected with rabies virus than would be expected as a result of the accepted mode of viral 
transcription (Palusa et al. 2012). In an analogous mechanism to alphaviruses, the 3’ UTR of 
the G mRNA was shown to interact specifically with the cellular poly(C) binding protein 2 
(PCBP2) in infected cells (Palusa et al. 2012). Importantly, this interaction was shown to 
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suppress deadenylation of the G transcript in cell extract systems, and the 72 nt element in the 
G mRNA 3’ UTR was shown to act as a stability element in reporter assays (Palusa et al. 2012). 
Therefore, rabies virus G mRNA likely binds specifically to the cellular PCBP2 to permit 
differential viral gene expression. 
 Deadenylation can also be suppressed by unique structural elements that bind and 
sequester the 3’ poly(A) tail of a transcript, essentially hiding the adenylate tract from 
deadenylases in the nucleus. The highly abundant polyadenylated nuclear (PAN) RNA 
generated by Kaposi's sarcoma-associated herpesvirus (a DNA virus in the Herpesviridae 
family) possesses an RNA stability element near the 3’ end of the RNA that associates with the 
poly(A) tail to form a triple helix structure (Mitton-Fry et al. 2010). This triple helix structure was 
shown to suppress deadenylation of an RNA reporter in vitro (Mitton-Fry et al. 2010). 
Importantly, many other viruses and even host non-coding RNAs were later shown to contain 
similar RNA stability elements that likely protect these transcripts from deadenylation (Tycowski 
et al. 2012; Brown et al. 2012). 
 
Viral evasion of 5’-3’ decay 
 
 Many viral RNAs, including flavivirus RNAs, do not contain poly(A) tails. It is not known 
whether or not these RNAs are recognized as deadenylation-mediated decay intermediates or 
are degraded through a deadenylation-independent mRNA decay pathway. However, there is 
some evidence that transcripts can be decapped without first being deadenylated. The yeast 
mRNA EDC1 can be deadenylated without first being decapped (Muhlrad and Parker 2005). 
Therefore, some viral RNAs might undergo 5’-3’ decay even though they lack a poly(A) tail. 
Several pieces of evidence indicate that flaviviral RNAs can be degraded by 5’-3’ and 3’-5’ 
exonucleases without first being deadenylated. First, replication-competent HCV RNAs 
transfected into Huh7.5 human liver cells had increased stability when XRN1 was depleted, and 
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accordingly XRN1 depletion resulted in enhanced HCV replication (Li et al. 2013(b)). Second, 
as described in Section I of the Introduction, subgenomic flavivirus RNAs generated from all 
viruses in the Flavivirus genus tested to date are formed due to incomplete 5’-3’ decay of the 
viral genome by XRN1 (Pijlman et al. 2008; Silva et al. 2010). Furthermore, the exosome may 
potentially also act on flavivirus RNAs, as one study demonstrated that YFV sfRNA was 
truncated from the 3’ end and therefore may be resistant to further 3’-5’ decay as well (Silva et 
al. 2010). Two major mechanisms by which viruses evade or likely shut down 5’-3’ decay by 
XRN1 are discussed below. 
 Some viruses may simply shield the 5’ termini of their RNAs from XRN1 through several 
distinct mechanisms. First, many viruses (including the alphaviruses and members of the 
Flavivirus genus) have 5’ methylguanosine caps added co-transcriptionally by viral proteins. The 
5’ methylated caps likely serve two important functions: proteiction from degradation by XRN1, 
and evasion of IFIT-mediated innate immune responses as discussed above Section I. Viruses 
that do not undergo capping during transcription use other mechanisms to ‘cap’ their RNAs, 
likely serving to protect them from 5’-3’ decay. First, these viral RNAs may acquire a 5’ 
methylated cap by stealing them from cellular RNAs (cap-snatching). The negative- or ambi-
sense RNA viruses including members of the Bunyaviridae, Arenaviridae, and the 
Orthomyxoviridae cap-snatch, likely to protect their transcripts from 5’-3’ decay and also 
undergo cap-dependent translation (Raju et al. 1990; Mir et al. 2008; Hopkins et al. 2013). 
Second, the RNAs of hepaciviruses and pestiviruses appear to contain 5’ triphosphates that are 
likely sterically hindered from entering the active site of XRN1, and as discussed above these 
viruses undergo cap-independent translation via IRES elements (Jinek et al. 2011). Finally, 
some viral RNAs can even be ‘capped’ by a covalently linked viral protein. The genomic RNAs 
of viruses in the Picornaviridae family (e.g. poliovirus) are ‘capped’ by VPg (virus protein, 
genome-linked), which is required for viral RNA synthesis but not viral RNA translation (Nomoto 
et al. 1977(a); Nomoto et al. 1977(b); Racaniello 2001). Therefore, the 5’ methylated cap 
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structure, triphosphate group, or VPg serve as cis-acting stability factors that blocks decay by 
XRN1. However, viral RNAs could become susceptible to XRN1-mediated decay if they are 
decapped or subjected to endonucleolytic cleavage events that reveal a terminal 5’ 
monophosphate group. 
 Finally, picornaviruses cause the RNA decay factors XRN1, the PAN3 deadenylase, 
DCP1 and DCP2 to undergo proteolytic degradation through cellular or viral protease-
dependent mechanisms (Dougherty et al. 2011). Picornavirus RNAs may also be targeted for 
decay by the AUF1, as this cellular protein relocalizes from the nucleus to the cytoplasm and 
binds the 5’ UTRs of poliovirus and human rhinovirus RNAs (Cathcart et al. 2013). These 
viruses avoid being degraded upon binding this destabilizing factor by proteolytically cleaving 
AUF1 during infection (Rozovics et al. 2012). Coxsackievirus B3 also causes redistribution of 
AUF1 into the cytoplasm and cleavage, and this also appears to require the activity of viral 
proteins (Wong et al. 2013). Therefore, these viruses use an aggressive mechanism to combat 
cellular exonucleolytic decay in addition to simply shielding their RNAs from XRN1. 
 
Viral evasion of quality control mRNA decay pathways 
 
 Although there is a dearth of research into the role of constitutive quality control mRNA 
decay pathways in degrading viral RNAs, there are several reasons why viral RNAs may be 
targeted for decay in this manner. First, as discussed above most viral RdRps lack proof-
reading activity, and therefore some viral transcripts likely contain aberrantly placed termination 
codons (or lack them altogether). Second, many viral RNAs do not have a nuclear experience 
and contain multiple open reading frames, and are therefore likely to undergo NMD. Indeed, 
although retroviral transcripts do have a nuclear experience, they are unspliced and susceptible 
to NMD (Hogg and Goff, 2010). Third, many viral RNAs contain stable structural elements that 
could potentially cause ribosome stalling during translation elongation and trigger no-go decay. 
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However, viruses have likely evolved mechanisms to avoid degradation by these pathways. For 
example, a structured RNA element in the avian Rous sarcoma virus was shown to be essential 
for protecting the transcript from NMD (Withers and Beemon 2011). It is likely that other viruses 
also suppress or evade these important quality control pathways in the cell. Finally, suppression 
of exoribonucleases (e.g. XRN1) could cause a reduction in the efficicacy of these quality 
control pathways. 
 
Unconventional miRNA-viral RNA interactions 
 
 Diverse viruses are known to generate unconventional miRNAs from their RNAs during 
infection, and can be positively or negatively regulated by host cellular miRNAs. Intriguingly, 
Shapiro et al. (2012) showed that SINV infection causes relocalization of the microprocessor 
Drosha from the nucleus to the cytoplasm, allowing miRNAs to be generated from viral RNAs. 
Therefore cellular miRNAs could serve an anti-viral function in mammalian cells (Shapiro et al. 
2012). Furthermore, miRNA target sites can be introduced into RNA viruses to restrict their 
replication to specific cell types. Influenza A virus that encodes a miR-192 binding site can 
replicate and be transmitted by ferrets (which don’t express miR-192) but is attenuated in mice, 
which express miR-192 in respiratory tract epithelial cells (Langlois et al. 2013). This implies 
that the tissue expression of certain host miRNAs could modulate where a virus may 
successfully propagate. 
 Conversely, HCV is known to steal a specific host miRNA to promote viral RNA 
replication; indeed HCV requires the host microRNA-122 to propagate effectively in human liver 
cells (Jopling et al. 2005). Although the exact function of miR-122 in enhancement of HCV 
replication remains unknown, recent studies have shown that miR-122 may serve to protect the 
HCV genome from degradation by shielding the terminus of the viral RNA from decay factors 
(Machlin et al. 2011; Shimakami et al. 2012; Mortimer and Doudna 2013; Li et al. 2013(b)).  
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 Finally, several herpesviruses deplete specific cellular miRNAs via highly abundant non-
coding viral RNAs. Herpesvirus saimiri (HVS) and murine cytomegalovirus (mCMV) both 
generate unique virus-derived RNAs that sponge up cellular miRNAs and cause their 
degradation (Buck et al. 2010; Cazalla et al. 2010; Libri et al. 2012). The mCMV transcript m169 
is predicted to contain an open reading frame, is polyadenylated and capped, and contains a 
miR-27 binding site in its 3’ UTR (Libri et al. 2012). Upon expression of m169 during mCMV 
infection or when expressed via an adenovirus vector, miR-27a and miR-27b are rapidly and 
specifically depleted (Libri et al. 2012; Marcinowski et al. 2012). ). HVS also selectively targets 
miR-27 for degradation via U-rich non-coding viral RNA called HSUR1 (Cazalla et al. 2012). 
Although the exact function of miR-27 in the context of herpesvirus infection remains unknown, 
it is possible that miR-27 negatively regulates the abundance of host cellular transcripts that 
would otherwise be beneficial to these disparate herpesviruses.  
 Poxviruses also appear to have evolved a unique mechanism by which many cellular 
miRNAs can be degraded during an infection. The poxvirus poly(A) polymerase induces cellular 
miRNA degradation by polyadenylating these small RNAs, targeting them for decay (Backes et 
al. 2012). Interestingly, the 3’ ends of virus-derived siRNAs generated during Vaccinia virus 
infection of Drosophila cells are 2’-O methylated, and this motif blocks the addition of a poly(A) 
tail and subsequent decay of these small RNAs. Therefore, diverse viral RNAs are susceptible 
to miRNA-mediated decay in cells and many use unique mechanisms by which they 
successfully interact with this RNA decay pathway. 
 
Dispersal of processing bodies during flavivirus infections 
 
 Several recent studies have shown that XRN1 may be involved in degradation of the 
HCV genome and the subcellular localization of XRN1 is altered during HCV infection. XRN1 is 
usually localized to processing bodies, discrete cytoplasmic foci that may be localized sites of 
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mRNA decay. Processing body composition is altered during HCV infection (Perez-Vilaro et al. 
2012). Intriguingly, XRN1, miR-122, and AGO2 have been shown to be localized in ring-like 
structures with the HCV core protein in lipid droplets (Ariumi et al. 2011; Berezhna et al. 2011). 
XRN1 is similarly re-localized to viral replication complexes in West Nile virus infected cells 
(Chahar et al. 2013). Furthermore, as observed in DENV and WNV infections, processing 
bodies are dispersed during HCV and poliovirus infections (Emara and Brinton 2007; Dougherty 
et al. 2011; Pager et al. 2013). Furthermore, a slew of RNA decay factors including XRN1, 
LSM1, TNRC6A, and DDX6 were shown to re-localize to viral replication complexes and 
increase viral replication in HeLa cells infected with WNV (Chahar et al. 2013).  
 Interestingly, DDX6 and CAPRIN1 are known to bind to the DENV 3’ UTR but the 
functional importance of many of these interactions remains to be characterized (Ward et al. 
2011; Roby et al. 2014). Furthermore, a recent study showed that the JEV C protein interacts 
directly with Caprin 1 (Katoh et al. 2013). However, CAPRIN1 and the G3BP1 proteins are 
known to interact with cellular factors present in stress granules (Solomon et al. 2007; Ward et 
al. 2011; Matsuki et al. 2013). The sequestration of these and other stress granule-associated 
proteins (e.g. TIA-1 and TIAR) in flavivirus replication complexes may therefore be an 
underlying mechanism for the observed defects in stress granule formation in flavivirus 
infections (Emara and Brinton 2007; Ward et al. 2011; Matsuki et al. 2013). 
 
Pathogenic consequences of viral interactions with the cellular RNA decay machinery 
 
 The regulation of cellular gene expression relies on a complex interplay between RNA 
synthesis, degradation, and translation as described above. Because changes in mRNA stability 
can influence the steady-state level of an mRNA, the ability of a virus to manipulate or inactivate 
mRNA decay factors could have multiple complex profound effects on host cellular gene 
expression. In addition to the constitutively expressed mRNA decay factors that regulate host 
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gene expression, cells may express a variety of virus-induced nucleases that are part of the 
anti-viral innate immune response to infection. Furthermore, many different viruses have been 
shown to influence the formation of mRNP granules, which likely also contributes to changes in 
cellular gene expression (Beckham and Parker 2008; Lloyd 2013). The mechanisms that 
underlie the innate immune response to viral infection leading to induced nuclease expression 
and how viruses interfere with the constitutive mRNA decay machinery are therefore important 
to understand in order to determine how cellular gene expression is changed during infection 
and how this contributes to pathogenesis. Viral RNAs can sponge host RNA stability factors, 
suppress host exoribonucleases, and disperse cytoplasmic RNA granules, all of which likely 
contribute to virus-induced pathology (Moon and Wilusz 2013). 
 Considering the importance of post-transcriptional mechanisms in controlling cellular 
gene expression, perturbation of the cellular RNA decay machinery likely causes dramatic 
changes in how the cell responds to infection or cell biology in general. The following discussion 
will focus on how pathology may be induced by three viral mechanisms: sponging/sequestration 
of host miRNAs or RNA binding proteins by viral RNAs, the production of viral nucleases that 
degrade cellular mRNAs, and the proteolytic degradation of host mRNA decay factors (depicted 




Figure 5. Mechanisms that viruses use to evade or suppress general host RNA 
decay factors and how this may contribute to virus-induced pathogenesis. HVS: 
Herpesvirus saimiri, mCMV: murine Cytomegalovirus, PV: Poliovirus, HRV: Human 
rhinovirus, DENV: the dengue viruses, HCV: hepatitis C virus, SINV: Sindbis virus, RV: 
Rabies virus, WNV: West Nile virus, KSHV: Kaposi Sarcoma-associated herpesvirus, 
SARS-CoV: Severe Acute Respiratory Syndrome coronavirus.Taken from: Moon SL, 
Wilusz J (2013) Cytoplasmic Viruses: Rage against the (Cellular RNA Decay) Machine. 
PLoS Pathog 9(12): e1003762.  
 
Sponging/stealing host miRNAs and RNA-binding proteins   
 
 Recent studies have demonstrated that viral RNAs can serve as sponges for cellular 
miRNAs and RBPs, consequently altering cellular gene expression. The seven HVS non-coding 
U-rich RNAs were discovered by northern blots targeting RNA products of the viral genome 
associated with T cell transformation (Cazalla et al. 2010; Lee et al. 1988). These HVS non-
coding RNAs (ncRNAs) are also associated with T cell activation and may increase the growth 
rate of transformed T cells (Cazalla et al. 2010). As discussed above, several of these HVS 
RNAs and an RNA generated by mCMV appear to selectively bind and degrade the host 
microRNA miR-27 (Buck et al. 2010; Cazalla et al. 2010; Libri et al. 2012). Could the sponging 
of miR-27 alter host gene expression and potentially cause pathology during infection with these 
lymphotropic viruses? Interestingly, the transcription factors RUNX1 and FOXO1, have been 
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identified as miR-27 targets, all of which are known to function in development and/or cell 
proliferation (Ben-Ami et al. 2009; Guttilla et al. 2009; Crist et al. 2009). The RUNX1 
transcription factor is essential for the development of lymphoid cells and differentiation of all 
hematopoietic cell lineages, and mutations in the RUNX1 gene are associated with leukemia 
(Kuo et al. 2009, Ichikawa et al. 2004; Schnittger et al. 2011; Kuo et al. 2009; Grossmann et al. 
2011). The FOXO1 protein has been shown to play a role in apoptosis, cell cycle progression, 
proliferation, and muscle cell differentiation (Guttilla et al. 2009; Crist et al. 2009). Therefore, the 
sponging and degradation of miR-27 by diverse herpesviruses could contribute to virus-induced 
oncogenesis or cause pathogenesis by aiding viral propagation. In support of this idea, mutant 
mCMV unable to target miR-27 were attenuated in a mouse model of infection and significantly 
fewer viruses were detected in lungs, spleen, and salivary glands compared to wild-type virus 
infections (Marcinowski et al. 2012). Therefore, viral interferance with normal miRNA-mediated 
decay processes can contribute to pathology. 
 We recently demonstrated that the sequestration of HuR by Sindbis virus RNA leads to 
changes in mRNA stability, polyadenylation, and splicing (Barnhart et al. 2013). Not only is HuR 
required for robust viral proliferation as the RNAs are stabilized by their interaction with HuR 
(Sokoloski et al. 2010), but the sponging of HuR in the cytoplasm of infected cells may also 
contribute indirectly to virus-induced pathology by altering host gene expression. The HuR 
protein is known to interact with a wide array of cellular transcripts in different cell types and 
stabilizes mRNAs (Lebedeva et al. 2011; Mukherjee et al. 2011; Peng et al. 1998). HuR 
associates with both intronic and exonic regions of transcripts in HeLa cells and can mediate 
alternative splicing (Lebedeva et al. 2011; Mukherjee et al. 2011). Furthermore, Mukherjee et al. 
(2011) showed that transcripts that bound to HuR in intronic sequences were also more stable, 
indicating that HuR couples pre-mRNA processing events with stabilization of the mature 
transcript, possibly by loading onto the mRNA in the nucleus. Mammalian Hu proteins regulate 
alternative splicing, as they bind U-rich transcripts and block the polyadenylation machinery 
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from recognizing upstream alternative polyadenylation signals (Zhu et al. 2007). Intriguingly, 
global analyses of HuR and AGO2 associated transcripts showed that HuR may compete with 
AGO2 to relieve miRNA-mediated gene silencing (Mukherjee et al. 2011), and it was later 
determined that HuR can cause the miRISC to dissociate from target transcripts (Kundu et al. 
2012). 
  Many studies have sought to characterize the RNAs that HuR associates with in a 
variety of cell types using several different experimental approaches. An analysis by St Laurent 
et al. (2012) of 4 published datasets containing all detected HuR interacting RNAs (St Laurent et 
al. 2012; Kishore et al. 2011; Mukherjee et al. 2011; Lebedeva et al. 2011) determined that 
1,156 RNAs were represented in all 4 datasets that were compared, and 3,508 RNAs were 
represented in 3 out of 4 datasets. These results indicate that HuR contributes to the post-
transcriptional regulation of many cellular transcripts, and sequestration of HuR on viral RNAs 
could have dramatic consequences for the cellular response to viral infection. Indeed, it may be 
that the sponging of HuR in the cytoplasm on viral RNAs could be one mechanism by which 
alphaviruses shut down host gene expression during infection. Surprisingly, HuR was shown to 
play a role in the post-translational regulation of the pro-inflammatory factor NFkB (Rhee et al. 
2010). This study showed that depletion of HuR by siRNA treatment in human embryonic 
vascular endothelial cells reduced monocyte binding, induction of ICAM-1 and VCAM-1 
expression, and NFkB phosphorylation upon two different pro-inflammatory stimuli (Rhee et al. 
2010). The authors determined that rather than altering mRNA stability, HuR regulated the 
phosphorylation state of the constitutively expressed inhibitors of NFkB, IκBα and IKKα/β, 
leading to NFkB activation and subsequent increased transcription of pro-inflammatory factors 
including VCAM-1 (Rhee et al. 2010). However, HuR is also known to be important for 
mediating proper immune responses by stabilizing AU-rich element containing transcripts (Fan 
and Steitz 1998). In a cell culture model of T cell activation, HuR was shown to relocalize from 
the nucleus into the cytoplasm where it stabilizes the short-lived transcripts of potent pro-
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inflammatory cytokines, including TNF-α and interferon-γ (Wang et al. 2006). Therefore there 
are a variety of interesting defects in post-transcriptional regulatory mechanisms that may arise 
due to the sponging of HuR on high affinity binding sites in alphavirus RNAs that could 
contribute to virus evasion of immune mechanisms or potentially immunopathogenesis.  
 
Inactivation of cellular RNA decay factors 
 
 As described above, poliovirus causes the rapid depletion of XRN1, DCP1, DCP2 and a 
PAN deadenylase through the activity of a viral protease or by targeting these proteins for decay 
by the proteasome (Dougherty et al. 2011). Because the 5’-3’ decay pathway is important for 
turnover of cellular mRNAs, reducing the abundance of XRN1 and the decapping enzymes 
likely has major effects on host gene expression. XRN1 is important for proper organismic 
development and growth (Grima et al. 2008; Till et al. 1998; Jones et al. 2013; Szankasi et al. 
1996; Larimer and Stevens 1990; Larimer et al. 1992). Furthermore, mutations in XRN1 have 
been associated with osteosarcoma in humans (Zhang et al. 2002; Kruzelock et al. 1997). 
Therefore the selective depletion of cellular decay factors could contribute to virus-induced 
defects in development, growth, and/or cell differentiation. 
 Picornaviruses are also known to induce the proteolytic decay of AUF1. Interestingly, 
AUF1 has been shown to participate in the degradation of AU-rich element containing mRNAs 
including those encoding cytokines and oncogenes (Laroia et al. 1999). It would therefore be 
interesting to determine if changes in the post-transcriptional regulation of ARE-containing 
transcripts results from the degradation of AUF1 by these positive-sense RNA viruses, and if 





Subgenomic flavivirus RNAs are generated by XRN1 and contribute to pathogenesis 
 
 Disparate viruses are known to interact with the cellular RNA decay machinery and as a 
result likely cause dramatic changes in cellular gene expression that could ultimately contribute 
to pathology. Although there is ample evidence that flavivirus-mediated pathology can derive 
from changes in host cellular gene expression (as discussed above in Section I), the exact 
mechanisms by which this occurs remain to be fully characterized. Because some viral RNAs 
interact with cellular RNA binding proteins (e.g. the SINV 3’ UTR) and microRNAs (e.g. mCMV 
RNAs) that likely contribute to changes in cellular gene expression during infection, we 
wondered if the flaviviruses might influence post-transcriptional regulatory processes in a similar 
manner. As discussed above, all members of the Flavivirus genus tested to date generate 
subgenomic RNAs that may be generated by incomplete 5’-3’ decay of the viral genome by 
XRN1 (Pijlman et al. 2008; Silva et al. 2010). Intriguingly, these sfRNAs are required for viral 
pathogenesis (Pijlman et al. 2008; Liu et al. 2014). Therefore, sfRNA serves as an important 
point of interaction between the cellular RNA decay machinery and viral gene products. 
 What is known about how sfRNA is formed in the cell? Two pieces of evidence inducate 
that sfRNAs are generated as XRN1 stalls on conserved elements in the flavivirus 3’ UTR upon 
processive 5’-3’ decay of viral RNAs. First, depletion of XRN1 using siRNAs reduced the 
abundance of Kunjin virus sfRNA in infected human cells, and second, it was later shown that 
YFV sfRNA could be generated by incubating a reporter RNA containing the viral 3’ UTR with 
recombinant yeast XRN1 (Pijlman et al. 2008; Silva et al. 2010). However, the XRN1 homologs 
in yeast and in trypanosomes known to stall on G-tracts and long, highly stable G-C stem-loops 
in reporter RNAs, but mammalian XRN1 has not been previously documented to stall on such 
sequence or structural elements (Muhlrad et al. 1994; Li et al. 2006). Mutational analyses of 
several conserved pseudoknot motifs revealed that they are important for formation of sfRNAs 
from the YFV and KUNV 3’ UTRs (Funk et al. 2010; Silva et al. 2010). However, the exact 
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mechanism by which these viral RNAs stall XRN1, and whether or not other sequence or 
structural determinants were necessary for sfRNA formation remains to be determined.  
 What is the role of sfRNA during viral infection? Intriguingly, these non-coding viral 
RNAs were shown to be essential for virus-induced pathology in WNV and DENV-2 infections 
(Pijlman et al. 2008; Liu et al. 2014). Mutant flaviviruses deficient in sfRNA formation display 
defects in viral growth in certain cell lines; therefore these viral RNAs likely aid viral propagation 
(Pijlman et al. 2008; Silva et al. 2010). Furthermore, several studies have demonstrated that 
sfRNA formation is important for viral evasion of innate immune responses in mammalian and 
insect cells, and DENV sfRNA was recently shown to trigger apoptosis (Schnettler et al. 2012; 
Schuessler et al. 2012; Chang et al. 2013; Liu et al. 2014; Roby et al. 2014). However, although 
the pathogenicity and growth of KUNV was partially restored when innate immune modulators 
were depleted, these observations do not directly implicate sfRNA accumulation in the 
suppression or evasion of innate immune pathways in mammals. Alternatively, altered cellular 
gene expression that occurs as a result of sfRNA accumulation could enhance viral growth 
and/or indirectly suppress innate immune pathways. Furthermore, sfRNA may play a role in 
allowing arthropod-borne flaviviruses to evade the anti-viral RNA interference response, as 
sfRNA has been shown to moderately suppress RNA interference activity in mosquito and non-
human primate cells (Schnettler et al. 2012). Arthropods rely on this small RNA-mediated decay 
pathway for antiviral immunity, and many viruses are known to suppress RNAi to enhance their 
propagation (Nayak et al. 2010; van Mierlo et al. 2012; Blair 2011). Considering that many RNA 
viruses successfully interface with the cellular RNA decay machinery by suppressing or evading 
decay factors, flaviviruses likely also interfere with RNA decay in the cell to suppress these 
activities. The following studies aimed to determine if sfRNA formation might allow flaviviruses 
to evade or otherwise successfully interact with the normal RNA decay machinery, thereby 







 As discussed above, viruses in the Flaviviridae replicate exclusively in the cytoplasm of 
the host cell (Lindenbach and Rice 2001). Importantly, the cytoplasm of eukaryotic cells 
contains constitutively expressed ribonucleases (e.g. XRN1) that participate in quality control 
pathways, normal turnover of cellular transcripts and in targeting invading viral transcripts for 
destruction. Flaviviral RNAs interact with cellular RNA decay enzymes (e.g. XRN1, RNAse L) 
and other factors known to play important roles in post-transcriptional processes (e.g. HuR, 
PCBP2, miR-122) but little is known regarding how these interactions might promote viral RNA 
stabilization and/or interfere with normal cellular gene expression, leading to virus induced 
pathology. Furthermore, although the importance of sfRNA to viral pathogenesis is clear 
(Pijlman et al. 2008; Liu et al. 2014), the mechanism by which sfRNA benefits the virus and/or 




 The studies described herein test the following hypotheses:  
(1) In addition to being a key factor in generating sfRNA, the major host exoribonuclease 
XRN1 is functionally inhibited by sfRNA, contributing to pathogenic changes in cellular 
gene expression during flavivirus infections.  
(2) Other members of the Flaviviridae (namely HCV and BVDV) generate XRN1 inhibitory 
RNAs through a similar mechanism via highly structured RNA elements present in their 
5’ UTRs, and these also contribute to virus-induced changes in cellular gene expression. 








Cell culture  
 
 All mammalian cells were cultured at 37C and mosquito cells were grown at 28C. All 
cells were maintained in 5% CO2 and media was routinely supplemented with 1% streptomycin 
and penicillin (Fisher Scientific-Hyclone). Human embryonic kidney 293T cells were maintained 
in Dulbecco’s Modified Eagle’s medium (DMEM; Mediatech) with 10% fetal bovine serum (FBS; 
Atlas Biologicals) and were a gift of the laboratory of Dr. Chaoping Chen at Colorado State 
University. Madin-Darby bovine kidney (MDBK) cells (Bos taurus) from ATCC (CCL-22) were 
cultured in Modified Eagle’s medium (MEM; Corning) with 10% donor equine serum (Hyclone) 
to prevent potential contamination with non-cytopathic BVDV that could be present in FBS 
stocks (Xia et al. 2011). The Macaca mulatta kidney epithelial cell line (LLC-MK2; a gift from the 
CSU Arthropod-borne Infectious Diseases Laboratories) and the baby hamster kidney cell line 
BHK-21 (ATCC CCL-10; Mesocricetus auratus) were maintained in MEM plus 10% FBS. Vero 
cells (Cercopithecus aethiops) were cultured in DMEM plus 5% FBS and Aedes albopictus 
C6/36 cells were grown in MEM plus 5% FBS (both cell lines were a gift of the Bowen laboratory 
at Colorado State University). All mammalian cells were split before cultures reached confluency 
by washing monolayers once with ice-cold phosphate buffered saline (PBS; Corning), 
incubating at 37C with 0.25% trypsin solution (Fisher Scientific-Hyclone) until cells detached 
and ~1/10 of each culture re-seeded for passaging. Mosquito cells were passaged by scraping 
only. All cells were routinely screened for Mycoplasma contamination using the Universal 
Mycoplasma PCR-based detection kit (ATCC 30-1012K) and DAPI staining for extra-nuclear 
DNA detection by immunofluorescence microscopy to confirm PCR results. MDBK cells were 
screened frequently for non-cytopathic BVDV by RT-PCR (Ridpath et al. 1994) and by using 
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immunofluorescence microscopy with a monoclonal antibody that recognizes both cytopathic 





 Lentiviruses were generated with the pLKO.1 plasmid or one that produces an shRNA 
that targets XRN1 mRNA (Sigma Aldrich, TRCN0000049677) were generated as follows 
(described in Stewart et al. 2003). Equal amounts (10 g) of each plasmid pCMVRΔ8.2, pVSV-
G, and TRCN0000049677 (i.e. XRN1 shRNA containing pLK0.1) or pLK0.1 (vector only control) 
were added to 1 mL of calcium chloride solution (0.3 M) and mixed gently. One mL of 2x HBS 
buffer (10 mM D-glucose, 10 mM potassium chloride, 40 mM HEPES, 1.5 mM dibasic sodium 
phosphate, 270 mM sodium chloride, pH 7.1) was then added to the calcium chloride solution. 
This solution was then used to transfect a 50% confluent monolayer of 293T cells in a T-75 flask 
in 5 mL of maintenance medium (MEM with 10% FBS). Medium was replaced with fresh 
maintenance medium containing 60 L of 5% butyric acid in PBS the following morning. 
Lentivirus was collected 48 hours later by centrifuging the medium to clarify at 1000xg for 10 
minutes in a tabletop centrifuge at 4 C and immediately frozen in 1 mL aliquots at -80 C. Each 
aliquot was used once and discarded to avoid loss of lentivirus integrity due to repeated freeze-
thaw cycles. Transductions of 293T cells were performed by rinsing a 75% confluent monolayer 
in a T-75 flask once with ice-cold PBS and adding 1 mL of lentivirus stock plus 3 mL fresh 
growth medium containing 5 g/mL polybrene. The cells were incubated for 1-2 hours and 
rinsed once with PBS, then overlaid with fresh maintenance medium. The next day, the medium 
was replaced. On the third day post-transduction, the cells were fed with maintenance medium 
containing 5 g/mL puromycin to select for cells expressing the puromycin resistance gene. 
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Puromycin-resistant cell pools were maintained in medium containing 1 g/mL puromycin. 




 Dengue virus type 2 strain Jamaica 1409 (GenBank M20558.1; received from Dr. Irma 
Sanchez-Vargas at Colorado State University) was amplified by seeding T-25 flasks of C6/36 
cells with a low multiplicity of infection (MOI) of a low passage virus stock (<4 passages) and 
incubated for 10 days in maintenance medium. Virus was harvested by scraping cells and 
clarified by centrifugation for 10 minutes at 1000xg at 4C in a tabletop centrifuge. Viral stock-
containing supernatants were adjusted to 20% FBS and 1 mL aliquots were immediately frozen 
at -80C and were used once and discarded to avoid loss due to repeated freeze-thaw cycles. 
Viral stocks were titered by making ten-fold serial dilutions in cold DMEM with 10% FBS and 
plating 0.5 mL of each dilution per well of confluent monolayers of LLC-MK2 cells in 12 well 
plates. The virus was allowed to adsorb for 2 hours at 37C in the incubator and then cultures 
were overlaid with a solution containing 2% methylcellulose in 0.5x MEM growth medium in PBS 
and allowed to incubate for 14 days at 37C. Virus was inactivated by addition of 7% 
formaldehyde (v/v in PBS) and incubation at room temperature for 2 hours. The viscous overlay 
was removed by pipetting and monolayers were washed gently with cold water. Crystal violet 
stain (2% crystal violet in 80% methanol) was added to each monolayer for 10 minutes then 
rinsed multiple times with cold water to visualize plaques.  
 Kunjin virus (KUNV) strain FLSDX (GenBank AY274504.1; a gift from the Khromykh 
laboratory but initial stocks were grown by the Bowen laboratory) and the mutant KUNV 
IRAΔCS3 (described in Pijlman et al. 2008) were amplified on Vero or BHK-21 cells. At four 
days post infection (or when cytopathic effect was evident) virus was collected as described 
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above. The concentration of virus stocks was determined by plaque titrations on BHK-21 or 
Vero cells as described above, except that plates were incubated for 5 days. 
 For BVDV propagation, we first received an aliquot of cytopathic bovine viral diarrhea 
virus, Singer strain type 1a (GenBank DQ088995.2) from Dr. Hana van Campen (Colorado 
State University) and virus was amplified on MDBK cells. BVDV was collected at 3 days post 
infection, medium was clarified by centrifugation, and aliquots were frozen at -80C. Virus was 




 Possession of all viral stocks and basic uses thereof was approved by the CSU 
Biosafety Office. Viral infections were performed as follows. Sub-confluent 293T cells (flavivirus 
infections) or MDBK cells (BVDV infections) were infected at an MOI of 1 or higher as indicated 
for each experiment. Virus was adsorbed for 2 or more hours and washed twice with warm 
(37oC) maintenance medium to remove residual viral particles. Cells were collected 24, 36, 48, 
or 96 hours later as indicated for analyses. Mock infected cells were also washed twice with 
warm maintenance medium. Hepatitis C virus infections (JFH-1 strain or using a replicon) were 
performed by Dr. Shelton Bradrick at Duke University and samples were collected for RNA 
isolation at 72 hours post infection. 
 
Kunjin virus mutagenesis and analysis of small RNAs from the viral 3’ UTR 
 
 Mutant Kunjin viruses predicted (by Chapman and Kieft, UC-Denver, personal 
communication and described in Chapman et al. 2014) to have defective sfRNA formation 
during infection were generated by overlap extension PCR. The FLSDXpro_HDVr Kunjin virus 
infectious clone (from the Khromykh laboratory; Liu et al. 2003) was used as a template for the 
construction of six individual mutant viruses. The high fidelity Phusion Hot Start II polymerase 
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(Thermo Scientific) was used for PCR using the mutagenic primers listed in Table 1 and 
assembled PCR products were inserted into the Age1 and Xho1 restriction sites. Plasmids were 
screened for the proper mutations by sequencing PCR amplicons or maxiprepped clones using 
the following primers: FLSDX Fw: 5’- ACTTTGTTAATTGTAAATAAATATTGTTAT; FLSDX Rv: 
5’-GCGTGGGACGTTGATTCGCCTTTGT. Plasmids were linearized with Xho1 and in vitro 
transcriptions performed using the MEGAscript® SP6 transcription kit (Life Technologies) 
followed by Turbo DNase treatment to remove template. Viral RNAs were purified by phenol-
chloroform-isoamyl alcohol (25:24:1) extraction and ethanol precipitation before RNA 
concentrations were determined. BHK-21 cells (one 90% confluent T-75 flask per virus) were 
electroporated with 5-10 µg of viral RNA, and virus was amplified by passaging once on BHK-21 
cells to generate working stocks. Viral titers were assessed by plaque titrations, infections were 
performed in 293T cells (MOI of 10), and total cellular RNA was collected at 48 hpi using 
TRIzolTM (Invitrogen). Total RNA was treated with DNase I (Fermentas) to remove residual 
genomic DNA. Northern blotting was performed as described below using 2 µg of total RNA 
from each sample and sfRNAs detected by using a probe complementary to the entire KUNV 3’ 
UTR.   
Table 1. Mutagenic primers used for the construction of six KUNV mutants predicted to 




Flanking primers CATACCGGTCGGAAAAGTGATCGACCTTGG CATCTCGAGCAATTGTTGTTGTTAACTTG 
UCA10498 AGTGAGGATCACAGGCCGG CCGGCCTGTGATCCTCACT 
G10519 TTCCCGGCACCGGAAGTTGAG CTCAACTTCCGGTGCCGGGAA 
G10680 TGGCGTGGCACTCTGCGGAG CTCCGCAGAGTGCCACGCCA 




 For mammalian transfections, the peGFP-N1 plasmid (Clontech; GenBank U55762.1) 
was used as a reporter plasmid. The DENV-2 3’ UTR (Jamaica 1409, 10273-10723) was 
amplified by RT-PCR from infected cell RNA and cloned into the Not1 site of the 3’ UTR of 
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eGFP. For in vitro transcription templates, viral sequences were inserted into the pGEM-4 
(GenBank X65303.1) multiple cloning site to permit either SP6 or T7 transcription to generate 
reporter RNAs, competitor RNAs, or internally labeled riboprobes. The first stem-loop of the 
DENV-2 3’ UTR was cloned into pGEM-4 in the XbaI and HindIII sites and was used as a 
reporter RNA for in vitro XRN1 decay assays (by John Anderson). For the DENV-2 competitor 
RNA, the 5’ half of the viral 3’ UTR was inserted into the XbaI and HindIII sites of pGEM-4 (by 
John Anderson). The HCV IRES element (nucleotides 1-389; Strain H77, GenBank 
AF009606.1) was cloned into pGEM-4 using the HCV16LUC plasmid (Bradrick et al. 2006) as a 
PCR template and inserted into the EcoRI and XbaI sites. The BVDV IRES element 
(nucleotides 1-440; GenBank DQ088995.2) was cloned into the EcoRI and HindIII sites of 
pGEM-4 using RNA from infected MDBK cells as RT-PCR template to amplify the BVDV insert. 
The first 200 nucleotides of the JEV 3’ UTR (isolate TC2009-1 GenBank JF499790.1, 
nucleotides 10395-10965) was cloned by assembly PCR into pGEM-4 in the HindIII and EcoRI 
sites (by Benjamin Dodd). All sequences are reported in Table 2. The probe template for sfRNA-
like decay intermediates from the peGFP-N1 plasmid containing the DENV-2 3’ UTR was 
generated by cloning the 3’ UTR of eGFP into the EcoRI and HindIII restriction sites of pGEM-4. 












Table 2. Sequences inserted into the pGEM-4 or peGFP-N1 vectors for this study.  





















JEV 5' end 


























Templates for generation of radiolabeled RNA constructs 
 
 Templates for in vitro transcriptions to generate radiolabeled reporter or competitor 
RNAs were obtained by linearizing pGEM-4 plasmids containing segments of the DENV-2 or 
JEV 3’ UTR or the HCV or BVDV IRES elements (as described above). To make the control 
reporter RNA or the DENV-2 sfRNA reporter, the pGEM-4 plasmid with or without the first stem-
loop of the DENV-2 3’ UTR (respectively) was linearized with Ear1 (Figure 6). In Figure 8, the 5’ 
half of the DENV-2 and the 5’ proximal 200 nt of the JEV reporter RNAs were generated by 
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linearizing the respective plasmids with HindIII. All DENV-2 competitor RNAs were generated by 
digesting the pGEM-4 plasmid containing the 5’ half of the DENV-2 3’ UTR with HindIII. For all 
competition assays, the control competitor template was made by digesting the empty pGEM-4 
vector with Sml1, and the reporter RNA was generated by linearizing pGEM-4 with Ear1. The 
reporter and competitor RNAs containing the HCV or BVDV 5’ UTRs were made by digesting 
the pGEM-4 plasmids containing the HCV or BVDV IRES elements with HindIII. 
 
In vitro transcriptions and in vitro XRN1 decay assays 
 
 Radiolabeled, capped or monophosphorylated reporter or competitor RNAs were 
transcribed using SP6 polymerase with linearized pGEM-4 templates as previously described 
(Wilusz and Shenk 1988) and gel purified. Probes for northern blots were generated using T7 
polymerase and EcoRI linearized pGEM-4 derivative templates (described above) and were 
also gel purified.  Radiolabeled RNAs were generated using α 32P-UTP with 10x molar excess 5’ 
GMP or 7meGpppG cap analog to create 5’ monophosphorylated (permissive) or 5’ capped 
(non-permissive) substrates for XRN1. About 30 fmol of radioactive RNAs were incubated in 
mosquito C6/36 or human HeLa cell cytoplasmic extracts (S100, prepared as described in 
Sokoloski et al. 2008 and Ford et al. 1999, respectively) or with recombinant yeast XRN1 
protein (New England Biolabs) and samples were collected at the indicated times by addition to 
400 µL HSCB solution. For competition assays, a 30x molar excess of lightly radiolabeled 
DENV-2 or JEV 3’ UTR or 66.7x molar excess of the BVDV or HCV 5’ UTR constructs were 
incubated with ~30 fmol of the reporter RNA. RNAs were purified by phenol chloroform isoamyl 
alcohol (25:24:1) extraction and ethanol precipitation using tRNA or glycogen as carrier and 
resolved on 5% denaturing polyacrylamide gels containing 7M urea. Decay products were 






 All plasmids were amplified in DH5α and purified using the Invitrogen PureLink HiPure 
plasmid maxiprep kit. Residual endotoxin was removed using the MiraClean endotoxin removal 
kit (Mirus). Human 293T cells were transfected using Lipofectamine 2000 (Life Technologies) 
with Opti-MEM1 Reduced Serum Medium according to the manufacturer’s instructions. Total 




 Cells were grown on coverslips or in 8-well chamber slides and at the indicated times 
post-infection were washed with cold PBS. Coverslips or chamber slides were then incubated 
with rocking at room temperature under 4% paraformaldehyde in PBS, then methanol, then 70% 
ethanol to fix and permeabilize cells. Cells were then blocked with 6% bovine serum albumin 
(Fraction V; Fisher) in PBS for 1 hour at room temperature or 4C overnight and stained with 
primary antibody to BVDV (Veterinary Medical Research and Development; bovine viral 
diarrhea virus types 1 and 2 Mab 3.12F1; 1:100) in 0.6% bovine serum albumin in PBS 
overnight at 4C with rocking. Coverslips were washed three times with PBS and incubated with 
secondary antibody (goat anti-mouse AlexaFluor 594; Life Technologies; 1:2,000) for 1 hour at 
room temperature, washed 5 times with PBS, and mounted using ProLong Gold with DAPI 
(Invitrogen). Cells were visualized using an Olympus IX71 inverted microscope and 




 Protein lysates from MDBK cells infected with BVDV for 24 hours or mock infected were 
generated by pelleting the cells, washing twice with cold PBS, and resuspending the pellets in 
RIPA buffer (50 mM Tris-Cl pH 7.5, 0.5% sodium deoxycholate [w/v], 1% NP-40 [v/v], 0.05% 
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sodium dodecyl sulfate (SDS) [w/v], 150 mM sodium chloride, 1 mM EDTA). Protein 
concentrations were determined by the Bradford assay (BioRad) and 20 g (for anti-JUN blots) 
or 30 g (for anti-FOS blots) total protein were separated by SDS-PAGE and transferred onto 
nitrocellulose membranes using a Trans-Blot Semi-dry Transfer cell (BioRad). Membranes were 
blocked with 5% milk in TBST (10 mM Tris -Cl pH 8, 150 mM sodium chloride, 1% Tween 20) 
overnight at 4C or 1 hour at room temperature, and primary antibody (rabbit anti-c-JUN [H-79; 
Santa Cruz Biotechnology; 1:200]; rabbit anti-c-FOS [H-125; Santa Cruz Biotechnology; 
1:1,000]; mouse anti-GAPDH [Millipore; 1:1,000]) was added to the blocking solution and rocked 
overnight at 4C. Blots were washed three times with TBST and secondary antibody (goat anti-
rabbit IgG HRP conjugate [BioRad; 1:20,000]; goat anti-mouse IgG HRP conjugate [Santa Cruz 
Biotechnology; 1:20,000]) in 5% milk (in TBST) was added and incubated for 1 hour at room 
temperature or overnight at 4C. SuperSignal West Pico chemiluminescent substrate (Thermo 
Scientific) was used to visualize HRP conjugates using a VersaDoc Imager and ImageLab 
software (BioRad). Relative band quantification was done by volumetric analysis and c-JUN or 
c-FOS values were normalized to GAPDH.  
 
Analysis of sfRNA-like decay intermediates by northern blotting 
 
For analysis of intermediates generated from eGFP RNAs containing the DENV-2 3’ 
UTR, 1 g of total RNA from transfected cells at 48 hpt was analyzed by northern blotting 
(described below). To determine if treatment of cells transfected with peGFP-N1 +/- the DENV-2 
3’ UTR with an siRNA to eGFP enhanced the formation of the DENV-2 sfRNA-like decay 
intermediate, 1 g of total RNA from cells collected at 24 hpt was analyzed. Decay 
intermediates generated from eGFP RNAs containing the BVDV or HCV IRES elements were 
detected at 48 hours post transfection in cells co-transfected with an anti-eGFP siRNA 
(described below) by northern blotting using 2 g of total RNA from cells that had been exposed 
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to actinomycin D for 30 minutes. For flavivirus sfRNA detection, 1 g of total RNA from cells 
infected with KUNV (0, 36, and 48 hpi) or DENV-2 (0, 3, and 4 dpi) was analyzed. 
For the detection of sfRNA-like decay intermediates from eGFP reporters or sfRNAs 
from DENV-2 or KUNV infected cells, total cellular RNA (1 or 2 g as indicated above) was 
separated on 5% denaturing polyacrylamide gels. To assess eGFP knockdown by northern blot, 
5 g of total RNA from transfected and infected (or mock-infected) cells was resolved on a 
denaturing agarose gel, and ethidium bromide-stained ribosomal RNA was visualized to ensure 
equal loading. RNA was then transferred onto a nylon membrane (Hybond-XL; GE Healthcare) 
by capillary action (agarose gels) or using a tank transfer unit (acrylamide gels). The blots were 
UV cross-linked before blocking for 30 minutes at 60C in hybridization solution (50% 
formamide, 1 mg/mL bovine serum albumin, 750 mM sodium chloride, 75 mM sodium citrate, 
0.1 mg/mL salmon sperm DNA, 1% SDS, 1 mg/mL polyvinylpyrrolidone, 1 mg/mL ficoll). In vitro 
transcribed, internally radiolabeled RNA probes (gel purified) complementary to the 3’ UTR of 
either KUNV, DENV-2, or a probe complementary to a region surrounding the siRNA-cleavage 
site of the eGFP open reading frame were used to detect sfRNAs by probing in hybridization 
buffer overnight at 60C. Blots were washed three times with wash solution (300 mM sodium 
chloride, 0.1% SDS, 30 mM sodium citrate) and three times with stringent wash solution (30 mM 
sodium chloride, 0.1% SDS, 3 mM sodium citrate) for twenty minutes each at 60C. Hybridized 
RNAs were visualized by exposing the blot on storage phosphor screens and imaging on the 
Typhoon Trio Imager (GE Healthcare).  
 
Analysis of mRNA stability and abundance 
 
 To generate mRNA decay curves, 293T cells were either mock infected or infected with 
DENV-2 (MOI of 1) or KUNV (MOI of 5), or MDBK cells were mock infected or infected with 
cytopathic BVDV (MOI of 10). At the indicated times post infection (3 or 4 dpi for DENV-2; 36 or 
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48 hpi for KUNV; 24 hpi for BVDV) the medium was replaced with fresh maintenance medium 
containing 5 g/mL of actinomycin D (Sigma) and incubated for 30 minutes before collecting the 
initial time point by resuspending the cell monolayer in TRIzolTM. The pLKO.1 and XRN1 shRNA 
expressing stable cell pools were analyzed after puromycin selection in the same manner. 
Analysis of mRNA stability in cells transiently transfected cells expressing the eGFP reporter 
with or without the DENV-2 3’ UTR was done by transcriptional shutoffs at 48 hours post 
transfection. Following transcription shut-off, RNA was extracted following the manufacturer’s 
protocol and treated with DNase I (Fermentas) to remove any residual genomic DNA. Total 
RNA from HCV (JFH-1 strain) infected Huh7.5 cells was obtained from Dr. Shelton Bradrick for 
half-life analysis. Reverse transcription using Improm-II reverse transcriptase (Promega) was 
performed by first annealing 0.5 or 1 g of total RNA with random hexamer primers (0.5 µg per 
reaction in a total volume of 5 µL) at 70ºC for 5 minutes and reaction tubes were immediately 
placed on ice. Each reaction then received 4 µL reverse transcription buffer (5x), 5.6 µL water, 1 
µL dNTPs (10 mM each), 2.4 µL magnesium chloride (25 mM), 1 µL RNase inhibitor, and 1 µL 
reverse transcriptase. The reactions were then incubated at 25ºC for 5 minutes, 42ºC for 1 hour, 
and 70ºC for 5 minutes in a thermocycler. The resulting cDNA was then diluted 1:1 with water to 
yield a total volume of 40 µL. 
 Quantitative PCR (qPCR) using the CFX96 real time PCR system (Bio-Rad) was then 
performed using SYBR green supermix. Each 10 µL qPCR reaction was generated by dividing a 
~30 µL master mix containing 2.64 µL cDNA solution plus 15 µL SYBR green supermix, 10.2 µL 
water, and 1.2 µL each primer (at 2.5 µM) into 3 reactions. All qPCR reactions were done using 
a two-step amplification procedure with an annealing temperature of 60ºC using clear 96 well 
plates. The abundance of each transcript in each time point indicated was determined relative to 
GAPDH (human cells) or ACTB (bovine cells) using the Ct method and plotted to determine 
half-life using an exponential decay curve. Primers were designed using the NCBI Primer-
79 
 
BLAST tool such that the annealing temperature was ~60ºC, the amplicon was ~100-200 nt in 
length, and all RNA isoforms in GenBank would be amplified (if applicable). Primers used for all 
qPCR experiments were standardized using ten-fold serial dilutions of plasmid or cDNA and 
only used if they had 89-110% efficiency (listed in Table 3). The average half-life plus or minus 
the standard deviation of two independent infections (for DENV-2 and KUNV infections) or three 
infections (BVDV and HCV) are reported, and Student’s t-test was used to determine 
significance. Error bars indicate standard deviation of each qPCR measurement from a 
representative decay curve. 





Organism/Virus Forward Reverse 
Efficiency 
(%) 

































































Dengue virus type 








Dengue virus type 



















































































































For all mRNA abundance experiments, the average, plus or minus the standard 
deviation of three infections are reported. RNA from Kunjin virus infected 293T cells (MOI of 5) 
was analyzed at 48 hpi for CXCL11, OASL, IL6, and CCL2 abundances. HCV (72 hpi) infected 
(or HCV replicon-expressing) purified cellular RNA was obtained from Dr. Shelton Bradrick. To 
determine the relative abundances of transcripts previously shown to be up-regulated upon 
AGO2 and/or DICER knockdown (Schmitter et al. 2006), human 293T cells were infected with 
KUNV (MOI of 10) or DENV-2 (MOI of 3) and RNA was collected at 60 hpi or 4 dpi 
(respectively). For transcript abundances in BVDV infections, MDBK cells were infected at a 
multiplicity of infection of 10 and RNA was collected at 24 hpi. 
 
Global analysis of RNA stability by RNA-seq 
 
 To determine if XRN1 suppression by sfRNA was correlated with stabilization of host 
mRNAs in general, we performed global analyses of RNA stability using RNA-seq. Another 
positive-sense ssRNA arthropod-borne virus, SINV, was used as a control for these studies and 
was previously shown to alter cellular mRNA stability by sequestering the cellular HuR protein 
(Barnhart et al. 2013). Human 293T cells were mock infected or infected with SINV (strain 
MRE16; MOI of 10) or the Kunjin viruses (MOI of 5) in triplicate cultures. Cells were treated with 
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actinomycin D (5 g/mL) for transcriptional shutoff at 24 hpi (Sindbis virus) or 48 hpi (KUNV or 
IRAΔCS3 KUNV). Four time points were collected: 0 (30 minutes post addition of actinomycin 
D), 0.5 hours, 1.5 hours, and 3 hours post shut-off. RNA was extracted from cell monolayers 
using TRIzolTM (Invitrogen) and 5 g of total RNA were sent to Rutgers University- New Jersey 
Medical School for library preparation and bioinformatics analysis by Drs. Bin Tian, Mainul 
Hoque, and Liu Liang. The purity and quality of all RNA samples was verified using a 
Bioanalyzer (Agilent) before pooling each triplicate sample and processing. Relative RNA 
abundances were gleaned from the 0 time point. For mRNA abundance comparisons, only 
transcripts that were detected in both conditions (RPKM >0.01) were analyzed. Gene Ontology 
analyses were done using DAVID and functional annotation of transcripts was done using the 
GOTERM_BP_FAT tool (Huang et al. 2009(a), Huang et al. 2009(b)). 
 
Global analysis of mRNA abundances by microarray 
 
 All microarray sample preparation and bioinformatic analyses were performed by Dr. 
Alexander Khromykh (University of Queensland, Brisbane, Australia), Dr. Yutaro Kumagai and 
Dr. Shizuo Akira (both at Osaka University, Suita, Osaka, Japan). Interferon-α receptor knock-
out mouse embryonic fibroblasts (IFNAR-/- MEF) were infected with either the sfRNA-deficient 
mutant IRAΔCS3 KUNV or the wild-type KUNV (FLSDX) at an MOI of 1 (described in Pijlman et 
al. 2008). Total RNA was collected from the cell monolayers at 48 hpi using TRIzolTM 
(Invitrogen), purified using an RNeasy Mini kit (Qiagen) and cDNA libraries were generated with 
the WT-Ovation RNA Amplification System and Encore Biotin Module (Nugen). Mouse 430 2.0 
Arrays (Affymetrix) were hybridized with the cDNA library and processed according to the 
manufacturer’s recommendations. For analysis, robust multiarray analyses values were 
generated and genes with a 3-fold or higher difference after transforming to yield a mean value 
of 0 with standard deviation of 1 underwent hierarchical clustering according to Akaike’s 
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information criteria to generate six clusters. The programs R and Bioconductor were used for all 
calculations.    
 
 
Fractionation of capped and uncapped mRNAs 
 
 To determine the relative amount of uncapped transcripts in infected cells, RNA was 
extracted from cells at 4 dpi (DENV-2), 2 dpi (KUNV) or 3 dpi (HCV JFH-1 strain or from Huh7.5 
cells expressing an HCV replicon from Dr. Shelton Bradrick) using TRIzolTM and 5 g was 
fractionated by immunoprecipitation using an antibody to the m3G and m7G cap structure 
(Synaptic Systems) using the manufacturer’s protocol with sepharose G beads. RNA was 
isolated from 10% of the input, the unbound supernatant fraction, and the immunoprecipitated 
fraction.   RNA from all fractions was reverse transcribed for the analysis of mRNA stability as 
described above. qPCR was done to detect the relative abundance of two short-lived transcripts 
FOS and TUT1, using the uncapped 7SL RNA as a reference gene to account for differences in 
fractionation efficiencies. For DENV-2 and KUNV infections, a representative graph depicting 
FOS and TUT1 mRNA abundance in the supernatant fraction normalized to the 10% input is 
shown. For HCV infections and HCV replicon expressing cells, the average amount of FOS and 
TUT1 relative to 7SL in the supernatant fraction normalized to the 10% input is reported plus or 
minus standard deviation of values from three independent infections. The relative abundances 
of capped and polyadenylated mRNAs were determined by performing reverse transcriptions 
using equal volumes of immunoprecipitated (capped) RNA and oligo-d(T) primer. The Ct 
method was used to normalize each transcript to GAPDH using the primers reported in Table 3.  
 
Co-immunoprecipitation of XRN1, AGO2, or DICER and viral RNAs 
 
 Human 293T cells were infected with KUNV (MOI of 5, 2 dpi) or DENV-2 (MOI of 1, 4 
dpi), or MDBK cells were infected with BVDV (MOI of 10, 1 dpi). XRN1-RNA co-
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immunoprecipitations from BVDV infected cells were performed as described in 
(Niranjanakumari et al. 2002) using the commercially available XRN1 C-1 antibody (Santa Cruz 
Biotechnology). For other immunoprecipitations, cells were washed three times with ice-cold 
PBS, overlaid with 1% formaldehyde (in PBS) to capture protein-RNA interactions, and rocked 
at room temperature for 15 minutes. To quench the reaction, glycine was added to a 
concentration of 0.25 M and cells were again rinsed with cold PBS three times. Cells were 
scraped into 500 L of cold RIPA buffer plus 1 L of RiboLock RNase Inhibitor (Fermentas) and 
frozen at -80C. Samples were then thawed on ice, sonicated to lyse cells and were then 
centrifuged to clarify. To immunoprecipitate XRN1-RNA complexes, 10% of the input was saved 
at -80C and lysate was incubated with either 2 L of XRN1 antibody (a gift from Dr. Jens 
Lykke-Andersen, UCSD), 20L of rabbit anti-DICER (Santa Cruz Biotechnology; clone H-212; 
sc-30226), 12 L of rat anti-AGO2 (Millipore; clone 11A9; MABE253) or an equal amount of 
normal rabbit (Santa Cruz Biotechnology; sc-2027) or mouse (Santa Cruz Biotechnology; sc-
2025) IgG plus 1 L of RNase Inhibitor (Fermentas) for 1 hour, rotating at 4C. Rehydrated 
Pansorbin Staph A-positive cells (Calbiochem) (or protein G sepharose 4 fast flow (GE 
Healthcare) for AGO2 immunoprecipitations) were then added to the lysates and rotated for 15 
minutes at 4 C. Pansorbin cells were pelleted and resuspended in RIPA buffer containing 1 M 
urea and washed five times with vigorous intermittent vortexing. Pellets were resuspended 
finally in TEDS buffer (50 mM Tris-Cl pH 7.0, 5 mM EDTA, 1% SDS and 10 mM DTT). All 
samples (including the 10% input) were then incubated at 70 C with shaking for 45 minutes to 
reverse cross-links. Pansorbin was pelleted and RNA was isolated from supernatants using 
TRIzolTM and glycogen as a carrier. Any residual genomic DNA was removed by treating with 
DNase I (Fermentas), and an equal volume of RNA from each fraction was reverse transcribed 
with Improm-II reverse transcriptase as described above. Either semi-quantitative PCR using 
GoTaq Flexi polymerase (Promega) or quantitative real time PCR (SYBR green, as above) was 
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performed with primers to the DENV-2 3’ UTR or open reading frame, the KUNV 3’ UTR or open 
reading frame, or the BVDV 5’ UTR (see Table 3 for sequence information). For qPCR 
quantification, the abundance of viral 3’UTR was compared to the abundance of viral open 
reading frame sequences and both were normalized to the 10% input fraction. For semi-
quantitative PCR, products were resolved on a 2% agarose gel and stained with ethidium 
bromide. 
 
eGFP knockdowns for RNA interference analysis 
 
 Human 293T cells were mock infected or infected with KUNV (MOI of 10) or DENV-2 
(MOI of 3) and at 24 hpi (KUNV-2) or 3 dpi (DENV-2) cells were transfected with 1 g of peGFP-
N1 plasmid with an siRNA to eGFP (5’-GCAAGCUGACCCUGAAGUUCAU) or an equal volume 
of water. After 24 hours, cell monolayers were dissolved in TRIzolTM and RNA was extracted 
according to the manufacturer’s protocol. Residual plasmid DNA was removed by digesting with 
DpnI and/or EcoRI (New England Biolabs) in the presence of RNase Inhibitor (Fermentas) 
followed by Turbo DNase treatment (Life Technologies) as done by Lee et al. (2012b). The 
abundance of eGFP mRNA in each sample was determined by northern blotting using 5 g of 
total RNA and quantified using RT-qPCR as above using the primers to the eGFP open reading 
frame spanning the siRNA cleavage site, indicated in Table 3. To measure the relative amount 
of eGFP knockdown in each condition by RT-qPCR, eGFP abundance in the siRNA treated 
samples was determined relative to the eGFP plus water control, and GAPDH was used as a 
reference gene. A representative northern blot is shown from each infection and the average +/- 
the standard deviation of RT-qPCR measurements from two independent transfections per 







Section I. Modulation of cellular mRNA stability by a non-coding flavivirus RNA  
 
Dengue virus type 2 sfRNA is generated by XRN1-mediated decay 
 
 Previous studies implicated XRN1 in the formation of sfRNA by demonstrating that 
XRN1-depleted cells infected with KUNV or YFV generated less sfRNA than wild-type cells 
(Pijlman et al. 2008; Silva et al. 2010). Furthermore, incubation of RNAs containing the YFV 3’ 
UTR with recombinant yeast XRN1 caused an sfRNA-like decay intermediate to form in vitro 
(Silva et al. 2010). We sought to expand these findings to determine if DENV-2 sfRNA formation 
by XRN1 was recapitulated in mammalian and mosquito systems. Because XRN1 specidically 
degrades monophosphorylated RNAs, we used 5’ monophosphorylated radiolabeled reporter 
RNAs containing either a control sequence or the DENV-2 3’ UTR to assess sfRNA formation in 
cytoplasmic extracts under conditions that favored 5’-3’ decay by XRN1. Reactions using 
recombinant yeast XRN1 were also performed to generalize the findings reported in Silva et al. 




Figure 6. Dengue virus type 2 sfRNA is formed as XRN1 stalls on the viral 3’ UTR. 
5’ monophosphorylated, radiolabeled reporter RNAs containing either the pGEM-4 
plasmid control sequence (Reporter Only) or the dengue virus type 2 3’ UTR (Reporter + 
DenV 3’ UTR) were incubated with (A) recombinant yeast XRN1 enzyme, (B) HeLa cell 
cytoplasmic extract, or (C) C6/36 mosquito cell cytoplasmic extract for the indicated times 
under conditions that favored 5’-3’ decay by XRN1. Decay products were separated on 
5% polyacrylamide gels and visualized by phosphorimaging. sfRNA-like decay products 
are indicated at right. This experiment was performed in our laboratory by John R. 
Anderson.  
 
When incubated with recombinant yeast XRN1, the control reporter RNA degraded rapidly and 
did not generate any decay intermediates. However, the addition of the DENV-2 3’ UTR to the 
reporter RNA caused an sfRNA-like decay intermediate to accumulate as the full-length RNA 
was rapidly degraded (Figure 6A). Importantly, a robust sfRNA-like decay intermediate was also 
observed as the 3’ UTR of DENV-2 was degraded in cytoplasmic extracts from HeLa cells 
(Figure 6B) or C6/36 mosquito cells (Figure 6C). These experiments strongly suggest that the 
structural elements in the DENV 3’UTR responsible for sfRNA formation can stall both 
mammalian and mosquito 5’-3’ exoribonuclease (presumably XRN1) activity, and that 
cytoplasmic extracts lack other activities capable of efficiently degrading sfRNA. 
 
sfRNA formation suppresses XRN1 activity 
 
 sfRNA accumulates to high levels during flavivirus infections (Pijlman et al. 2008) and 
therefore could potentially have a significant effect on cellular gene expression if it is able to 
sequester host factors.. Because XRN1 is highly processive and is able to degrade many 
endogenous highly structured RNAs (Jinek et al. 2011; Stevens 2001; Stevens 1978), and yeast 
XRN1 has been shown to stall on G-tracts or artificial C-G stem-loops (Decker and Parker 1993; 
Vreken and Raue 1992), we wondered if the stalling of XRN1 on flavivirus RNAs could also 
suppress XRN1 activity. If sfRNA remained associated with XRN1 for a time after stalling 
because the enzyme could not rapidly dissociate from the RNA substrate, then overall 
availability of XRN1 would be compromised by sfRNA formation and cellular substrates for 
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XRN1-mediated decay (i.e. decapped 5’ monophosphorylated transcripts) would be stabilized, 
much as is seen when XRN1 is depleted in yeast (Blewett et al. 2011).  
We used cytoplasmic extracts from HeLa and C6/36 cells as well as recombinant yeast 
XRN1 protein in competition assays to determine if the ability of XRN1 to degrade a 
monophosphorylated control RNA was impeded by sfRNA formation. Figure 7A shows the 
results of our competition assays in HeLa extract. On average, ~30% of a monophosphorylated 
reporter RNA remained after incubation in HeLa cytoplasmic extract for 30 minutes. Similar 
levels of the reporter RNA remained when a 30-fold molar excess of a lightly radiolabeled non-
specific competitor transcript (generated from the linearized pGEM-4 vector) was added to the 
reaction. Interestingly, the addition of a 5’ capped DENV-2 3’ UTR competitor RNA that contains 
the necessary structures required for sfRNA formation but is not a substrate for XRN1 due to its 
blocked 5’ end, had no effect on the decay of the reporter RNA as ~31% of the RNA remained 
after 30 minutes. However, when the DENV-2 3’ UTR competitor RNA contains a 5’ 
monophosphate and is therefore a substrate for XRN1, the reporter RNA was dramatically 
stabilized and ~70% of the RNA remained following the 30 minute incubation. Importantly, this 
effect was not only observed in human cell extracts, but also in C6/36 mosquito cell extracts 
(Figure 7B). Finally, the suppression of XRN1 activity observed in human and mosquito extracts 
did not require other cellular factors, as incubation of recombinant yeast XRN1 with the DENV-2 





Figure 7. Subgenomic flavivirus RNA formation inhibits XRN1 activity. A 5’ 
monophosphorylated RNA containing the DENV-2 3’ UTR inhibits 5’-3’ decay in (A) HeLa 
cell cytoplasmic extract, (B) C6/36 mosquito cell cytoplasmic extract and (C) with 
recombinant yeast XRN1 alone. The Control lanes do not contain competitor RNA. A 
lightly radiolabeled competitor RNA bearing either a 5’ cap or monophosphate was used 
at 30X molar excess of the 5’ monophosphorylated, radiolabeled reporter RNA for the 
indicated times. Non-specific competitor RNA was generated from a pGEM-4 template 
and compared to the DENV-2 3’ UTR competitor containing the 5’ half of the DENV-2 3’ 
UTR. Products were resolved on 5% polyacrylamide gels and visualized by 
phophorimaging. Numbers below the gels are the average +/- standard deviation of the 
percent RNA remaining in the last time point from three independent experiments. This 
experiment was performed in our laboratory by John R. Anderson. 
 
 
Suppression of XRN1 activity is likely a general property of sfRNAs 
 
 To determine if suppression of XRN1 activity is a general property of subgenomic 
flavivirus RNAs, we cloned the 5’ proximal 200 nucleotides of the JEV 3’ UTR which was 
predicted to harbor sfRNA-forming sequences/structures (Pijlman et al. 2008) and used our in 
vitro RNA decay assays to assess XRN1 activity. Figure 8A shows that a monophosphorylated 
reporter RNA containing the JEV 3’ UTR formed an abundant sfRNA in HeLa cell extracts as 
well as when incubated with recombinant yeast XRN1 in the absence of any other factors. A 
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monophosphorylated RNA containing the 5’ half of the DENV-2 3’ UTR (a ~230 nt RNA) was 
used as a positive control in these experiments. Furthermore, the presence of the JEV 3’ UTR 
radiolabeled competitor RNA provided at 30-fold molar excess was strongly associated with the 
stabilization of the monophosphorylated control RNA (Figure 8B), albeit not as potently as the 
DENV 3’ UTR. The JEV 3’ UTR RNA may have less apparent ability to suppress XRN1 activity 
compared to the DENV 3’ UTR RNA in this experiment for two reasons. First, the DENV 3’ UTR 
RNA harbors two XRN1-resistant structures capable of forming two sfRNAs (data not shown) 
and the JEV 3’ UTR RNA has only one XRN1-resistant structure. The DENV 3’ UTR RNA may 
therefore be more resistant to XRN1 than the JEV 3’ UTR RNA because of additional secondary 
or tertiary RNA structural elements that stabilize the sfRNA. Second, the DENV 3’ UTR RNA 
may be less susceptible to 3’-5’ decay in HeLa cytoplasmic extract than the JEV 3’ UTR RNA, 
as in Figure 8A we observe the depletion of the JEV sfRNA-like decay intermediate more rapidly 
than the DENV sfRNA-like decay intermediate, possibly through 3’-5’ decay. Therefore, the 
suppression of 5’-3’ exonucleolytic decay in HeLa cytoplasmic extract by the JEV 3’ UTR 
(Figure 8B) could be less potent than that of the DENV 3’ UTR because the JEV sfRNA-like 
decay intermediate is less stable (and therefore accumulates to lower levels) than the DENV 
sfRNA. These data indicate that sfRNA formation in and of itself is capable of repressing XRN1 






Figure 8. Suppression of XRN1 activity is likely a conserved function of flavivirus 
sfRNAs. (A) JEV sfRNA is formed as XRN1 stalls on the viral 3’ UTR. Radiolabeled, 5’ 
monophosphorylated reporter RNAs were incubated in HeLa cytoplasmic extract under 
conditions that favor 5’-3’ decay (left panel) or with recombinant yeast XRN1 (right panel) 
containing either pGEM-4 reporter sequence (Control RNA), the 5’ (proximal) 200 nt of 
the JEV 3’ UTR, or the 5’ half of the DENV-2 3’ UTR (used as a positive control). (B) 5’-3’ 
decay of a reporter RNA is inhibited in HeLa cytoplasmic extract in the presence of a 
competitor RNA containing the first 200 nt of the JEV 3’ UTR. A 5’ monophosphorylated 
radiolabeled reporter RNA containing the pGEM-4 sequence was incubated with a 30x 
molar excess of competitor RNA bearing a 5’ monophosphate containing either pGEM-4 
sequence (Control RNA), the first 200 nt of the JEV 3’ UTR (JEV 3’ UTR) or the 5’ half of 
the DENV-2 3’ UTR (DENV 3’ UTR) in HeLa cytoplasmic extract. RNAs were isolated 
from the reaction at the indicated times, resolved on 5% denaturing polyacrylamide gels, 
and exposed to a phosphorimager screen to visualize. The numbers below the gel in (B) 
are the average percent RNA remaining in each time point +/- the standard deviation. 
The experiment shown in (B) was performed by John R. Anderson and the first 200 
nucleotides of the JEV 3’ UTR was assembled by PCR and cloned into pGEM-4 by 
Benjamin J. Dodd.  
 
 Finally, to determine if XRN1 activity is suppressed during infection of human cells with 
flaviviruses, we measured the relative abundance of uncapped cellular transcripts that would 
likely normally be substrates for XRN1. We used an antibody that recognizes 5’ methylated 
RNA cap structure to fractionate total RNA purified from human 293T cells infected with DENV-
2 when sfRNA had accumulated to high levels (4 days post infection; dpi) or from mock infected 
cells. Antibody was used in excess so that all capped RNAs would be immunoprecipitated away 
from the uncapped RNAs. We used the uncapped 7SL RNA as a reference gene for RT-qPCR 
measurements and confirmed that its abundance was unchanged during viral infection. The 
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amount of uncapped transcripts in mock or DENV-2 infected cells relative to 10% of the RNA 
input was then determined. Figure 9 (top panels) shows that there was an increase in the 
relative abundance of two short-lived mRNAs, FOS and TUT1, in the uncapped fraction of RNA 
purified from DENV-2 infected cells relative to mock infected cells. Furthermore, this effect was 
not specific to DENV-2 infections, as uncapped mRNAs accumulated in KUNV infected cells (2 
dpi; bottom panels of Figure 9). Importantly, this increase in uncapped mRNAs was strongly 
associated with sfRNA formation. Cells infected with a mutant KUNV that cannot generate 
sfRNA (the CS3ΔIRA mutant described in Pijlman et al. 2008) did not cause an increase in the 
relative abundance of uncapped cellular transcripts (Figure 9, bottom panels). Therefore, we 
have observed defects in XRN1 activity due to sfRNA accumulation using both cell extract-
based experiments and cell culture models of infection.  
 
 
Figure 9. sfRNA accumulation during two flavivirus infections is correlated with an 
increase in the abundance of uncapped mRNAs. Human 293T cells were infected with 
dengue virus type 2 (DenV; top panels), Kunjin virus (KUN) or a Kunjin virus mutant that 
does not make sfRNA1 or sfRNA2 (KUN sfRNA-) at an MOI of 1, and total RNA collected 
2 dpi or 4 dpi (respectively). Following fractionation of total RNA with an antibody to the 5’ 
methylguanosine cap structure, RT-qPCR was performed to measure the relative 
abundance of two endogenous transcripts FOS and TUT1. Values shown above are from 




XRN1 may be sequestered by sfRNA 
 
 If sfRNA formation inhibited XRN1 activity, we hypothesized that the most likely scenario 
by which this could occur would be if the sfRNA acted as a reversible inhibitor of the enzyme. 
Therefore, the RNA should be physically associated with XRN1 for a time, potentially due to a 
slow rate of dissociation as XRN1 frees itself from the stable RNA decay product. To look for an 
association between sfRNA and XRN1, cells were infected with DENV-2 or KUNV, and at 4 dpi 
or 2 dpi (respectively) we assessed the interaction between XRN1 and sfRNA by RNA co-
immunoprecipitations using an antibody against XRN1. Protein-RNA interactions were stabilized 
in infected cells by formaldehyde cross-linking prior to cell lysis. As depicted in Figure 10A, we 
can observe the specific physical interaction between RNAs containing the DENV-2 or KUNV 3’ 
UTRs and XRN1 by semi-quantitative RT-PCR. Furthermore, RNAs containing the viral 3’ UTRs 
were enriched in the XRN1-co-immunoprecipitated fraction by ~4x or ~2x (respectively) 
compared to RNAs that contained the viral open reading frames as determined by qRT-PCR 
(Figure 10B). We normalized the abundances of the RNAs containing the viral 3’ UTR or open 
reading frame (ORF) in the XRN1 immunoprecipitation fraction to the 10% input fraction to 
account for the minimal increase in the overall amount of viral 3’ UTR-containing RNAs 
observed in infected cells due to sfRNA accumulation. Additionally, the efficiencies of the 
primers used to amplify the viral 3’ UTR or ORF were within 2% of each other, and therefore 
differences in primer efficiency did not account for these observations. Overall, these data 





Figure 10. Subgenomic flavivirus RNA is physically associated with XRN1 during 
infection. Lysates generated from formaldehyde cross-linked 293T cells infected with 
dengue virus type 2 (DenV; MOI of 1) or Kunjin virus (KUN; MOI of 1) for 4 days or 2 
days (respectively) were immunoprecipitated with XRN1 antibody (α-XRN1 lanes) or 
matched quantities of normal rabbit IgG (IgG lanes) and co-precipitating RNAs were 
detected by RT-PCR (A) or RT-qPCR (B) using primers to the viral open reading frame 
(ORF) or the 3’ untranslated region (3’ UTR). In (B), the relative RNA levels in the XRN1 




Cellular mRNA stabilization is strongly associated with sfRNA accumulation 
 
 Because XRN1 is the major 5’-3’ exoribonuclease in the cytoplasm of yeast and 
mammalian cells (Nagarajan et al. 2013; Bashkirov et al. 1997; Stevens 1978), and deletion or 
siRNA-mediated depletion of XRN1 results in increased mRNA stability in yeast (Blewett et al. 
2011; Haimovich et al. 2013; Sun et al. 2013) and an ARE-containing reporter RNA in 
mammalian cells (Stoecklin et al. 2006), we wondered if defects in XRN1 activity due to sfRNA 
formation might influence the rate at which cellular mRNAs were degraded. Therefore, we first 
created a pool of human 293T cells stably expressing a short hairpin RNA (shRNA) to XRN1 to 
deplete the exonuclease. Figure 11A shows that the abundance of XRN1 mRNA in this cell pool 
was reduced to ~30% compared to cells stably expressing the pLKO.1 empty vector. To 
determine if XRN1 depletion alters the stability of endogenous cellular mRNAs, we performed 
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transcriptional shut-offs using actinomycin D and followed the degradation of two short-lived 
transcripts (FOS and TUT1) by RT-qPCR over a time course. Figure 11B shows that TUT1 and 
FOS mRNAs are significantly stabilized in the cells deficient in XRN1 compared to the control 
cells harboring pLKO.1. The TUT1 mRNA was 1.6-fold more stable and FOS was 1.8-fold more 
stable on average in cells depleted of XRN1 (average half-lives are reported in the graph insets 
in Figure 11). These transcripts, therefore, are very likely to be degraded by XRN1 in human 
293T cells.  
 
 
Figure 11. XRN1 depletion leads to increased stability of two short-lived transcripts 
in human 293T cells. (A) The abundance of XRN1 mRNA was assessed using RT-
qPCR to show XRN1 knockdown efficiency in human 293T cells stably expressing an 
shRNA to XRN1(XRN1 KD) compared to cells expressing the empty vector pLKO.1 
(LKO.1).  (B) The stability of FOS and TUT1 mRNAs was determined after transcriptional 
shutoff by actinomycin D treatment by RT-qPCR using GAPDH as a reference gene. 
Average half-lives (minutes) +/- the standard deviation are reported from two 
independent experiments. * indicates p<0.05 by Student’s t-test. 
 
As reduction of XRN1 activity leads to stabilization of cellular mRNAs (Figure 11) and 
sfRNA inhibits XRN1 in vitro (Figure 8) we predicted that cellular mRNAs were likely to be 
stabilized during flavivirus infections. To test this, we performed transcriptional shut-off 
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experiments by applying actinomycin D to mock infected or DENV-2 infected cells at 4 days 
post infection and collecting total RNA samples over a 3 hour time course at 3 or 4 days post 
infection. As DENV-2 sfRNA accumulated (Figure 12A), both TUT1 and FOS mRNAs became 
more stable over the course of the DENV-2 infection (Figure 12B). By 4 dpi, when sfRNA was 
most abundant, FOS was 2.7-fold and TUT1 was 2.1-fold more stable in DENV-2 infections than 
in mock infected cells. Therefore, the accumulation of sfRNA in a DENV-2 infection was 
associated with stabilization of two endogenous cellular transcripts that are likely substrates of 
XRN1. This indicates that XRN1 activity is repressed during DENV-2 infection. 
 
Figure 12. DENV-2 sfRNA accumulation is associated with stabilization of two 
short-lived cellular mRNAs. (A) Northern blotting was performed to visualize dengue 
virus type 2 (DenV2) sfRNA accumulation over the course of an infection (0, 3, and 4 
days post infection). (B) The stability of TUT1 and FOS mRNAs was assessed by 
actinomycin D transcriptional shutoff of cells infected with DENV-2 at 0, 3 and 4 days 
post infection by RT-qPCR using GAPDH as a reference gene. Average transcript half-
life (minutes) plus or minus the standard deviation of two independent infections are 
shown. * indicates p<0.05 by Student’s t-test. 
 
To determine if mRNA stability was also altered in another flavivirus infection, we 
examined TUT1 and FOS mRNA stability at 36 and 48 hpi with KUNV when sfRNA 
accumulated to high levels as assessed by northern blot (Figure 13A, left panel). Intriguingly, 
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both cellular transcripts were significantly stabilized in conjunction with sfRNA accumulation 
(Figure 13A, right panels). Furthermore, the stabilization of FOS and TUT1 mRNAs only 
occurred during KUNV infection when sfRNA was present, as an sfRNA-deficient Kunjin virus 
(that replicated to the same level as wild-type KUNV, Figure 15C) did not alter cellular mRNA 
stability during infection (Figure 13B). Additionally, we later determined that TUT1 mRNA is 
destabilized during Sindbis virus infection (Barnhart et al. 2013; Appendix 6). These results 
provide more substantial evidence that stabilization of cellular mRNAs is dependent on sfRNA 




Figure 13. The stabilization of short-lived cellular mRNAs during Kunjin virus 
infection depends on sfRNA accumulation. Human 293T cells were infected with wild-
type Kunjin virus (KUN) (A) or an sfRNA-deficient mutant Kunjin virus (KUN MUT) at an 
MOI of 1 (B) and transcription was inhibited by actinomycin-D treatment at 0, 36, and 48 
hours post infection. Northern blotting was performed to assess sfRNA accumulation over 
the course of an infection (left panels) and mRNA stability of TUT1 and FOS was 
determined by RT-qPCR using GAPDH as a reference gene (right panels). The average 
half-lives (minutes) from two independent infections +/- standard deviation are shown. * 





 Although the results above demonstrated that sfRNA formation was necessary for the 
stabilization of cellular mRNAs (Figure 13), we also wished to determine whether sfRNA 
production is sufficient on its own to facilitate changes in mRNA stability in the complete 
absence of other aspects of a viral infection. We therefore cloned the DENV-2 3’ UTR into the 
peGFP-N1 reporter plasmid to express GFP containing the 3’ UTR of DENV-2 downstream of 
the GFP open reading frame. We transfected equal amounts of each peGFP plasmid into 293T 
cells and 48 hours post transfection performed transcriptional shut-offs with actinomycin D to 
assess changes in mRNA stability. As depicted in Figure 14A, the presence of the DENV-2 3’ 
UTR facilitated the formation of an sfRNA-like RNA decay product that accumulated in 
transfected cells. Cells transfected with the sfRNA-producing DENV 3’ UTR construct displayed 
a 2.1-fold increase in the half-lives of both FOS and TUT1. Of note, the stability of both FOS 
and TUT1 mRNAs was not enhanced by the peGFP-N1 empty vector alone (Figure 14B).These 
results support that sfRNA formation in the absence of viral infection is capable of suppressing 
Xrn1 activity in human cells.  
 
Figure 14. The accumulation of sfRNA in the absence of viral infection is 
associated with the stabilization of cellular transcripts. Plasmids expressing GFP 
alone (“GFP Only”) or a GFP mRNA containing the dengue virus type 2 3’ UTR in the 
GFP 3’ UTR(“DenV 3’ UTR”) were transfected into 293T cells and samples were taken 48 
hours post transfection. (A) Northern blotting for the DENV2 3’ UTR shows an sfRNA-like 
decay intermediate forms in transfected cells. (B) Transfected cells were treated with 
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actinomycin D to shut off transcription and FOS and TUT1 mRNA stability was assessed 
by RT-qPCR using GAPDH as a reference gene. The mean of two independent 




sfRNA accumulation is correlated with dramatic changes in cellular gene expression 
 
 Considering that sfRNA formation significantly stabilizes cellular transcripts during 
infections with two different flaviviruses and that changes in mRNA stability are often tightly 
coordinated with mRNA abundance, we sought to determine if sfRNA accumulation influences 
cellular gene expression during an infection. Our collaborators Dr. Khromykh (University of 
Queensland) and Drs. Kumagai and Akira (Osaka University) assessed changes in host gene 
expression at 48 hpi by microarray using mouse embryonic fibroblasts deficient in the interferon 
/ receptor (IFNAR-/-). This cell line is highly permissive for KUNV replication and there was 
no difference in the intracellular level of wild-type and mutant KUNV RNA at 48 hpi when total 
RNA samples were collected (Figure 15C). For analysis, these cells were either mock infected, 
infected with the wild-type KUNV, or the sfRNA-deficient KUNV.  Figure 15A depicts a heat map 
representing 416 mRNAs that were 3-fold or more over-expressed in the wild-type KUNV 
infected cells compared to mock infected cells. Importantly, 378 of these transcripts were not 
over-expressed upon infection with the sfRNA-deficient KUNV. Gene Ontology analysis of this 
set of transcripts revealed that factors involved in cell adhesion, innate immune response, 
inflammation, stress responses and cell proliferation were significantly over-represented 
(p<0.01). Furthermore, human 293T cells showed similar up-regulation of four of these immune 
factors as determined by RT-qPCR in the wild-type KUNV infected cells compared to the 
sfRNA-deficient KUNV infections (Figure 15B). In 293T cells the abundances of OASL and 
CXCL11 were dramatically increased (by ~575- and ~472-fold, respectively) during wild-type 
KUNV infections versus mock infected cells. In contrast, the murine Oasl1, Oasl2 and Cxcl11 
transcripts were elevated to a lesser extent as determined by microarray (by 20-, 12.97-, and 
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15.9-fold, respectively). These differences are likely due to the absence of type I interferon 
signaling in the IFNAR-/- MEFs compared to the interferon-competent human 293T cells. In 
contrast, the transcripts encoding interleukin-6 (IL6) and the chemokine CCL2 were elevated by 
4.5- and 3.5-fold (respectively) in human 293T cells, and by 15.2- and 4.71-fold (respectively) in 
the IFNAR-/- MEFs. These results both generalize our findings to other cell types (and species) 
and confirm the results derived from microarray analysis. 
Interestingly, previous studies reported that transcripts encoding the four immune factors 
IL6, OASL, CCL2, and CXCL11 were elevated in other flavivirus infections. The interferon-
induced transcript OASL was shown to be elevated in DENV, HCV, and WNV infections and 
plays an important role in the host antiviral response (Fink et al. 2007; Schoggins et al. 2011; 
Yakub et al. 2005; Perelygin et al. 2002). The chemokine CXCL11 is induced by type I 
interferon, NFκB, and/or pro-inflammatory cytokines and is a T cell chemoattractant that has 
been suggested to be involved in neuroinflammatory disorders (Cole et al. 1998). Furthermore, 
CXCL11 was elevated in cell culture models of DENV infection and in human patients (Fink et 
al. 2007). Finally, IL6 and CCL2 have previously been shown to be elevated in WNV, DENV, 
JEV, and other flavivirus infections (Cheeran et al. 2005; Munoz-Erazo et al. 2012; Tolfvenstam 
et al. 2011; Nazmi et al. 2011; Palus et al. 2013). Therefore, sfRNA accumulation is likely 
contributing to dramatic changes in cellular gene expression in a cell-type independent manner 
that could substantially alter the host response to infection and potentially enhance 
immunopathogenesis.  
Short-lived cellular transcripts may be elevated in flavivirus infections as a result of direct 
suppression of XRN1 activity leading to mRNA stabilization. However, transcripts might also be 
over-expressed as an indirect result of XRN1 suppression. We observed that the transcription 
factor FOS and the uridyl transferase TUT1 were significantly stabilized at the mRNA level 
during WNV and DENV-2 infections. As discussed above, FOS over-expression could 
potentially contribute to increased transcription as part of the AP-1 transcription factor complex. 
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Furthermore, TUT1 modifies miRNAs by adding uridines to their 3’ ends, causing a reduction in 
miRNA abundance likely by targeting the miRNAs for decay (Wyman et al. 2011; Knouf et al. 
2013). Therefore, because TUT1 was stabilized in several flavivirus infections in an sfRNA-
dependent manner, this protein is likely upregulated during infection. Consequently, the 
observed over-expression of transcripts in wild-type KUNV infections could also result from 
elevated levels of transcription factors and repressors of miRNA-mediated decay like FOS and 
TUT1. 
 Interestingly, a subset of mRNAs was less abundant in the wild-type KUNV infected cells 
compared to mock infected cells and cells infected with the sfRNA-deficient KUNV (bottom 
portion of the heat map shown in Figure 15A). Gene Ontology analysis of the down-regulated 
transcripts showed that stress responses, cellular response to viral infection, and negative 
regulators of apoptosis were over-represented (p<0.01). These changes in gene expression 
could be either direct or indirect effects of sfRNA accumulation. Because XRN1 has been 
previously demonstrated in yeast systems to directly affect transcription, transcripts that are 
reduced in abundance during sfRNA-producing viral infections could be down-regulated as a 
direct result of XRN1-suppression (Sun et al. 2013; Haimovich et al. 2013). Otherwise, 
suppression of XRN1 by sfRNA could indirectly reduce the abundance of many mRNAs by 







Figure 15. sfRNA accumulation leads to dramatic changes in cellular gene 
expression. (A) Mouse embryonic fibroblasts lacking the interferon α/β receptor (MEF 
IFNAR-/-) were mock treated or infected with Kunjin virus (KUN WT) or an sfRNA 
deficient mutant Kunjin virus (KUN sfRNA MUT) and total RNA was isolated from each 
sample at 48 hours post infection. The relative abundance of cellular transcripts was 
determined by microarray analysis and following robust multiarray analysis (RMA), 
hierarchical clustering was done for genes with threefold or more difference in RMA 
values after transformation to give a mean of 0 and a standard deviation of 1. The red-
blue color key below the heat map depicts the transformed values. (B) The relative 
abundances of four transcripts shown to be up-regulated in wild-type KUNV infected MEF 
IFNAR-/- cells in (A), IL6, CCL2, CXCL11, and OASL were assessed in infected 293T 
cells (48 hours post infection) using RT-qPCR with GAPDH set as a reference gene. The 
average +/- standard deviations of three independent infections are shown and 
significance determined by Student’s t-test. The sfRNA-deficient mutant KUNV replicate 
to similar levels in (C) 293T cells and in (D) MEF IFNAR-/- as determined by RT-qPCR 
for the Kunjin virus open reading frame from total RNA isolated at 48 hours post infection. 
Average genome copy number +/- standard deviation from three independent infections 
is shown. Experiments and results shown in (A) and (D) were performed by the Akira 





Global changes in cellular mRNA stability in arthropod-borne virus infections  
 
 Because sfRNA accumulation appears to correlate with (1) stabilization of two short-
lived transcripts and (2) dysregulation of cellular mRNA abundances, we next sought to 
determine the global impact of sfRNA accumulation on cellular RNA stability during infection. 
Therefore, we compared cellular RNA stability in mock-infected cells or cells infected with either 
wild-type KUNV or two viruses that do not generate sfRNA (Sindbis virus and the sfRNA-
deficient CS3ΔIRA Kunjin virus). Human 293T cells were mock infected or infected with Sindbis 
virus (MOI of 5), wild-type or the CS3ΔIRA Kunjin virus (MOI of 5) and transcription was halted 
using actinomycin D at 24 hpi (mock or SINV) or 48 hpi (the Kunjin viruses). Samples were 
collected in triplicate at 0 (30 minutes post-actinomycin D addition), 0.75, 1.5, and 3 hours post 
transcriptional shut-off. Mike Barnhart performed transcriptional shutoffs and RNA isolations 
from the SINV and mock infected cells. Total RNA was isolated from triplicate infections and 
Drs. Bin Tian, Mainul Hoque and Liu Liang performed library preparation and RNA-seq analysis 
at Rutgers New Jersey Medical School. For sequencing analyses, the triplicate samples 
collected for each time point in each infection were pooled. 
 
Changes in mRNA abundance and stability in KUNV and SINV infections 
 
  We determined that ~3000 cellular RNAs had acceptable half-lives (i.e. they had >10 
mapped reads in the ‘0’ time point, a half-life > 0 and p<0.05 as determined by Dr. Liu Liang), 
and were present in both mock infected cells and cells infected with SINV, KUNV, or the sfRNA-
deficient KUNV to enable direct comparisons of RNA stability (Figure 16A). Of note, the level of 
depth that these samples were sequenced at likely excluded an interesting set of transcripts that 
are of low abundance (<10 reads/sample) in mock infected cells. Therefore, short-lived 
transcripts may be under-represented in these datasets. Accordingly, neither TUT1 nor FOS 
(that we analyzed previously (e.g. Figures 11-13) were present in these RNA-seq data sets. 
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However, we were able to observe some interesting trends in the analyses of the more 
abundant transcripts present in each condition. 
 
 
Figure 16. Global analysis of mRNA stability in sfRNA-forming and sfRNA-deficient 
arthropod-borne virus infected cells. (A) Venn diagrams indicate the number of 
comparable half-lives generated in mock and Sindbis, Kunjin, or sfRNA(-) Kunjin virus 
infected cells that can be compared directly for analysis. (B) A list of the median RNA 
half-life (minutes) in each sample. 
 
The median RNA half-life for each condition was compared to determine if sfRNA 
accumulation corresponded with overall stabilization of cellular RNA. Some interesting trends 
emerged from this comparison. As depicted above in Figure 16B, cellular RNA from KUNV 
infected cells had the longest median half-life at 243 minutes, and RNA from the sfRNA-
deficient KUNV infected cells had the shortest median half-life of 171 minutes. The shorter 
median RNA half-life observed in cells infected with the sfRNA-deficient KUNV could be due to 
the induction of antiviral nucleases that target cellular mRNAs. Considering that KUNV infected 
cells have the most stable median RNA half-life and the sfRNA-deficient KUNV has the least 
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stable median RNA half-life, these results could potentially indicate that sfRNA formation leads 
to an overall stabilization of RNAs. This is consistent with the cellular RNA stabilization by 
sfRNA that we noted above (in Figures 11-13).  
Intriguingly, some striking patterns emerge when we compare the distribution of RNAs 
that were determined to be >2x differentially stabilized during each infection compared to mock 
infected cells. Cells infected with KUNV have only 75 destabilized RNAs compared to mock 
infected cells, but the sfRNA-deficient KUNV infected cells had 478 destabilized RNAs (Figure 
17A, left). Therefore, in the absence of sfRNA accumulation, Kunjin virus-infected cells have 
more destabilized RNAs than stabilized RNAs. If the normal cellular response to infection is to 
destabilize a substantial portion of transcripts, then suppression of XRN1 activity by sfRNA 
formation could impede the normal cellular response.  
 Correspondingly, cells infected with wild-type KUNV have many more stabilized RNAs 
(259) than those infected with the sfRNA-deficient KUNV (76; Figure 17A). Furthermore, when 
we directly compare the RNAs that were 2-fold or more stabilized or destabilized in KUNV 
infections with the sfRNA(-) KUNV infections, we can see very strong association between 
sfRNA accumulation and RNA stabilization (Figure 17A). Wild-type KUNV infected cells have 
740 stabilized transcripts and only 58 destabilized transcripts when directly compared to the 
sfRNA-deficient KUNV infections (Figure 17B). It is important to note that with the size of these 
datasets (~3,000 RNAs/set), changes in stability or abundance that alter <150 RNAs could 
potentially be due to random chance (as 5% of a sample size of ~3,000 is ~150). Accordingly, 
analysis of RNAs from cells infected with SINV did not reveal dramatic differences in host 
mRNA stability. Figure 17C shows the distribution of >2x destabilized or stabilized RNAs in 
SINV infected cells and reveals a very slight over-representation of destabilized transcripts 
overall (which may not be significant). Thus, only infection with the sfRNA-forming KUNV shifts 





Figure 17. sfRNA accumulation is correlated with the stabilization of the majority of 
differentially stabilized transcripts in Kunjin virus infections. (A) The number of 
transcripts that were >2x or more destabilized in cells infected with the wild-type KUNV or 
the sfRNA-deficient KUNV (left panel), and the number of transcripts that were >2x or 
more stabilized in wild-type KUNV or sfRNA-deficient KUNV infected cells at 48 hpi (MOI 
of 5) compared to mock infected cells (right panel). (B) The RNAs that are >2x or more 
stabilized or destabilized in the wild-type KUNV infected cells compared directly to the 
sfRNA-deficient Kunjin virus infected cells are shown. (C) Differentially stabilized (>2x vs 
mock) RNAs in cells infected with SINV at 24 hpi at an MOI of 5 are also reported. 
  
 We were next interested in ascertaining the relative changes in cellular RNA 
abundances of our subset of ~3,000 transcripts (Figure 16A) during each viral infection. We 
hypothesized that sfRNA-forming flavivirus infections would have more up-regulated transcripts 
than sfRNA-deficient virus infections, as sfRNA accumulation was previously shown to be 
associated with the stabilization of mRNAs. As depicted in Figure 18A , cells infected with 
KUNV had more transcripts that were 2-fold or more increased in abundance (323 RNAs) than 
transcripts that were 2-fold or more reduced in abundance (171 RNAs) compared to mock 
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infected cells. This is precisely what one might expect since sfRNA accumulation is strongly 
associated with stabilization of cellular mRNAs.  Interestingly, cells infected with the sfRNA-
deficient KUNV also had only slightly more up-regulated RNAs (242 RNAs) than down-regulated 
RNAs (196 RNAs; Figure 18B). This is again consistent with the absence of significant cellular 
mRNA stabilization due to the lack of sfRNA production by these viruses. 
 
Figure 18. Transcripts that were >2x more or less abundant in virus infected cells 
compared to mock-infected cells by RNA-seq analysis. Values were derived from the 
‘0’ time point of actinomycin D shutoff samples. Only RNAs that were detectable 
(RPKM>0.01) in both mock and infected cells were compared. Substantially up- or down-
regulated RNAs in (A) Kunjin virus (KUNV) versus mock (B) sfRNA(-) Kunjin virus and 
(C) Sindbis virus (SINV) infected cells compared to mock infected cells are reported. 
 
To reinforce this observation, we analyzed the dysregulation of cellular mRNA stability during 
SINV infections (which naturally do not make sfRNA). SINV-infected cells had slightly more 
RNAs that were reduced in abundance (170 RNAs) than were increased in abundance (121 
RNAs) compared to mock infected cells (Figure 18C). The twenty transcripts that were most up- 
or down-regulated in each viral infection are reported in 3. Therefore, although limitations in the 
depth of sequencing performed may have excluded observations of the stability of many 
mRNAs in each infection, the available data do suggest that sfRNA formation is associated with 






Analysis of the relationship between transcript abundance and stability in arbovirus 
infected cells 
 
 During viral infection, one might expect that overall cellular gene expression would be 
significantly altered as the cell attempts to respond to the presence of foreign nucleic acids and 
proteins as well as the stresses of viral replication/remodeling of the cell. As described in the 
Introduction, recent studies suggest that transcription and mRNA decay are co-regulated in the 
cell by a crosstalk-type of mechanism that results in a significant buffering of mRNA 
abundances following disruption of decay or transcription (Sun et al. 2013; Haimovich et al. 
2013). Studies in yeast suggest that XRN1 is involved in mediating this buffering mechanism 
(Sun et al. 2013).  However, during the cellular response to infection, buffering is likely to be 
inactivated in order to allow mRNA decay and transcription to act together to achieve rapid 
changes in gene expression. Thus since we speculate that cells would likely substantially alter 
the level of many mRNAs upon infection, one might expect to see a positive correlation between 
mRNA half-lives and overall transcript abundance, as the buffering between transcription and 
mRNA stability is relaxed in infected cells to promote a more rapid response. As seen in Figure 
19A, this is precisely what we observed in SINV infected cells. Buffering of gene expression 
appears to be relaxed as destabilized mRNAs are generally reduced in abundance and 




Figure 19. Relationships between mRNA abundance and stability in arthropod-
borne virus infected cells. Log transformed fold-change values for transcripts that had 
acceptable abundances and stability in mock infected cells compared to (A) Sindbis virus 
infected cells (SinV), (B) sfRNA-deficient KUNV infected cells (sfRNA(-) KunV) and (C) 
wild-type Kunjin virus infected cells (KunV) reveal the degree to which changes in mRNA 
abundance correlate with changes in mRNA stability in each infection. Scatterplots were 
fit with a linear regression line and the R
2
 value and number of transcripts per chart 
indicated in the inset panels. Abundance values were obtained from the ‘0’ time point of 
actinomycin D shutoffs (30 minutes post drug application). Pearson coefficients were 
used to calculate statistical significance:  Mock vs KunV p = 0.811; Mock vs sfRNA(-) 
KunV p<0.0001; Mock vs SinV p<0.0001.  
 
As seen in Figure 19B, the exact same trend of relaxed buffering of cellular gene expression is 
observed in cells infected with the KUNV mutant that fails to express sfRNA. Interestingly, cells 
infected with wild-type KUNV that generates high levels of sfRNA during infection fail to show a 
positive correlation between cellular mRNA abundance and mRNA stability (Figure 19C). Given 
the recent suggestion that XRN1 may play a major role in regulating the buffering of gene 
expression in yeast (Sun et al. 2013; Haimovich et al. 2013), our observation that cells infected 
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with sfRNA-producing KUNV fail to be able to regulate buffering lends support to the idea that 
XRN1 also regulates this process in mammalian cells. These data also suggest that sfRNA-
producing viruses are targeting not only mRNA decay/stability by repressing XRN1, but also are 
targeting transcriptional regulaton through interfering with the buffering process. Thus additional 
studies with KUNV and other sfRNA-producing viruses may allow insight into mechanistic 
aspects of the crosstalk between mRNA stability and transcription in mammalian cells.      
 
Section II. Investigation of hepacivirus and pestivirus suppression of XRN1 activity 
 
XRN1 stalls on RNA structures in the 5’ UTR of hepaciviruses and pestiviruses 
 
 Our prior results showed that sfRNA formation was a highly conserved mechanism by 
which all arthropod-borne flaviviruses tested to date suppress XRN1 activity and dramatically 
alter cellular mRNA stability during infection. Although viruses in the Flaviviridae family in the 
Hepacivirus and Pestivirus genera do not form sfRNAs from their 3’ UTRs (Pijlman et al. 2008), 
we wondered if they could use an analogous mechanism for suppressing XRN1 activity. Figure 
20 shows representative predicted secondary structures of the 3’ UTR of flaviviral RNAs and the 
5’ UTRs of hepacivirus and pestivirus RNAs (adapted from Liu et al. (2009a)). Interestingly, 
there are conserved secondary and higher-order structures predicted to occur within the 5’ 
UTRs of HCV and BVDV RNAs that could potentially stall the XRN1 exoribonuclease.  
 
Figure 20. Diagrams of the predicted conserved secondary structures of 
representative flavivirus UTRs. The flavivirus 3’ UTR is known to harbor pseudoknot 
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structures and additional structural elements implicated in sfRNA formation. Both 
hepacivirus and pestivirus 5’ UTRs also have higher order structures that are implicated 
in cap-independent translation via internal ribosome entry site (IRES) elements (modified 
from Liu et al. 2009(a)). UTR = untranslated region; sfRNA = subgenomic flavivirus RNA.  
 
 To test the hypothesis that XRN1 stalls on the 5’ UTRs of hepacivirus and pestivirus 
RNAs, we use our in vitro assay to compare the 5’-3’ decay of reporter RNAs containing a 
control sequence or the HCV or BVDV 5’ UTRs. As depicted in Figure 21A, the BVDV 5’ UTR 
generated at least one distinct RNA decay intermediate when incubated with recombinant 
XRN1. Furthermore, the HCV 5’ UTR also generated a decay intermediate  in HeLa cell extract 
under conditions that favor 5’-3’ decay (Figure 21B, left panel) and when the RNA is incubated 
with recombinant yeast XRN1 (Figure 21B, right panel). Therefore the ability of XRN1 to 
degrade these RNAs may be hampered by RNA structure in an analogous fashion to that used 
by the flaviviruses. An unconventional interaction between the liver-specific microRNA miR-122 
(Lagos-Quintana et al. 2002) and the HCV 5’ UTR was previously shown to facilitate viral 
replication (Jopling et al. 2005). Importantly, our results indicate that formation of the HCV RNA 
decay intermediate does not per se rely on the presence of miR-122, as this liver-specific 




Figure 21. XRN1 stalls on the BVDV and HCV 5’ untranslated regions. (A) A 5’ 
monophosphorylated RNA containing the BVDV 5’ UTR forms an sfRNA-like decay 
intermediate when degraded by recombinant yeast XRN1. This experiment was 
performed in our laboratory by John R. Anderson. (B) The hepatitis C virus 5’ UTR also 
makes an sfRNA-like decay intermediate in HeLa cytoplasmic extract under conditions 
that highly favor 5’-3’ decay (left panel) and when the RNA is incubated with recombinant 
yeast XRN1 (right panel). Arrows in (B) indicate the sfRNA-like decay intermediates 
formed as the HCV 5’ UTR is degraded in the 5’-3’ direction by XRN1. 
 
We next wished to determine if HCV and BVDV 5’ UTRs generated decay intermediates 
in human cells in culture using GFP reporter constructs, as we previously demonstrated that 
insertion of the DENV-2 3’ UTR into the 3’ UTR of GFP caused the formation of a distinct 5’-3’ 
decay intermediate (Figure 14A). Human 293T cells were therefore transfected with the empty 
reporter plasmid peGFP-N1, or peGFP-N1 with the DENV-2 3’ UTR, the HCV 5’ UTR, or the 
BVDV 5’ UTR inserted into the Not-1 site of the peGFP-N1 plasmid (shown in Figure 22A). As 
expected, we were able to detect a distinct 5’-3’ decay intermediate in cells transfected with the 
DENV-2 3’ UTR-containing GFP construct at 24 hours post transfection in 293T cells (Figure 
22B, center lane). However, we were unable to detect distinct decay intermediates in cells 
transfected with the HCV or BVDV 5’ UTR-containing reporter constructs alone (data not 
shown). Because the GFP reporter transcript is likely quite stable, we hypothesized that the 
addition of an siRNA that targets a region in the open reading frame of GFP (upstream of the 3’ 
UTR) would stimulate 5’-3’ decay of the reporter transcript following endonucleolytic cleavage 





Figure 22. Distinct decay intermediates are generated from GFP reporter 
constructs containing the HCV and BVDV 5’ UTRs. (A) Schematic of the transcript 
produced by the reporter constructs used for this experiment. The 3’ UTR of DENV or the 
5’ UTR of either HCV or BVDV were inserted into the GFP 3’ UTR of the peGFP-N1 
reporter plasmid. (B) One μg of total RNA from 293T cells transfected with the empty 
GFP vector (GFP only) or GFP containing the DENV-2 3’ UTR with or without treatment 
with anti-GFP siRNA (24 hours post transfection) was separated on a 5% denaturing 
PAGE gel and northern blots were done using a probe to the DENV-2 3’ UTR. The 
sfRNA-like decay intermediates are indicated by the arrow. (C) The empty GFP vector 
(GFP only) or GFP with the HCV or BVDV 5’ UTR inserted as indicated in (A) were 
transfected into 293T cells, all with siRNA against GFP added. Total RNA was collected 
48 hours post transfection and 2 μgs of RNA were resolved on a 5% denaturing PAGE 
gel. Northern blots were done using a probe to the GFP 3’ UTR (3’ to the BVDV or HCV 
5’ UTR insertion) to detect 5’-3’ decay intermediates. The sfRNA-like decay intermediates 
are indicated by the arrow at right. Both (B) and (C) show representative northern blots. 
 
 
Figure 22B shows that when the anti-GFP siRNA is transfected into cells expressing the 
GFP + DENV-2 3’ UTR reporter construct, the sfRNA-like decay intermediate accumulates to 
much higher levels. Furthermore, co-transfection of 293T cells with the anti-GFP siRNA and 
peGFP-N1 with the HCV 5’ UTR or the BVDV 5’ UTR revealed distinct sfRNA-like decay 
intermediates (Figure 22C). Therefore, the BVDV and HCV 5’ UTRs can generate distinct 5’-3’ 
decay intermediates in human cells, albeit to a lesser extent than those formed by as the DENV-
2 3’ UTR degrades. These results are consistent with our in vitro cell extract based experiments 
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that support the hypothesis that other host and viral factors are not required for the stalling of 
XRN1 on the HCV and BVCV 5’ UTRs (Figure 21).  
 
XRN1 enzymatic activity is repressed by the HCV and BVDV 5’ UTRs 
 
 Because sfRNA was previously shown to stall and suppress XRN1 activity, we next 
wished to assess the ability of HCV and BVDV 5’ UTRs to inhibit XRN1 activity. Using 
competition assays in HeLa cell extracts, we determined that the accumulation of decay 
intermediates from both the HCV and BVDV 5’ UTRs was associated with suppression of 
XRN1-mediated decay of a reporter RNA (Figure 23). Interestingly, the RNA decay 
intermediates formed by HCV and BVDV are not as robust as those formed by DENV-2 and 
JEV in the same assay. However, we observed a significant increase in reporter RNA stability 
when the HCV and BVDV competitor RNAs were supplied at 66.7-fold the molar amount of the 
reporter RNA (versus 30-fold the molar amount of DENV-2 and JEV 3’ UTRs used for the 
competition assays reported above in Figures 5 and 6). This may indicate that the HCV and 
BVDV 5’ UTRs are not as strongly inhibitory as the DENV-2 and JEV 3’ UTRs in our HeLa cell 
extract system. 
 
Figure 23. Subgenomic RNAs generated from hepacivirus and pestivirus 5’ UTRs 
suppress XRN1 activity in HeLa cytoplasmic extracts. (A) A 5’ monophosphorylated 
reporter RNA susceptible to XRN1-mediated decay was incubated with ~66.7x molar 
excess of 5’ monophosphorylated competitor RNAs in HeLa cell extract and RNA was 
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isolated at 0, 5, and 10 minutes to resolve on a 5% denaturing polyacrylamide gel. The 
percent reporter RNA remaining was determined by quantification following 
phosphorimaging. (A) Shows the average +/- standard deviation of the percent reporter 
RNA remaining in each time point from three independent experiments with an HCV 5’ 
UTR competitor RNA or a control competitor RNA. (B) Shows the average +/- standard 
deviation of the percent reporter RNA remaining at each time point in the presence of 
BVDV 5’ UTR competitor or a control RNA competitor from two independent experiments. 
Student’s t-test was used to assess significance, with * indicating p<0.05 and ** p< 0.01. 
The above experiments were performed by John R. Anderson in our laboratory. 
 
 To determine if XRN1 activity was suppressed in human Huh7.5 cells infected with HCV, 
we analyzed the relative abundance of uncapped cellular transcripts. We hypothesized that if 
XRN1 activity was compromised by the formation of HCV subgenomic RNA, we would observe 
a significant increase in uncapped cellular RNAs compared to mock-infected cells. HCV 
infections were performed in collaboration with Dr. Shelton Bradrick (Duke University).  As 
depicted in Figure 24A, human Huh7.5 liver cells infected with HCV (JFH-1 strain) showed a 
small but significant increase in the relative abundance of uncapped cellular mRNAs compared 
to mock infected cells. Interestingly, this effect was not dependent on the presence of HCV 
structural proteins, as Huh7.5 cells harboring a replicon HCV RNA also had an increase in the 
abundance of uncapped short-lived cellular transcripts (Figure 24B; the I389/NS3-3′ replicon is 
described in Lohmann et al. 1999). Thus we conclude that XRN1 activity is likely suppressed in 
HCV infections, as uncapped mRNAs accumulate to a similar degree as observed in DENV-2 
and KUNV infected cells (Figure 8) and the 5’-3’ decay of a reporter transcript in HeLa cell 





Figure 24. Uncapped mRNAs accumulate in HCV infected cells. (A) Total RNA from 
Huh7.5 cells either mock infected or infected with the JFH-1 strain of HCV (72 hpi) was 
fractionated into capped and uncapped portions, and the relative abundance of FOS and 
TUT1 mRNAs in the uncapped fraction (normalized to the 10% input fraction) was 
determined by RT-qPCR using the uncapped 7SL RNA as a reference gene. (B) RNA 
from Huh7.5 cells harboring an HCV replicon (I389/NS3-3'UTR) was fractionated and 
analyzed as in (A). Shown above are the averages +/- standard deviations of the relative 
abundances of each transcript from three independent infections. Infections and RNA 
extractions were performed by Dr. Shelton Bradrick at Duke University. Student’s t-test 
was performed to assess significance, with * indicating p < 0.05 and ** p < 0.001. 
 
 Previously published data show that the HCV 5’ UTR is degraded in the 5’-3’ direction, 
presumably by XRN1 (Li et al. 2013(b)). Although it was not interpreted as stalling of the XRN1 
exonuclease, the accumulation of what appears to be distinct 5’-3’ decay intermediates of the 5’ 
end of the HCV genome were observed (Li et al. 2013(b)). The authors of this study used an 
RNA ligation procedure to capture monophosphorylated HCV RNAs from infected cells in 
culture for cloning and sequence analysis of the HCV 5’ UTR (Li et al. 2013(b)). Interestingly, 
the 5’ end of the majority of these reported sequences was ~55 nt or ~80 nt from the end of the 
full-length 5’ UTR of the HCV genomic RNA (Li et al. 2013(b)). Furthermore, it was recently 
demonstrated that an in vitro transcribed RNA containing the HCV 5’ UTR physically associates 
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with XRN1 in 293T cells (Bradrick et al. 2013). These data indicate that the stalling of XRN1 on 
the HCV/BVDV 5’ UTR may similarly cause a delay in the dissociation of the enzyme from the 
RNA substrate, leading to XRN1 suppression. Consistent with this, we have preliminary 
evidence indicating that BVDV RNA is associated with XRN1 during infections of bovine MDBK 
cells (Figure 25). Co-immunoprecipitation of XRN1 and associated RNAs from infected cells 
revealed a specific interaction between the BVDV genomic RNA and XRN1. 
  
 
Figure 25. The BVDV genomic RNA is physically associated with XRN1 during 
infection. Bovine MDBK cells infected with cytopathic BVDV were formaldehyde cross-
linked and lysed for co-immunoprecipitation with antibody to XRN1 (XRN1) or a non-
specific control antibody (IgG). Total RNA from the 10% input fraction and the 
immunoprecipitated fraction was reverse transcribed and the relative abundance of 
BVDV RNA was assessed in each fraction using primers to the BVDV 5’ UTR. Shown 
above is an intriguing preliminary result from one experiment showing the relative amount 
of BVDV RNA +/- the error of measurement in the immunoprecipitation fraction relative to 
the 10% input fraction from one experiment. 
 
The stability of mRNAs encoding oncogenes and angiogenic factors is dysregulated in 
hepacivirus and pestivirus infected cells 
 
 Previous studies have demonstrated that several oncogenes and angiogenic factors are 
up-regulated in various models of HCV infection and/or in patient tissues. The oncogene c-FOS 
has been shown to positively regulate HCV replication in cell culture (Kang et al. 2011(a)) and c-
JUN over-expression can contribute to HCV-induced hepatocellular carcinoma (HCC) (Machida 
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et al. 2010). The oncogene c-myc is increased in the livers of HCV patients and in a transgenic 
mouse model of HCV infection (Higgs et al. 2013). Vascular endothelial growth factor A 
(VEGFA) is angiogenic and is known to be over-expressed in non-tumor regions of livers from 
patients with HCV-associated HCC (Chiang et al. 2008). Interestingly, VEGFA treatment was 
shown to increase liver mass by inducing liver sinusoidal endothelial cells to produce 
hepatocyte growth factor, ultimately leading to liver cell proliferation (LeCouter et al. 2003). 
Hypoxia inducible growth factor 1α (HIF1A) is another angiogenic factor that enhances HCV 
propagation and also stimulates the migration and altered cell polarity of hepatocytes in a cell 
culture model of metastasis (Wilson et al. 2012; Mee et al. 2010). Finally, chemokine (C-X-C 
motif) ligand 2 (CXCL2) is induced by the pro-inflammatory transcription factor NFκB, and is up-
regulated in a tree-shrew (Tupaia spp.) hepatocyte model of HCV infection (Guitart et al. 2005). 
It follows then that hepatocellular carcinoma may be a result of the over-expression of potent 
oncogenic and angiogenic factors in HCV infected liver cells. 
  We previously demonstrated that sfRNA formation/XRN1 repression by arthropod-borne 
flaviviruses is correlated with increased expression of several pro-inflammatory factors and 
XRN1 suppression, and that HCV RNAs can inhibit XRN1 activity (Figures 14 and 22). We 
therefore sought to determine if changes in mRNA stability might account for the increased 
expression of several factors implicated in the development of hepatocellular carcinoma due to 
HCV. As seen in Figure 26A, the transcripts of three oncogenic factors, c-FOS (FOS), c-JUN 
(JUN), and c-myc (MYC), are significantly increased in abundance in HCV infected cells 
compared to mock infected cells. The three angiogenic factors vascular endothelial growth 
factor A (VEGFA), hypoxia induced factor 1 (HIF1A), and the chemokine CXCL2 are also 
significantly increased compared to control cells. We next evaluated mRNA stability in cells 
infected with HCV (JFH-1 strain) or mock infected by actinomycin D transcriptional shut-offs at 
72 hpi. Figure 26B shows representative mRNA decay curves of all six transcripts of oncogenes 
or angiogenic factors in mock and HCV infections and the average half-life from three 
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independent infections is also reported (graph insets). Strikingly, all six transcripts were 
significantly more stable in HCV infected cells when compared to mock infected cells. 
Therefore, changes in mRNA stability during HCV infection could account for the increased 
expression of several oncogenes and angiogenic factors implicated in HCV-induced 
hepatocellular carcinoma. One potential mechanism by which this could occur is by suppression 
of XRN1 by HCV RNAs, as we demonstrated occurs in flavivirus infections. 
 
Figure 26. Six oncogenic or angiogenic factors implicated in HCV-induced 
hepatocellular carcinoma are up-regulated and stabilized at the mRNA level in HCV 
infected human cells. (A) Human Huh7.5 cells were infected with the JFH-1 strain of 
HCV and at 72 hpi RT-qPCR analysis was performed to assess the relative abundance of 
FOS, JUN, MYC, VEGFA, HIF1A, and CXCL2 using GAPDH as a reference gene. 
Shown are the averages +/- standard deviations of the relative mRNA abundances from 
three independent infections. (B) The stability of each transcript was assessed by 
actinomycin D shut-off and RT-qPCR analysis of mock infected or HCV-infected cells (72 
hpi). A representative decay curve for each transcript is shown with the average +/- 
standard deviation of the half-life (minutes) calculated from three independent infections 
in the inset panels. Hepatitis C virus infections and RNA isolations were done by Dr. 
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Shelton Bradrick at Duke University. Student’s t-test was used to assess significance with 
* indicating p < 0.05, **p<0.01, and ***p<0.005. 
 
 If changes in mRNA stability during HCV infection were due to the stalling of XRN1 on 
highly structured viral RNAs, then we hypothesized that the related pestiviruses would also 
cause stabilization of short-lived cellular RNAs. To address this, we infected bovine MDBK cells 
with cytopathic BVDV and assessed the abundance and stability of two short-lived mRNAs, JUN 
and FOS, which were shown to be up-regulated and stabilized in human liver cells infected with 
HCV. Importantly, c-JUN and c-FOS are oncogenes, but are also known to play important roles 
in organism development and growth- and thus could have a major impact on the pathogenesis 
of BVDV infections. A large-scale bioinformatics and literature mining approach to identify novel 
transcription factors important for bovine embryo development identified c-FOS as one such 
factor (Turenne et al. 2012). Furthermore, studies using a murine cell culture model of 
mammalian development revealed that c-FOS and c-JUN expression can be induced only in 
differentiated cells, and c-JUN expression increases over the course of chemical-induced 
differentiation of mouse embryonal carcinoma cells (de Groot et al. 1990). In mammalian cells, 
c-FOS and c-JUN proteins can together form a heterodimer called the AP-1 transcription factor 
complex, which is specifically known to be important for proper bone development and growth 
(Wang et al. 1992) in addition to promoting carcinogenesis in certain systems (as discussed 
above). The c-FOS protein regulates mammalian bone development, growth, and 
hematopoiesis (Ruther et al. 1987; Wang et al. 1992). Intriguingly, c-FOS and c-JUN were 
shown to be up-regulated at the mRNA level in bovine B cell lymphosarcoma BL3 cells infected 
with cytopathic BVDV through an unknown mechanism (Neill and Ridpath 2008). Infection of 
pregnant heifers with BVDV can lead to abortions (Brownlie et al. 1989), defects in fetal growth 
(Grooms et al. 2004; Done et al. 1980), and fetal bone malformations (Webb et al. 2012; Webb 
et al. 2013). These developmental abnormalities could be contributed to by dysregulated host 
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gene expression resulting from BVDV infection, potentially by aberrant expression of short-lived 
growth factors including c-FOS or c-JUN in the developing embryo. 
At 24 hpi, when all cells are infected with BVDV (as determined by immunofluorescence 
assays (Figure 27A), both JUN and FOS are significantly up-regulated at the mRNA level 
(Figure 27B).  Furthermore, as observed in HCV infected cells, the stability of JUN and FOS 
mRNAs is significantly increased in cells infected with BVDV compared to mock infected cells 
(Figure 27C). These results indicate that significant changes in mRNA stability are observed in 
HCV and BVDV infections, possibly due to the suppression of XRN1 by highly structured viral 
RNAs. Because we have demonstrated that distinct decay intermediates are detected in cells 
transfected with reporter constructs bearing the 5’ UTRs of BVDV and HCV (Figure 22), we are 
currently working to determine if changes in mRNA stability consistent with suppression of 
XRN1 activity occur in the absence of viral infection.  
 
 
Figure 27. The abundance and stability of FOS and JUN mRNAs are significantly 
increased in BVDV infected cells. (A) Indirect immunofluorescence analysis of MDBK 
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cells mock infected or infected with BVDV (24 hpi, MOI of 10) using a primary antibody 
that recognizes all strains of cytopathic and non-cytopathic BVDV and a secondary 
antibody tagged with Alexafluor 594 (red). Nuclei are stained by DAPI and are shown in 
blue. Photographs are representative of three independent infections. (B) The two short-
lived mRNAs FOS and JUN are more abundant in BVDV infected cells as determined by 
RT-qPCR analysis with beta actin (ACTB) set as the reference gene. The average +/- 
standard deviation of each transcript abundance from three independent infections are 
shown. (C) Both FOS and JUN are significantly stabilized during BVDV infection 
compared to mock-infected cells as determined by actinomycin D transcriptional shut-offs 
and RT-qPCR using ACTB as a reference gene. Representative decay curves are shown 
with the average +/- standard deviation of each half-life (minutes) from three independent 
replicates reported in the inset panels. Statistics reported in (B) and (C) are p-values from 
Student’s t-test with * indicating p < 0.05, **p<0.01, ***p<0.005. 
 
 
Cellular mRNAs that are stabilized and increased in abundance in HCV and BVDV 
infections are intact and translatable 
 
 If the changes in post-transcriptional regulation of gene expression that were reported 
above in HCV and BVDV infected cells are contributing to changes in cell or organism biology 
as a result of infection (e.g. hepatocellular carcinoma due to HCV infection), then the proteins 
encoded in those transcripts must be expressed differentially. We therefore assessed the 
relative abundance of the translatable form (i.e. capped and polyadenylated) of the six 
transcripts we determined to be up-regulated and stabilized at the mRNA level in HCV infections 
(Figure 26). We fractionated total RNA from Huh7.5 cells mock infected or infected with HCV 
using an antibody that recognizes the 7-methylguanosine cap structure to generate a pool of 
RNA that contained capped RNAs only. We then reverse transcribed the capped RNA using an 
oligod(T) primer to capture polyadenylated RNAs. Using qPCR to quantify the relative 
abundance of each transcript in mock and HCV infected cells, we found a significant increase in 
the amount of capped and polyadenylated mRNAs encoding oncogenes or angiogenic factors in 
HCV infected cells (Figure 28A). Furthermore, bovine MDBK cells infected with BVDV showed a 
significant increase in the abundance of both FOS and JUN proteins as assessed by western 
blotting (Figure 28B). These results contrast with previous findings that FOS and JUN proteins 
are down-regulated in BL3 cells infected with BVDV, although the abundance of ACTIN was 
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also surprisingly severely reduced in BVDV infected samples in that study (Neill and Ridpath 
2008). These data imply that there could be cell-type specific defects in general protein 
synthesis during BVDV infections. However, in MDBK cells, we did not observe a comparable 
decrease in the house-keeping protein GAPDH, and western blots were performed using equal 
quantities of total protein from mock and BVDV infected cells (Figure 28B). Furthermore, 
monocytes infected with cytopathic BVDV were shown to have no change in the abundance of 
actin protein by western blot in another study (Lee et al. 2008). Our results indicate that the 
abundance of polyadenylated and capped mRNAs or protein is positively correlated with the 
stability of several important cellular transcripts encoding oncogenic or growth factors in BVDV 




Figure 28. Inhibition of XRN1 may feedback and inhibit the entire 5’-3’ decay 
pathway during HCV infection. (A) Stabilized, up-regulated transcripts encoding 
oncogenes and angiogenic factors are capped and polyadenylated. Total RNA from 
Huh7.5 cells mock infected or infected with HCV was fractionated to remove uncapped 
RNAs, and oligo d(T) was used to selectively reverse transcribe polyadenylated RNAs. 
The relative abundance of each mRNA was then assessed by qPCR using GAPDH as a 
reference gene. The average +/- standard deviation of three independent infections is 
shown above with significance assessed by Student’s t-test (* indicates p < 0.05, ** p < 
0.01, *** p < 0.005). Hepatitis C virus infections and isolation of total RNA were 
performed by Dr. Shelton Bradrick at Duke University. (B) Bovine MDBK cells infected 
with BVDV have increased levels of JUN and FOS proteins compared to mock infected 
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cells. Representative western blots are shown above with the average +/- standard 
deviation of the chemiluminescent signal from three independent infections is shown 
relative to GAPDH. Student’s t-test was done to determine significance and * indicates 
p<0.01, ** indicates p<0.001. 
 
 
Section III. Towards the elucidation of the structure of the XRN1-resistant sfRNA 
 
Kunjin virus sfRNA formation requires a three-helix junction in vivo 
 
 Previous work identified several conserved pseudoknot-like structural motifs in the 3’ 
UTRs of flaviviruses that were associated with sfRNA formation (Pijlman et al. 2008; Funk et al. 
2010; Silva et al. 2010), but the exact structure required to stall XRN1 remained unknown. 
Recent work in the Kieft laboratory (University of Colorado, Denver, Anschutz School of 
Medicine) demonstrated that formation of sfRNA likely depends on a more complex structure 
that involves the interactions of several pseudoknots together to stabilize the RNA and prevent 
XRN1-mediated decay (Chapman et al. 2014; Chapman et al. in press). Using phylogenetic and 
biochemical approaches, each XRN1-resistant (sfRNA-forming) viral 3’ UTR motif was shown to 
contain a conserved three-helix junction upstream from a pseudoknot and a hairpin. Importantly, 
the ~19 nucleotides required for these structures to form were conserved among all sfRNA-
forming flaviviruses tested using in silico analyses (Chapman et al. 2014). Furthermore, the 
crystal structure of the XRN1-resisant sfRNA formed by the Murray Valley encephalitis virus 
(MVEV) 3’ UTR determined by the Kieft laboratory (Chapman et al. in press) indicated that the 
resistance of these sfRNAs to XRN1 was likely conferred by a set of interwoven pseudoknots 
that stabilizes the 5’ end of the viral RNA, keeping the 5’ end from entering the active site of 
XRN1 (Chapman et al. in press). This complex three-dimensional structure was predicted to be 




 We therefore generated six mutant Kunjin viruses using the FLSDX(pro)_HDV infectious 
clone (Liu et al. 2003) to determine the impact on XRN1 stalling in living cells of mutating 
conserved sequences in the 3’ UTR predicted to be essential for sfRNA formation. Three 
sfRNAs are usually formed from the KUNV 3’ UTR during infection.  The largest one, sfRNA1, is 
the most abundant sfRNA in wild-type KUNV infections and sfRNAs 1 and 2 are likely the most 
biologically relevant.  In support of this, the low cytopathogenic sfRNA-deficient KUNV 
(CS3ΔIRA) used in the studies depicted in section I of this results section fails to generate both 
sfRNA1 and sfRNA2, but sfRNA3 accumulates to low levels as shown in Figure12B. The 
CS3ΔIRA KUNV has a 3 nt substitution in stem-loop II of the KUNV 3’ UTR that abrogates 
sfRNA1 formation, and a 10 nt deletion near stem-loop IV that abolishes sfRNA2 formation 
(Pijlman et al. 2008). In collaboration with the Kieft laboratory, we made targeted mutations in 
the KUNV 3’ UTR that were predicted to abrogate the formation of sfRNA1 and/or sfRNA 2 (the 
sequences of each mutant virus 3’ UTR are reported in Appendix 5). Based on biochemical, 
phylogenetics, and structural studies, the Kieft laboratory determined that C10519 and C10680 
were required for stabilization of the interwoven pseudoknot structures that allowed the 
formation of sfRNA1 and sfRNA2 (respectively) in the KUNV 3’ UTR.They also determined that 
nucleotides AGU10498-10500 and UGU10658-10660 were likely essential for KUNV sfRNA1 
and sfRNA2 formation (respectively) based on the crystal structure of MVEV sfRNA (Chapman 
et al. in press). Therefore, three viruses with a G substituted for C10519 and/or C10680 were 
generated, and three viruses with AGUUCA10498-10500 and/or UGUACA10658-10660 
mutations were made to determine if these nucleotides were required for sfRNA formation in 





Figure 29. Kunjin virus sfRNA formation depends on the formation of a three-helix 
junction involving interwoven pseudoknots. Mutation of nucleotides in the 3’ UTR of 
Kunjin virus predicted to disrupt (A) the closing of a ring structure to protect the viral RNA 
from XRN1-mediated decay or (B) the stabilization of a three-helix junction abrogate or 
severely limit sfRNA1 or sfRNA2 formation. 
 
 
Human 293T cells were infected (MOI of 10) with each virus and total RNA collected at 
48 hpi was separated on a 5% polyacrylamide gel for northern blotting to assess sfRNA 
formation. The northern blot shown in Figure 29A show that AGU10498-10500 and UGU10658-
10660 are required for the formation of sfRNA1 and sfRNA2 (respectively). Similarly, the 
northern blot shown in Figure 29B shows that the CG10519 and CG10680 mutations also 
abrogated sfRNA1 and sfRNA2 formation as predicted. These data demonstrate that in the 
context of a KUNV infection of human cells, sfRNA formation relies on the formation of a 






Section IV. Additional functions of sfRNA: suppression of RNA interference 
 
sfRNA-mediated inhibition of Argonaute-2 may inhibit RNAi 
 
 Our data indicate that one important role of sfRNA during viral infection is to suppress 
the host exoribonuclease XRN1. However, sfRNA from DENV-2 and WNV has also been shown 
to suppress RNA interference (RNAi) in non-human primate and mosquito cells, although the 
mechanism by which this occurs has not been fully characterized (Schnettler et al. 2012). 
Furthermore, the single previous study on sfRNA and RNAi that was published while our studies 
were ongoing used replicon constructs or RNA transfections in lieu of viral infections (Schnettler 
et al. 2012). Thus conclusions that can be drawn may be limited by this experimental design.  
One possible mechanism by which sfRNA suppresses RNAi is by acting as a competitive 
inhibitor or sink for DICER and/or AGO2 (the cytoplasmic effector proteins required for this 
process) due to its highly-structured nature (Rauscher et al. 1997).   
 Intriguingly, AGO2 can bind long hairpin-containing miRNA precursors (Cifuentes et al. 
2010; Yang et al. 2010; Cheloufi et al. 2010) and shRNAs (Yang et al. 2012; Liu et al. 2013(b)) 
in vertebrate cells. These results indicate that AGO2 can bind and process RNAs that are larger 
than typical siRNAs or miRNAs. Therefore, we hypothesized that the mechanism by which 
sfRNA suppresses RNAi is through the binding and sequestration of Argonaute-2 (AGO2) and 
DICER. To test the hypothesis that AGO2 may be inhibited by sfRNA, we first assessed AGO2 
activity in human cells during DENV-2 infection. Human 293T cells were infected with DENV-2 
(MOI of 3) or mock infected, and 3 days later were transfected with a reporter plasmid encoding 
eGFP and an siRNA to eGFP or water as a negative control. After 24 hours, total RNA was 
collected from the cells and the abundance of eGFP mRNA was assessed by northern blotting 
(Figure 30A) or RT-qPCR (Figure 30B) to determine if there were any defects in eGFP 





Figure 30. siRNA-mediated knockdown of the reporter eGFP is suppressed in 
DENV-2 infected cells when sfRNA is abundant. (A) A representative northern blot to 
detect eGFP mRNA using a probe that spans the siRNA-target site, with ethidium 
bromide-stained 18S rRNA as a loading control depicted at the bottom of the panel. Mock 
and DENV-2 infected cells (MOI of 3) were transfected with peGFP-N1 plasmid +/- an 
siRNA to eGFP (or water as the negative control) at 3 days post infection. Twenty-four 
hours later, total RNA was collected and 5 micrograms from each sample was resolved 
on a denaturing agarose gel and probed for eGFP. (B) To quantify the relative repression 
of eGFP knockdown in DENV-2 infected cells relative to mock infected cells, RT-qPCR 
was done using primers that span the siRNA-target site to detect the relative abundance 
of intact eGFP mRNA using GAPDH as a reference gene. The siRNA-containing samples 
were normalized to the samples that were not transfected with siRNA (water only). 
Shown above is the average +/- standard deviation of two independent infections. * 
indicates p <0.05 by Student’s t-test. Abbreviations: DV= dengue virus type 2. 
 
 As depicted in Figure 30A, eGFP mRNA was dramatically reduced in abundance by 24 
hours post-transfection with an siRNA targeted to the eGFP open reading frame. Interestingly, 
human 293T cells infected with DENV-2 showed a repression of eGFP knockdown by siRNA as 
measured by northern blot (Figure 30A). For a more quantitative assessment of the relative 
suppression of siRNA-mediated eGFP knockdown, the relative abundance of intact eGFP 
mRNA was assessed using primers that span the siRNA-mediated AGO2 cleavage site (Figure 
30B). This method was used to ensure that qRT-PCR measurements were actually measuring 
intact eGFP mRNA that was not cleaved endonucleolytically by the siRNA-AGO2 complex. We 
determined that cells infected with DENV-2 slightly (~2-fold) de-repress eGFP expression in the 
presence of anti-eGFP siRNA. This is in agreement with previous findings that Vero cells 
harboring a WNV or dengue virus type 1 replicon have a ~2-fold increase in luciferase activity in 
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the presence of anti-luciferase shRNA compared to untransfected Vero cells (Schnettler et al. 
2012).  
 
Figure 31. siRNA-mediated knockdown of the reporter eGFP is suppressed in an sfRNA-
dependent manner in Kunjin virus infected 293T cells. (A) A representative northern blot showing 
eGFP mRNA abundance with 18S rRNA stained with ethidium bromide as a loading control. Human 293T 
cells were mock infected or infected with wild-type Kunjin virus (WT) or an sfRNA-deficient Kunjin virus 
(MUT) lacking sfRNA1 and sfRNA2 (MOI of 10). After 24 hours, the cells were transfected with peGFP-N1 
and either water (- siRNA) or an siRNA to eGFP (+ siRNA). Total RNA from each sample was collected 
48 hpi and 5 micrograms of each was resolved on a formaldehyde agarose gel and blotted using an RNA 
probe to the eGFP open reading frame. (B) RT-qPCR was done to quantify the relative knockdown of 
eGFP by siRNA using GAPDH as a reference gene. Results are the average +/- standard deviation of two 
independent infections. The * indicates p<0.05 using Student’s t-test. 
 
 To determine if sfRNA formation is required for the de-repression of eGFP gene 
expression during other flavivirus infections, we infected human 293T cells with a wild-type 
Kunjin virus or an sfRNA-deficient Kunjin virus. As shown in Figure 31, KUNV infection also 
partially rescues eGFP mRNA expression in the presence of anti-eGFP siRNA. As determined 
by RT-qPCR of RNAs from mock infected and infected cells, the relative knockdown of eGFP is 
significantly decreased in wild-type but not sfRNA-deficient Kunjin virus infected cells. Similar to 
the DENV-2 infections, the reduction in eGFP knockdown was calculated to be ~3-fold. Of note, 
the sfRNA-deficient Kunjin virus used in this study is capable of generating at least one small 
sfRNA (sfRNA3, visible in the left panel of Figure 13B) that could be responsible for these small 
increases in gene expression. This may be particularly relevant in this experiment, as cells were 
infected at a high multiplicity of infection (10) and collected 60 hpi, when the smaller sfRNA3 
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had likely accumulated to a potentially significant level. Our results indicate that one major 
mechanism by which RNAi is suppressed by sfRNA in human cells is through the inhibition of 
AGO2 activity. 
 Schmitter et al. (2006) showed that when AGO2 and/or DICER are knocked down in 
293T cells, subtle but significant changes in the abundance of many mRNAs results. 
Accordingly, as an alternative method of measuring AGO2 and/or DICER activity in cells 
infected with DENV-2 or KUNV, we looked for changes in the abundance of a set of transcripts 
that was shown to be increased (less than 2-fold) when AGO2 and/or DICER were depleted by 
shRNA-mediated knock-downs (Schmitter et al. 2006). This set of transcripts included 
aquaporin 3 (AQP3), armadillo repeat containing, X-linked 4 (ARMCX4), clathrin, heavy chain 
(CLTC), catenin (cadherin-associated protein) β 1 (CTNNB1), and motile sperm domain 
containing 2 (MOSPD2). Intriguingly, a small but significant increase in the expression of five 
transcripts shown to be elevated upon depletion of AGO2 and/or DICER was observed in cells 
infected with DENV-2 (Figure 32A). To assess the impact of sfRNA formation on these changes 
in mRNA abundances during infection and to determine if this was a DENV-2 specific effect, we 
next assessed the abundance of these transcripts in KUNV infected cells. Cells infected with 
wild-type KUNV had a significant increase in four out of five transcripts evaluated (Figure 32B, 
dark grey bars). Interestingly, although cells infected with the sfRNA-deficient KUNV also 
showed a slight increase in the abundance of two of these transcripts, overall the increased 
abundance of four of the transcripts correlated with sfRNA accumulation. However, as 
discussed above, the sfRNA-deficient KUNV generates a small sfRNA (sfRNA3), albeit to lower 
levels than sfRNA1 and sfRNA2 in wild-type virus infections. Therefore, the enhanced 
abundance of two of the four transcripts in the sfRNA-deficient KUNV infected cells could be 
due to the low amount of sfRNA3 that accumulates by 60 hpi.  
As an aside, AQP3, ARMCX4, and MOSPD2 were not represented in the RNA-seq 
datasets from KUNV or sfRNA-deficient KUNV infections (Figure 17). Furthermore, the 
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abundance of CLTC and CTNNB1 were not substantially altered in KUNV or sfRNA-deficient 
KUNV infected cells (Figure 18). This is likely due to the lower multiplicity of infection and/or 
earlier time post infection that the RNA samples for sequencing analysis were collected at. 
However, our qRT-PCR results indicate that changes in gene expression consistent with AGO2 
and/or DICER depletion are altered in flavivirus infected cells, potentially as a result of the direct 
inhibition of AGO2 or DICER activity by sfRNA.  
 
Figure 32. Changes in mRNA abundances in sfRNA-forming viral infections 
recapitulate those observed upon AGO2 and/or DICER knockdown. (A) Human 293T 
cells were infected with dengue virus type 2 (MOI of 3) or mock infected, and total RNA 
was collected 4 dpi. The relative abundance of five mRNAs, aquaporin 3 (AQP3), 
armadillo repeat containing, X-linked 4 (ARMCX4), clathrin, heavy chain (CLTC), catenin 
(cadherin-associated protein) β 1 (CTNNB1) and motile sperm domain containing 2 
(MOSPD2) was assessed by RT-qPCR using GAPDH as a reference gene. (B) Total 
RNA from human 293T cells were mock infected or infected with Kunjin virus (KunV) or 
an sfRNA-deficient Kunjin virus (sfRNA-KunV) (MOI of 10) were collected 60 hpi and 
differences in mRNA abundances were assessed as in (A). The significance of the 
observed differences transcript abundance in infected cells compared to mock infected 
cells was evaluated using Student’s t-test with * indicating p<0.05, **p<0.01, *** p<0.005. 
 
 
sfRNA may bind and sequester AGO2 and DICER to alter RNA interference 
 
One previous study indicated that DICER activity was specifically suppressed by sfRNA 
in WNV and DENV-2 replicon systems (Schnettler et al. 2006). However, our data suggest that 
AGO2 may also be suppressed by sfRNA. To test the hypothesis that sfRNA sequesters either 
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of these nucleases, we performed RNA-protein co-immunoprecipitation assays to determine if 
sfRNA was physically bound to either nuclease during infection. 
 
 
Figure 33. Kunjin virus sfRNA is physically associated with DICER and AGO2 
during infection in human cells. Human 293T cells were infected with Kunjin virus 
(MOI of 10) and formaldehyde cross-linked to preserve RNA-protein interactions before 
immunoprecipitation with (A) anti-DICER antibody or (B) anti-AGO2 antibody. A normal 
IgG control antibody was used to account for non-specific interactions. Genomic RNAs 
were distinguished from sfRNAs by RT-PCR analysis using primers to the open reading 
frame (ORF) or the 3’ untranslated region (3’ UTR) as indicated above the panels. One 
co-immunoprecipitation experiment is shown. 
 
Importantly, both DICER and AGO2 were shown to be physically associated with Kunjin virus 
RNAs containing the 3’ UTR but not the viral open reading frame (Figure 33). These results will 
be validated by assessing DENV-2 sfRNA association with DICER and AGO2 and quantified by 
RT-qPCR. Future experiments will investigate the ability of DICER and AGO2 to bind to the 
highly structured sfRNAs using electrophoretic mobility shift assays. Finally, sfRNA may serve 
as an inhibitor of AGO2, DICER, and XRN1, leading to dysregulated gene expression during 













 The above studies sought to test the hypothesis that the formation of sfRNA during 
flavivirus infection suppresses the activity of the 5’-3’ exoribonuclease XRN1. We demonstrated 
that sfRNA is formed by XRN1-mediated decay in mammalian, mosquito, and yeast systems as 
a result of highly structured conserved elements in the flaviviral 3’ UTRs. The formation of 
sfRNA was then found to be strongly associated with defects in XRN1 activity as measured in 
cell-free extract systems and in infected cells in culture. Furthermore, global analysis of mRNA 
decay in cells infected with Kunjin virus or two sfRNA-deficient viruses revealed sfRNA-
dependent changes in the relationship between stability and abundance of cellular RNAs 
consistent with XRN1 depletion observed in previous studies in yeast. Interestingly, these 
results may indicate that the cellular response to infection is compromised in sfRNA-producing 
viral infections. Finally, we demonstrated that suppression of XRN1 via highly structured viral 
RNAs may be conserved among all members of the Flaviviridae, as the 5’ UTRs of HCV and 
BVDV form distinct decay intermediates upon 5’-3’ decay by XRN1 and suppress XRN1 activity 
in vitro. These studies have therefore identified a novel mechanism by which all members of the 
Flaviviridae suppress a major aspect of the cellular RNA decay machinery, and this potentially 
contributes to virus-induced pathology. 
 
Conserved structural elements in flaviviral untranslated regions suppress XRN1 activity 
 
 The results presented herein and findings from other laboratories demonstrate that the 
XRN1 exoribonuclease in yeast, mammal, and mosquito systems stalls on highly structured 
conserved viral RNA elements in the 3’ UTRs of flavivirus RNAs. How do these RNAs disrupt 
XRN1-mediated decay of the viral genomic and/or messenger RNAs? Interestingly, although 
previous studies demonstrated that pseudoknot-like structures present in flavivirus 3’ UTRs are 
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major contributors to the stalling of XRN1 (Pijlman et al. 2008; Silva et al. 2010; Funk et al. 
2010), in collaboration with the Kieft laboratory (University of Colorado-Denver), we have 
demonstrated that sfRNA formation in cells relies on the interaction between multiple 
pseudoknots mediated by a conserved cytosine upstream of the stem-loops previously 
implicated in sfRNA formation (Chapman et al. 2014; Chapman et al. in press). Mutagenesis of 
the KUNV 3’ UTR in which this essential cytosine was converted to a guanine completely 
abrogated sfRNA formation in infected 293T cells (Figure 29). Furthermore, structural analyses 
of the XRN1-resistant RNA structure in the MVEV sfRNA revealed that a three-helix junction 
centered on the conserved cytosine nucleotide was responsible for the stalling of XRN1 
(Chapman et al. in press). Mutation of three nucleotides at the base of either of two stem-loops 
implicated in KUNV sfRNA formation predicted to disrupt this three-helix junction abrogated 
sfRNA formation in infected cells in culture (Figure 29). Importantly, these studies will likely 
enhance our ability to design effective drugs to target the sfRNA structure present in all 
flavivirus infections. Chemicals that disrupt the secondary structure of flavivirus RNAs could be 
used to potentially destabilize the structure and facilitate effective 5’-3’ decay by XRN1. We are 
currently assessing the ability of small molecules used to disrupt stable stem-loop structures 
formed by CUG repeat elements in toxic RNAs observed in myotonic dystrophy (Lee et al. 2009; 
Coonrod et al. 2013) to abrogate sfRNA formation in vitro as a proof of concept. Furthermore, 
oligonucleotides with perfect complementarity to the regions in the flavivirus 3’ UTR that span 
the base of each stem-loop could be applied to again facilitate XRN1-mediated decay by 
opening up the stable triple-helix structure. Finally, as has been suggested in other works 
(Pijlman et al. 2008; Liu et al. 2014), sfRNA-deficient flaviviruses should be tried as potential 
vaccine candidates as they are less pathogenic than wild-type viruses.  
 Intriguingly, we have observed that the HCV and BVDV 5’ UTRs also stall XRN1, leading 
to the formation of distinct XRN1-mediated decay intermediates. We are currently cloning out 
the 5’ ends of monophosphorylated BVDV and HCV RNAs that had been incubated with XRN1 
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to determine the exact RNA sequence/structures that stall XRN1. However, based on the sizes 
of the HCV and BVDV 5’ UTR decay intermediates we observe in our cell extract and 
recombinant yeast XRN1 decay assays, we notice that the 5’ ends of these decay intermediates 
roughly correspond with the bases of several predicted stem-loop structures conserved 
throughout the genera (Isken et al. 2007). We are currently generating deletion mutant 
constructs of the HCV 5’ UTR to determine which region is required for the stalling of XRN1. 
Furthermore, because the stalling of XRN1 appears to be a common function of the IRES 
elements of both BVDV and HCV, we are currently working to determine if other viral IRES 
elements (e.g. Poliovirus) can stall XRN1. It will be interesting to determine if the stalling of 
XRN1 on distinct viral RNA structures is a function conserved among flaviviruses or potentially 
shared among viral RNAs that lack 5’ methylated cap structures. 
 Intriguingly, other viral RNAs may also be resistant to XRN1-mediated decay. The RNAs 
generated by the yeast Narnavirus contain a long stem-loop at their 5’ ends that was shown to 
block XRN1 (Esteban et al. 2008). However, this mechanism is likely distinct from what is 
observed in the decay of flavivirus RNAs. Rather than allow XRN1 to initiate degradation of 
these RNAs, this structure likely ‘hides’ the 5’ end of the RNA. A recent study of the structure of 
Drosophila XRN1 revealed that the processive exonucleolytic activity of the enzyme works in 
concert with an unwinding activity to effectively process RNA duplexes only when a 5’ overhang 
on the RNA is >8 in length (Jinek et al. 2011). Therefore, these RNAs likely do not act as 
competitive inhibitors of XRN1 to reduce XRN1 activity like sfRNAs. However, some plant 
viruses (e.g. Soybean dwarf virus and Red clover necrotic mosaic virus) are known to generate 
small subgenomic non-coding RNAs (<500 nt) that could potentially be a result of incomplete 5’-
3’ decay of the viral genome by XRN1 (Yamagishi et al. 2003; Iwakawa et al. 2008). Indeed, 
one study demonstrated that Red clover necrotic mosaic virus and other members of the 
Dianthovirus genus (positive-sense single-stranded RNA viruses of plants) generate these 
subgenomic RNAs as a result of incomplete 5’-3’ decay in tobacco protoplast extracts (Iwakawa 
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et al. 2008). Furthermore, these RNAs appear have some ability to suppress viral translation 
(similar to what was observed in a study of the JEV sfRNA; Fan et al. 2011). However, unlike 
KUNV sfRNAs, the Red Clover Necrotic Mosaic virus subgenomic RNA appears to be packaged 
into nascent virions (Pijlman et al. 2008; Iwakawa et al. 2008). The role of these sgRNAs in viral 
pathogenesis remains uncharacterized. 
 
Could endogenous cellular transcripts stall and suppress XRN1 activity? 
 
 One important finding from these studies is the observation that multiple viral RNAs are 
capable of stalling and suppressing XRN1 activity. Although we have discussed this capability in 
the context of viral infection and pathogenesis, it is possible that cellular transcripts also may 
encode XRN1-resistant structural elements. For example, some cellular transcripts are thought 
to be translated via IRES-mediated mechanisms, potentially to allow gene expression under 
conditions that suppress cap-mediated translation mechanisms (e.g. during mitosis or hypoxia) 
and/or to facilitate ribosome scanning through highly structured RNA elements (reviewed in 
Komar and Hatzoglou 2011; Le Quesne et al. 2001). If conserved structural elements in internal 
ribosome entry sites that are essential for translation initiation also happen to be resistant to 
XRN1-mediated decay, then cellular mRNAs that have been demonstrated to undergo IRES-
mediated translation may stall and suppress XRN1 activity.  
 At least three other sets of transcripts with unique properties could be capable of stalling 
XRN1. First, a recent study demonstrated that the 3’ UTRs of many transcripts in human and 
mouse cells are expressed at different levels than the associated open reading frames (Mercer 
et al. 2011). In other words, it appears that different regions of an mRNA show different 
abundances – which is strongly suggestive of differential decay of portions of the transcript. This 
study also demonstrated using in situ hybridization that the subcellular and/or tissue-specific 
localization of the 3’ UTRs of three transcripts (Col1a1, Nfia, and Myadm) were different from 
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the corresponding open reading frames in mice during development (Mercer et al. 2011). Thus 
these cellular mRNAs could potentially be generating sfRNA-like decay intermediates from 
structured elements in their 3’ UTRs. Second, transcripts that have been characterized as 
having unconventional transcription start sites or splice sites may potentially be generated as a 
result of incomplete degradation of the parent transcript by XRN1. Therefore, re-analyzing 5’-
RACE data may reveal some interesting stall sites for RNA decay factors in cellular mRNAs. 
Finally, changes in the structure of mRNAs due to mutations or altered temperature could 
potentially facilitate the stalling of XRN1 on cellular mRNAs. For example, temperature-induced 
changes in RNA secondary structure have been described in Influenza A virus (Chursov et al. 
2012) and tick-borne encephalitis virus (Elvang et al. 2011). A recent study demonstrated that 
up to 15% of transcribed single nucleotide variants cause local changes in mRNA structure in 
humans (Wan et al. 2014), indicating that small changes in the sequence of a transcript can 
impact RNA structure. Furthermore, recent studies demonstrated that single nucleotide 
variations in the 5’ UTR of thrombin-activatable fibrinolysis inhibitor can significantly alter the 
structure and stability of the transcript (Boffa et al. 2008; Halvorsen et al. 2010). Therefore, 
because XRN1 is capable of stalling on structured viral RNAs, unique mRNA structures 
resulting from mutations or enhanced structural stability due to decreased temperature could 
potentially stall XRN1 in human cells. The identification of potential XRN1-resistant cellular 
transcripts will be important, because suppression of XRN1 could lead to defects in post-
transcriptional regulatory mechanisms that may cause disease. Interestingly, transcripts that 
change conformation and adopt more stable higher-order structures at low temperatures and/or 
potentially during stress responses due to alterations in salt availability or concentration in the 
cytoplasm) and suppress XRN1 activity could dramatically alter the host response, potentially 




Changes in gene expression during sfRNA-forming viral infections are consistent with 
studies of XRN1-deficient organisms  
 
We hypothesized that sfRNA-forming viral infections would cause a global increase in 
the stability of cellular transcripts, and that this would also correspond with an overall increase in 
the steady-state abundance of cellular transcripts. In support of this hypothesis, we found that in 
conjunction with sfRNA-mediated suppression of the major exonuclease XRN1, there are 
substantial changes in the steady-state abundance of certain cellular RNAs including pro-
inflammatory innate immune factors and the stability of short-lived transcripts was significantly 
increased (Figures 14, 16, 17). However, although we expected a substantial increase in the 
overall abundance of mRNAs as a result of XRN1 suppression in flavivirus infected cells, out of 
the ~3000 transcripts assessed in KUNV infections, the vast majority of transcripts were not 
substantially altered in abundance (e.g. most were less than 2-fold reduced or increased in 
abundance relative to mock infected cells). Fruit flies engineered to have reduced expression of 
the XRN1 homolog pacman also show few changes in the overall abundance of transcripts, 
although they also display dramatic phenotypic changes including developmental defects 
(Grima et al. 2008; Jones et al. 2013). Therefore, XRN1 depletion and/or enzymatic suppression 
can contribute to phenotypic changes without altering the steady-state abundance of the 
majority of mRNAs in a given system.  
We also determined that sfRNA formation in Kunjin virus infections was strongly 
associated with the stabilization of cellular transcripts (Figure 17). In agreement with these 
findings, previous studies using XRN1-deficient yeast demonstrated that a majority of transcripts 
are generally more stable in these systems compared to wild-type yeast (He et al. 2003; 
Haimovich et al. 2013; Sun et al. 2013; Medina et al. 2014). The analysis of global changes in 
mRNA stability in KUNV and the sfRNA-deficient KUNV and SINV infections therefore provided 
another piece of evidence that XRN1 activity is suppressed as sfRNA accumulates. Although 
dramatic changes in overall mRNA abundance were not observed in Drosophila lacking XRN1, 
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it was also demonstrated that several mRNAs, including the mRNA of heat shock protein 
Hsp67Bc were increased in abundance in the XRN1-deficient Drosophila wing imaginal discs 
(Jones et al. 2013). Importantly, these changes in mRNA abundance were likely due to mRNA 
stabilization, as the abundance of the intron-containing pre-mRNAs were not substantially 
altered in the mutant flies compared to controls (Jones et al. 2013). These results indicate that 
changes in the post-transcriptional regulation of certain mRNAs could impact organism 
phenotype in the absence of global changes in mRNA abundance. Indeed, the Arabidopsis 
homolog of XRN1, XRN4, may have some sequence specificity (Rymarquis et al. 2011). 
However, this is potentially an indirect result, as certain transcripts undergoing 5’-3’ turnover 
more rapidly than others and/or targeted for 5’-3’ decay by RNA binding proteins (or miRNAs) 
that have sequence and/or RNA structure specificity might be over-represented in an XRN-
deficient organism (Jones et al. 2012). Furthermore, the decapping complex can be specifically 
recruited to mRNAs that undergo miRNA-mediated decay, ARE-mediated decay, or to 
transcripts that contain other unique structural or sequence elements (reviewed in Ling et al. 
2011). In this fashion, the suppression of XRN1 could lead to the stabilization and/or over-
expression of a specific subset of transcripts, although the mammalian XRN1 exonuclease itself 
does not appear to exhibit sequence specificity. 
Our global analyses RNA stability in arbovirus infected cells supports the idea that XRN1 
suppression does not lead to the up-regulation of mRNAs on a global scale. Furthermore, these 
results may indicate that altered abundance and/or stability of a select subset of transcripts 
occurs upon XRN1 suppression, as appears to be the case in Drosophila wing morphogenesis 
(Jones et al. 2013). Although our RNA-seq approach to determine global changes in mRNA 
stability and abundance during arthropod-borne virus infections yielded important insights into 
the relationships between rates of mRNA decay and steady-state mRNA abundances, 
potentially very interesting groups of transcripts that are likely expressed at levels below the 
depth of sequencing were unfortunately not included in our datasets. These include FOS, TUT1 
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and the pro-inflammatory cytokines detected by qRT-PCR and microarray reported in Figure 15. 
Therefore, our global analyses of mRNA stability and abundance were not adequate for directly 
answering the question of whether or not short-lived transcripts induced by viral infections were 
stabilized by sfRNA. Importantly, we were able to directly assess the stability and steady-state 
abundance of a set of short-lived transcripts in HCV and BVDV infected cells known to be 
involved in pathologies associated with these viral infections. We determined that stabilization of 
these transcripts may be an important mechanism by which they are elevated in abundance 
overall. Therefore, XRN1 suppression by viral RNAs could contribute to pathology by altering 
the abundance and stability of a select group of normally short-lived transcripts. 
 
Dysregulation of mRNA stability and abundance in arbovirus infections points to defects 
in homeostatic mechanisms that likely coordinate mRNA synthesis and decay 
 
The relationship between mRNA stability and mRNA abundance in the constitutively 
expressed transcripts that likely serve a more general house-keeping function was analyzed 
using the datasets generated using RNA-seq for viral infections (Figures 16, 17 and 18). We 
demonstrated that sfRNA-deficient KUNV or SINV infected cells display a positive correlation 
between mRNA stability and abundance (Figure 19A and B). This might be expected if the cell 
undergoes a highly coordinated anti-viral response that requires concerted changes in mRNA 
abundance and stability. In contrast, cells infected with the sfRNA-forming KUNV displayed no 
correlation between changes in mRNA stability and abundance (Figures 18C and 19D). We 
hypothesize that this lack of coordination between mRNA stability and abundance in cells 
infected with sfRNA-forming flaviviruses indicates a defect in the host response to infection that 
may be involved in the sfRNA-dependent pathologies observed in other studies (Pijlman et al. 
2008; Liu et al. 2014). How could this apparent defect in coordinated changes in cellular gene 
expression regulatory mechanisms contribute to pathology? If the cell is unable to rapidly react 
to the presence of viral pathogen associated molecular patterns (as discussed in the 
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Introduction), then the virus could gain a foothold in the cell for the establishment of replication 
complexes and host cell re-modeling earlier in the infection. Furthermore, post-transcriptional 
regulatory mechanisms are essential for controlling the expression of pro-inflammatory factors 
like TNF-α (also discussed in the Introduction). Defects in the coordinated regulation of 
transcription and mRNA decay could therefore promote excessive inflammation in infected cells 
that could perhaps not rapidly reduce the expression of pro-inflammatory factors. Exactly how 
mRNA decay processes influence mRNA synthesis in mammalian cells remains to be explored.  
 
Coordination between XRN1 and early steps in the deadenylation-dependent RNA decay 
pathway 
 
We demonstrated that short-lived oncogenes and angiogenic factors are more abundant 
and stable at the mRNA level in HCV and BVDV infected cells. Importantly, these mRNAs are 
not uncapped decay intermediates (although we determined that a small amount (~<10%) of 
cellular transcripts lacking 5’ caps do accumulate in HCV, DENV-2, and KUNV infections) and 
the majority of these transcripts are polyadenylated, capped, and therefore theoretically 
translatable (Figure 28). In BVDV infected cells, c-FOS and c-JUN were more abundant at the 
RNA and protein levels, demonstrating that stabilization of these mRNAs could contribute to 
elevated gene expression. How could changes in XRN1 activity influence the abundance of 
capped and polyadenylated mRNAs and/or protein? Aside from mechanisms that mediate 
coordination of mRNA decay and synthesis as discussed above, it is also likely that the distinct 
enzymatic processes in the 5’-3’ deadenylation-dependent decay pathway are also coordinated. 
There are three pieces of evidence that would support this idea. First, mRNA decay factors 
including CCR4-NOT family members, XRN1, DCP1a, DCP2, and AGO2 are often co-localized 
in discrete cytoplasmic foci (P-bodies) in human cells (Cougot et al. 2004; Liu et al. 2005; Sen 
and Blau et al. 2005), and XRN1 is known to directly interact with EDC4 in the decapping 
complex in human cells (Braun et al. 2012). Therefore these factors exist in close physical 
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proximity to one another and could directly or indirectly interact. Second, the decapping factor 
DCS1 has been shown to regulate XRN1 activity, potentially by causing a change in the XRN1 
protein conformation and/or stabilizing the protein to increase the affinity of XRN1 for its RNA 
substrate (Sinturel et al. 2012). Therefore, there is precedence for the ability of a protein factor 
involved in a distinct mRNA decay process to regulate XRN1. Finally, as discussed in the 
Introduction, the proteins involved in deadenylation, decapping, and 5’-3’ decay directly or 
indirectly interact through protein scaffolds, and the presence of disordered regions in many of 
these proteins may facilitate ribonucleoprotein aggregation (Decker et al. 2007; Reijns et al. 
2008; Ozgur et al. 2010; Braun et al. 2012; Chang et al. 2014; Jonas and Izaurralde 2013). We 
have demonstrated that sfRNA formation directly inhibits XRN1 activity and that changes in 
mRNA stability consistent with XRN1-deficiency are observed in flavivirus infections. In addition 
to these findings, P-bodies are dispersed in DENV, WNV and HCV infected cells, indicating that 
the interactions between these various mRNA decay factors are potentially disturbed upon 
infection (Emara and Brinton 2007; Pager et al. 2013). Furthermore, as discussed in the 
Introduction, HeLa cells infected with WNV recruit XRN1, LSm1, TNRC6A, and the RNA 
helicases DDX3, and DDX6 to viral replication complexes (Chahar et al. 2013). The 3’ UTR or 
sfRNA of DENV-2 was shown to interact with the P-body components DDX6 (Ward et al. 2011) 
and XRN1 (Figure 10). Furthermore, the HCV 5’ UTR interacts with AGO2 (Conrad et al. 2013; 
Bradrick et al. 2013), LSm1-7 (Scheller et al. 2009) and XRN1 (Bradrick et al. 2013). It is 
therefore possible that viral RNAs (either full-length or sfRNAs/sfRNA-like HCV RNA decay 
intermediates) bind and sequester several RNA binding proteins normally present in 
ribonucleoprotein complexes that may coordinate disparate steps in the mRNA decay process. 
Therefore, the formation and accumulation of sfRNA/sfRNA-like decay intermediates could 
directly and indirectly perturb P-body formation by sequestering RNA binding proteins and 
nucleases like XRN1 and AGO2. Furthermore, recent studies have demonstrated that XRN1 
may have the ability to act as a transcription factor in yeast (Sun et al. 2013; Haimovich et al. 
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2013; Medina et al. 2014), although XRN1 in mammalian and yeast cells is predominantly 
localized in the cytoplasm and therefore may not directly regulate transcription (Heyer et al. 
1995; Ingelfinger et al. 2002). The potential sequestration of XRN1 on sfRNAs in flavivirus 
infected cells could also potentially disrupt feedback mechanisms that normally exist in the cell 
to coordinate mRNA synthesis in decay. Consequently, defects in coordination between early 
steps in the deadenylation-dependent mRNA decay pathway and coordination between mRNA 
synthesis and decay could be caused by XRN1-mediated formation of sfRNA as illustrated in 
Figure 34. 
 
Figure 34. The suppression of XRN1 activity by highly structured flaviviral RNAs 
could disrupt normal feed-back mechanisms that regulate mRNA synthesis and 
decay. The coordination between XRN1 and other RNA decay factors (e.g. 
deadenylases and decapping factors) and/or transcription factors is represented by the 
gray dotted lines, and this coordination is likely dysregulated in flavivirus infections.  
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A role for XRN1 suppression in flavivirus-mediated pathology 
 
 Suppression of XRN1 activity by flaviviruses could lead to pathology by enhancing viral 
replication (either by stabilization of viral RNAs or other impacts on viral replication) or by 
dysregulating the host response to infection. We did not measure the rate of viral RNA decay 
during infection, although our data support the hypothesis that sfRNA accumulation would lead 
to increased viral RNA stability. This is highly likely, as a recent manuscript demonstrated that 
XRN1 is the primary exonuclease involved in degrading HCV RNAs (Li et al. 2013(b)) and the 
formation of sfRNAs in flavivirus infections relies on XRN1-mediated decay of the parent 
transcript. Furthermore, there are some clues in the literature that innate immune mechanisms 
are dysregulated during flavivirus infections of mammalian cells as a result of sfRNA 
accumulation (Schuessler et al. 2012, Chang et al. 2013). There are several potential 
mechanisms discussed below by which XRN1 suppression could contribute to flavivirus-, 
hepacivirus-, and pestivirus-induced pathology. 
 
XRN1 is important for proper cell growth/proliferation and development 
 
 The suppression of XRN1 by highly structured flavivirus RNAs could contribute to 
changes in cell biology that may enhance or promote virus-induced pathology in the host. As 
discussed above, XRN1 depletion in yeast causes changes in mRNA stability- but how does 
XRN1 deficiency affect the biology of the cell? Several studies have demonstrated that XRN1 is 
likely important for regulating basic processes in cell growth, proliferation, and development. In 
the yeast Schizosaccharomyces pombe, XRN1 deficiency was shown to increase cell size, 
cause a loss of cell viability in the stationary phase, and also made these organisms 
hypersensitive to anti-mitotic drugs (Szankasi et al. 1996). Furthermore, Saccharomyces 
cerevisiae lacking XRN1 also have increased cell size and increased doubling time in 
conjunction with stabilization of cellular mRNAs (Larimer and Stevens 1990; Larimer et al. 
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1992). These studies demonstrate that XRN1 activity is strongly associated with defects in 
essential cell behaviors including cell growth and proliferation.   
 In more complex organisms, XRN1 has been implicated in the processes of 
development, response to stress/stimuli, and has even been suggested as a tumor suppressor 
protein. Studies in Drosophila demonstrate that XRN1 is differentially expressed during 
organism development, indicating that it may play an important regulatory role in mediating this 
complex process (Till et al. 1998). As discussed above, further studies in Drosophila showed 
that XRN1 is essential for normal wing development (Jones et al. 2013), epithelial sheet sealing 
(Grima et al. 2008) and spermatogenesis (Zabolotskaya et al. 2008). In mammals, less is known 
about the role of XRN1 in development and cell growth; however, a role for XRN1 in neuronal 
cell differentiation was proposed in one study. XRN1 expression can be induced by glial-cell 
derived neurotropic factor (GDNF) in human neuroblastoma cells (Shimoyama et al. 2003). 
Because GDNF induces differentiation of these neuronal cells, XRN1 could play a role in 
mediating this process (Shimoyama et al. 2003). Finally, XRN1 may potentially be important for 
the regulation of cell growth and proliferation, as it may be involved in the onset and/or 
progression of osteogenic sarcoma (Kruzelock et al. 1997; Zhang et al. 2002). Osteogenic 
sarcoma-derived cell lines and patient-derived osteogenic sarcoma biopsy specimens were 
shown to have reduced XRN1 expression when compared to a control human fetal osteoblast 
cell line (Zhang et al. 2002).  
 XRN1 activity in yeast is suppressed in the presence of lithium (Dichtl et al. 1997). 
Interestingly, lithium toxicity in yeast was abrogated by the overexpression of HAL2 protein, an 
enzyme known to break down adenosine 3’, 5’ bisphosphate (pAp) into 5’ adenosine 
monophosphate and inorganic phosphate (Dichtl et al. 1997). The authors of this study 
demonstrated that XRN1 may be regulated in this context by the build-up of pAp as a result of 
lithium-mediated suppression of HAL2 activity as XRN1 activity was abrogated in vitro in the 
presence of pAp (Dichtl et al. 1997). A later study demonstrated that HAL2 expression is likely 
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regulated by BDF1, a member of the Fsh/Brd bromodomain-containing protein family, and that 
in the absence of BDF1 yeast cells were particularly sensitive to salt stress (Liu et al. 2009(b); 
Chen et al. 2013(b)). Over-expression of HAL2 rescued resistance to salt stress in a Bdf1 
deletion strain (Chen et al. 2013(b)). These studies are potentially interesting in the context of 
mammalian development, because BRD4, another Fsh/Brd bromodomain-containing protein, 
was shown to be essential for normal development in mice (Houzelstein et al. 2002). Mice with 
reduced BRD4 expression have pre- and post-natal defects including malformation of the head, 
liver defects (including reduced liver cell proliferation), lack subcutaneous fat, and cataracts 
(Houzelstein et al. 2002). Mice lacking BRD4 completely are embryonic lethal (Houzelstein et al. 
2002). If BRD4 similarly regulates HAL2 expression in mammalian cells as occurs in yeast, 
when BRD4 is under-expressed, we might expect to see a reduction in Hal2 expression. 
Reduced HAL2 expression could cause an accumulation of pAp, potentially leading to XRN1 
suppression. Although these data are indirectly implicating XRN1 in the cellular response to 
lithium and salt stress, there are other pieces of evidence that implicate that XRN1 activity is 
important for organism response to stress. Intriguingly, the plant homolog of XRN1, XRN4, is 
known to be important for mediating the organism response to a variety of stresses, including 
heat and ethylene toxicity (Potuschak et al. 2006; Olmedo et al. 2006; Merret et al. 2013). 
Therefore, XRN1 might be important for mediating the cellular anti-flaviviral response. 
 
Inhibition of RNA interference by sfRNA 
 
 RNA interference is arguably the most important innate immune response that 
arthropods use to protect themselves from flavivirus induced pathology (Blair 2011; Sanchez-
Vargas et al. 2009). Therefore, the ability of flaviviruses to suppress the RNAi pathway to some 
degree is likely very important for these viruses to exist in the arthropod vector long enough to 
be transmitted to the next host. Our studies have demonstrated that siRNA-mediated silencing 
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of gene expression in mammalian cells is limited during DENV-2 and KUNV infections in an 
sfRNA-dependent fashion (Figures 29 and 30). Because RNAi is likely most important in the 
context of the viral infection of the arthropod vector, we are currently assessing the degree to 
which RNAi is suppressed in vivo in the mosquito vector. Although sfRNA formation in the 
mosquito vector has not been demonstrated in the literature, preliminary evidence suggests that 
sfRNA accumulates to high levels in DENV-2 infected Aedes aegypti mosquitoes (data not 
shown). Furthermore have demonstrated using cytoplasmic extracts from Aedes albopictus 
C6/36 cells that sfRNA also inhibits XRN1 activity in this system (Figure 7C). As discussed in 
the Introduction, there is some evidence that sfRNA reduces DICER activity in non-human 
mammalian cells (Schnettler et al. 2012) and a recent manuscript demonstrated that microRNAs 
are significantly reduced in abundance DENV-2 infected cells (Kakumani et al. 2013), possibly 
indicating that DICER and/or AGO2 activity is suppressed during flavivirus infections. Disruption 
of both AGO2 and DICER by sfRNA would be possible considering the importance of RNAi to 
the arthropod anti-viral response. However, another possibility that we are currently assessing is 
the potential for feedback mechanisms to exist between components of the RNAi pathway. If 
AGO2 suppression feeds back and reduces DICER activity, or if XRN1 (known to degrade 
AGO2-mediated endonucleolytic decay products; Orban and Izaurralde 2005) suppression 
feeds back and suppresses AGO2 activity, then sfRNA could be indirectly suppressing RNAi 
during infection. We are pursuing this by assessing the knockdown efficiency of a reporter RNA 
in cells deficient in XRN1, AGO2, or DICER. However, the intriguing preliminary finding that the 
3’ UTR of KUNV is directly associated with AGO2 and DICER in infected cells implies that 




Future directions  
Determine the impact of sfRNA formation on viral RNA stability 
 
 Co-opting cellular RNA stability factors can stabilize viral RNAs (Sokoloski et al. 2010), 
and the sponging of the host HuR protein by Sindbis virus RNAs can dramatically alter cellular 
mRNA stability and processing (Barnhart et al. 2013). Therefore, the suppression of the major 
cytoplasmic 5’-3’ exoribonuclease XRN1 by sfRNA likely stabilizes both viral and cellular RNAs. 
We demonstrated that sfRNA formation requires XRN1 to actively degrade viral RNAs and that 
RNAi-mediated decay of a reporter transcript containing the DENV-2 3’ UTR or the 5’ UTR of 
HCV or BVDV enhances the formation of sfRNA. Therefore, some flaviviral genomes may act 
as bait for the RNA decay machinery to ultimately cause the stabilization of viral RNAs later in 
the infection. Answering this question of flaviviral RNA stability will require overcoming a 
technical limitation in the system. Although there is not currently a commercially available 
inhibitor of flavivirus transcription (homologous to actinomycin D in mammalian cells) to directly 
address this hypothesis, several other experimental approaches could be undertaken. A broad-
spectrum antiviral drug, HPA-23 ((NH4)18(NaW21Sb9O86)17), was demonstrated to inhibit 
transcription of a diverse array of viruses (Werner et al. 1976; Tsiang et al. 1978), including 
DENV-2 (Bartholomeusz et al. 1994). Initial experiments using HPA-23 were not successful in 
shutting off flaviral transcription in our laboratory, perhaps due to the low solubility and perhaps 
stability of this compound in aqueous solutions. Alternatively, a metabolic labeling approach in 
which labeled ribonucleosides are applied to infected cells in culture and integrated into nascent 
viral genomes may also be attempted (assuming viral RNA dependent RNA polymerases can 
efficiently incorporate these modified ribonucleotides) as reported in Azarkh et al. (2011). 
Finally, as was done in Sokoloski et al. (2010), the use of a temperature-sensitive flaviviruses 
engineered to lose RdRp activity upon transfer to a higher temperature could yield viral RNA 
stability data. However, no temperature sensitive mutants with defects in the flaviviral 
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polymerase have been described in the literature to our knowledge, although targeted mutations 
predicted to abrogate polymerase activity at higher temperatures by disrupting the tertiary 
structure of the enzyme could be employed to potentially generate such mutants. Therefore, 
future studies should seek to address the role of XRN1 suppression in the stabilization of 
flavivirus RNAs. 
 
Examine the mechanisms by which flavivirus RNAs are degraded in the cell 
 
 Although XRN1 is likely a key player in mediating the degradation of flavivirus RNAs, as 
demonstrated by sfRNA accumulation, the initial steps in the decay of flavivirus RNAs are 
unknown. It would be interesting to determine if induced nucleases (e.g. RNase L) contribute to 
endonucleolytic cleavage of viral RNAs to facilitate XRN1-mediated decay of 5’ phosphorylated 
RNAs. Furthermore, although RNAi is likely not a major mechanism by which viral RNAs are 
targeted for decay in mammalian somatic cells, AGO2-mediated decay of viral transcripts in 
mammalian cells has been recently documented (Li et al. 2013(c); Maillard et al. 2013). Indeed, 
we demonstrated that targeting a reporter RNA containing the 3’ UTR of DENV-2 or the HCV or 
BVDV 5’ UTR with an upstream siRNA lead to increased accumulation of sfRNA-like decay 
intermediates in human 293T cells. Because flavivirus RNAs are not polyadenylated but contain 
5’ methylguanosine caps, it would be interesting to determine if they are shunted directly into 
the decapping and 5’-3’ decay pathway. Interestingly, there is some evidence that the YFV 
genome undergoes 3’-5’ decay, as a 3’ truncated sfRNA was detected in infected mammalian 
cells (Silva et al. 2010). The hepacivirus and pestivirus RNAs lack methylated 5’ caps, and 
because XRN1 is unable to effectively degrade 5’ triphosphorylated RNAs (Jinek et al. 2011) it 
would be interesting to determine how these RNAs are dephosphorylated to allow XRN1-
mediated decay. It is also likely that viral RNAs can be targeted by quality control pathways in 
the cell, considering that they (1) do not have a nuclear experience and thus are not present in 
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proper ribonucleoprotein complexes (Wilusz and Wilusz 2010) and (2) viral RNA-dependent 
RNA polymerases are error-prone and likely integrate premature termination codons, fail to add 
a termination codon, or highly structured viral RNAs could stall on the ribosome during 
translation. Using a combination of RNAi-mediated gene silencing of key endo- and 
exonucleases and assessment of viral RNA stability using one of the methods described above 
should enable the elucidation of how flavivirus RNAs are degraded in the cell. 
 
Directly assess the role of XRN1 suppression in pathology 
 
 Although we have demonstrated that the major 5’-3’ exoribonuclease XRN1 is 
suppressed by sfRNAs and that significant changes gene expression occur in association with 
sfRNA accumulation, future studies should directly address the hypothesis that XRN1 inhibition 
during viral infection leads to pathology. Two studies have demonstrated that sfRNA is 
important for KUNV and DENV-2 mediated cytotoxicity/pathogenicity in either a mouse model of 
infection or in cell culture (Pijlman et al. 2008; Liu et al. 2014). How exactly do sfRNAs from 
diverse flaviviruses mediate pathology, and could the sfRNA-like decay intermediates observed 
in BVDV and HCV infections also contribute to pathology?  
 Because XRN1 has been implicated as a tumor suppressor protein (Zhang et al. 2002), 
it is possible that the suppression of XRN1 by sfRNA-like decay intermediates observed in HCV 
infections could contribute to the onset of HCV-induced HCC. We are currently assessing the 
relationship between carcinogenesis and XRN1 suppression using focus formation assays in 
Huh7 and NIH3T3 cell culture models. Hepatitis C virus infections can also cause fibrosis 
(Razavi et al. 2013), and XRN1 has been demonstrated to be important for epithelial sheet 
sealing in Drosophila, a model for wound healing. To determine if XRN1 suppression by viral 
RNAs could contribute to defects in wound healing/fibrosis during infection, we are also 
performing in vitro wound healing/cell migration assays (as done in Lee et al. 2012(b)). 
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 As discussed above, XRN1 is important for proper organismic development, cell 
growth/proliferation, and respond to various stimuli. It has therefore been postulated that XRN1 
coordinates a proper cellular response to various cues that permit a dramatic change in global 
gene expression (Jones et al. 2012). Because we observed dramatic changes in cellular gene 
expression in flavivirus infections that occurred in an sfRNA-dependent fashion, it is possible 
that XRN1 is also important for mediating the proper cellular response to viral infection. The 
observation that transcript abundances were generally not correlated with transcript stability in 
wild-type KUNV infected cells, but that there is a positive correlation between these values in 
two sfRNA-deficient RNA virus infections supports the hypothesis that sfRNA disrupts the 
normal cellular response to infection.  
 Gene ontology analysis of the transcripts that were >2-fold more stable in KUNV infected 
cells relative to the sfRNA-deficient KUNV infected cells revealed that several biological 
processes may be altered as a result of sfRNA formation. There was a significant enrichment 
(p<0.001) in transcripts encoding factors involved in the cell cycle process, microtubule 
cytoskeleton organization, nuclear division, ribosome biogenesis, and the cellular response to 
stress. As discussed in the Introduction, organisms that have defects in XRN1 expression also 
display abnormalities in many of these processes, including cell proliferation (Jones et al. 2012; 
Nagarajan et al. 2013). These results lend further support to the idea that sfRNA suppresses 
XRN1 activity during infection. Furthermore, the transcripts that were selectively stabilized in 
association with sfRNA formation may encode factors that are particularly important for the 
cellular response to viral infection. Gene ontology analysis revealed a significant enrichment 
(p<0.001) in transcripts of proteins involved in RNA processing, RNA splicing, protein 
catabolism, macromolecular complex subunit organization, regulation of protein ubiquitination, 
and other processes that are likely important for remodeling the cell by altering cellular gene 




 Flavivirus infected cells undergo ER stress, as demonstrated by several studies (e.g. Yu 
et al. 2013; Ambrose and Mackenzie 2011). This is further supported by our RNA-seq data as 
GO analysis of the transcripts >2x increased in abundance in KUNV or sfRNA(-) KUNV 
infections showed a significant (p<0.01) enrichment in transcripts encoding factors involved in 
the response to ER stress, ER overload response, and the unfolded protein response. 
Therefore, one possible experiment to demonstrate the importance of XRN1 in mediating cell 
responses to stress would be to deplete human cells of XRN1 (by shRNA-mediated gene 
silencing) or treat cells with sfRNA-forming constructs, and challenge cells with chemical 
inducers of ER stress (e.g. brefeldin A; Klausner et al. 1992) to determine if post-transcriptional 
changes in gene expression and/or cytotoxicity are observed in association with XRN1 
suppression. These studies will provide insight into the direct mechanisms by which XRN1 
suppression could lead to pathology during a viral infection. 
 
Determine if XRN1 suppression enhances viral RNA recombination 
  As described above in the Introduction, the gene expression strategy of flaviviruses 
relies on the translation and proteolytic processing of a polyprotein encoded in a single viral 
RNA. However, the organization of the viral genome and the generation of distinct viral proteins 
can be greatly influenced by changes in the viral RNA sequence caused by mutation or 
recombination events. Furthermore, sfRNAs have been shown to be essential for Kunjin virus 
pathogenesis (Pijlman et al. 2008). Theoretically, changes in the organization /sequence of the 
viral RNA due to recombination events or mutations could alter the RNA structures such that 
sfRNA formation is enhanced or suppressed. Therefore, changes in the flaviviral RNA sequence 
due to recombination or mutation could ultimately contribute to viral pathogenesis. 
 It is likely that mutation of nascent viral genomes due to error-prone flavivirus RdRp 
activity is the primary mechanism by which genetic diversity is expanded in these viruses. For 
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example, the error rate of DENV RdRp is known to be fairly high and is in the same range as 
other single stranded RNA viruses at 10-3-10-5 mutations per nucleotide (Jin et al. 2011; Drake 
1993; Holmes and Burch 2000). Similarly, HCV mutation rates were estimated to be ~3×10⁻⁵ 
mutations per nucleotide in human patients (Ribeiro et al. 2012). However, recombination of 
viral RNA genomes can occur as viral RdRps dissociate from one template and re-initiate 
transcription on another template to generate a novel RNA sequence (i.e. template switching; 
Simon-Loriere and Holmes 2011). Recombination can therefore change the genome structure 
and substantially alter the protein products generated by a virus. Interestingly, viral genomes of 
members of all three genera in the Flaviviridae family have been reported to undergo RNA 
recombination events, the outcome of which leads to either deletion of internal segments or 
results in the insertion of host or viral RNA sequences into the viral genome (Tautz et al. 1994; 
Tautz et al. 1996; Meyers et al. 1989; Meyers et al. 1998; Simon-Loriere and Holmes 2011 
Pesko et al. 2012). Although some phylogenetic studies have pin-pointed specific instances in 
which certain flaviviruses including DENV have likely undergone recombination events, 
experimental evidence indicates that flavivirus recombination is probably a rare event (Holmes 
et al. 1999; Tolou et al. 2001; Uzcatequi et al. 2001; Taucher et al. 2010; Faye et al. 2014). 
However, the pestiviruses and hepaciviruses are known to undergo recombination events quite 
frequently (Gallei et al. 2005; Cristina and Colina 2006; Moreno et al. 2006; Reiter et al. 2011; 
Simon-Loriere and Holmes 2011; Scheel et al. 2013). Importantly, recombination is a significant 
mechanism by which changes in cytopathogenicity of BVDV infections can occur (Meyers et al. 
1991; Gallei et al. 2005). In some cases, viral or host protease recognition sites are inserted into 
the BVDV genome between NS2 and NS3 (likely through recombination events) leading to 
proteolysis; however, some insertions do not have an obvious proteolysis target site and cause 
cleavage of NS2 and NS3 through unknown mechanisms (Tautz et al. 1996, Meyers et al. 1989; 
Meyers et al. 1991, Mendez et al. 1998; Becher et al. 2002). 
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 Intriguingly, studies in plants have demonstrated that XRN1 is likely involved in 
suppressing viral RNA recombination events (Serviene et al. 2005; Cheng et al. 2006; Jaag and 
Nagy 2009). This may be because XRN1 is involved in degrading viral and cellular transcripts, 
effectively removing decapped (and therefore potential substrates for RNA-RNA recombination) 
RNAs from the cytoplasm that could be incorporated into nascent viral genomic RNAs during 
RdRp template switching. Importantly, as discussed above, non-cytopathic BVDV can transform 
into cytopathic BVDV and therefore cause severe mucosal disease in infected animals (Tautz et 
al. 1998). Therefore, if XRN1 suppression enhances viral recombination events in mammalian 
systems as well as plant systems, then this could be an important mechanism by which 
flaviviruses evolve to become more pathogenic. 
 It would be particularly interesting to determine if the suppression of XRN1 by viral RNAs 
could increase the recombination frequency in flavivirus infections. There are three experiments 
that could be done to test this hypothesis. First, SINV is known to undergo RNA-RNA 
recombination (Weiss and Schlesinger 1991; Raju et al. 1995) in tissue culture models of 
infection. The 3’ UTR of DENV-2 or the 5’ UTRs of HCV or BVDV could be provided in trans to 
determine if (1) there are more viral recombinants (by sequence) or (2) there is an increase in 
defective interfering particles (non-infectious virions that likely increase in abundance in 
association with increased RNA-RNA recombination events). Finally, we are currently working 
to determing the exact sequences/structures necessary in the BVDV and 5’ UTRs by deletion 
mutagenesis that facilitates XRN1 suppression. This should facilitate the construction of replicon 
constructs and/or infectious clones that lack the XRN1 resistance element that can be used to 






Development of a novel screening assay for anti-flavivirals 
 
 Although there are accepted vaccines in use for several flaviviruses including YFV and 
JEV, there are no targeted, highly effective treatments for any pathogens in the Flavivirus 
genus. There is a profound need for novel, targeted anti-flaviviral therapies. Because all of 
these viruses have similar replication cycles, they likely use similar aspects of the cellular gene 
expression machinery to promote viral proliferation that could be targeted for new anti-viral 
therapeutics. The research presented herein describes a unique mechanism that all members of 
the Flaviviridae may use to successfully interact with the host RNA decay machinery. 
The formation of sfRNA during flavivirus infection has been shown to be important for viral 
replication in certain cell lines (Pijlman et al. 2008; Silva et al. 2010). Furthermore, we have 
demonstrated that the up-regulation of cytokines, chemokines, and other pro-inflammatory 
factors is dramatically enhanced by sfRNA formation in Kunjin virus infections. Cells infected 
with HCV and BVDV have significant defects in mRNA stability consistent with XRN1 
suppression that likely contribute to the over-expression of cellular transcripts implicated in viral 
pathogenesis including hepatocellular carcinoma due to HCV infection. Because these viruses 
also appear to suppress XRN1 activity through unique structures in their 5’ UTRs, anti-viral 
compounds that destabilize the RNA structures required for XRN1 suppression will likely have 
two important functions: suppression of both viral replication and pathogenesis. A high 
throughput cell-free drug screening assay in which sfRNA formation is monitored could 
therefore provide a starting point for the generation of novel anti-viral compounds that could 
potentially mitigate disease caused by any virus in the Flaviviridae family. Importantly, 








  Through the experiments presented herein, we have demonstrated several important 
findings. First, the stalling of XRN1 on complex, conserved structural elements in flavivirus 3’ 
UTRs also suppress XRN1 activity. Secondly, other members of the Flaviviridae family, namely 
hepatitis C virus and bovine viral diarrhea virus, generate XRN1-mediated decay intermediates 
from their highly structured 5’ UTRs. Furthermore, the stalling of XRN1 on these RNA structures 
also suppresses XRN1 activity, indicating that inhibition of the major 5’-3’ exonuclease XRN1 is 
likely conserved among all members of the Flaviviridae. Third, XRN1 suppression by viral RNAs 
contributes to dramatic changes in cellular mRNA stability and likely dampens the host 
response to infection. This could contribute to the enhancement of virus-induced pathology that 
is observed in wild-type sfRNA forming KUNV and DENV-2 infections but not during infections 
with mutant viruses deficient in sfRNA formation (Pijlman et al. 2008; Liu et al. 2014). The 
studies presented herein will therefore contribute to our understanding of how post-
transcriptional mechanisms regulate cellular gene expression in the context of viral infection.  
Additionally, our studies suggest that one mechanism by which sfRNA suppresses RNA 
interference is by binding to AGO2 and DICER to suppress their activities during infection. This 
is potentially important for persistent infections of the arthropod vectors of many of the 
flaviviruses, as RNAi is an essential antiviral immune mechanism in these organisms (Blair 
2011). Finally, we provide a foundation for the further study of how viruses evade and suppress 
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Appendix 1. List of abbreviations used. 
 
AGO2 argonaute 2 
ARE AU-rich element 
BDV border disease virus 
BVDV  bovine viral diarrhea virus 
C core or capsid protein 
CDC Centers for Disease Control 
cHP capsid hairpin 
CNS central nervous system 
CSFV classic swine fever virus 
DENV dengue virus 
DENV-2 dengue virus type 2 
DMEM Dulbecco's modified Eagle's medium 
dsRNA double stranded RNA 
E envelope protein 
eiF3 eukaryotic translation initiation factor 3 
ER endoplasmic reticulum 
G glycoprotein 
GBV G.B. viruses 
GFP green fluorescent protein 
GO gene ontology 
HCC hepatocellular carcinoma 
HCV hepatitis C virus 
HIF1A hypoxia inducible factor 1A 
HIV-1 human immunodeficiency virus type 1 
HVS herpesvirus saimiri 
IFIT interferon induced proteins with tetratricopeptide repeats 
IFN interferon 
IFNAR1 IFNα and IFNβ receptor complex 1   
IL interleukin 
IRES internal ribosome entry site 
IRF interferon response factor 
ISG interferon stimulated gene 
JEV japanese encephalitis virus 
KUNV Kunjin virus 
MAVS mitochondrial antiviral signaling  
mCMV murine cytomegalovirus 
MDA5 melanoma differentiation antigen 5  
MDBK Madin-Darby bovine kidney 
MEF mouse embryonic fibroblasts 




mRNA messenger RNA 
MYD88 myeloid differentiation 88  
NFκB nuclear factor κ B 
NLRP3 NOD, LRR and pyrin domain containing 3  
NMD nonsense-mediated decay 
NS nonstructural protein 
OAS oligoadenylate synthetase 
ORF open reading frame 
PABP poly(A) binding protein 
PAGE polyacrylamide gel electrophoresis 
PAMP pathogen associated molecular pattern 
PAN polyadenylated nuclear 
PARN poly(A) specific ribonuclease 
P-body processing body 
PBS phosphate buffered saline 
PCBP2 poly( C) binding protein 2 
PCR polymerase chain reaction 
PRR pathogen recognition receptor 
qPCR quantitative polymerase chain reaction 
RdRp RNA-dependent RNA polymerase 
RIG-I official symbol: DDX58; retinoic acid-inducible gene 1 
RISC RNA induced silencing complex 
RNAi RNA interference 
RNase L ribonuclease L 
RNP ribonucleoprotein 
RT reverse transcription 
SD standard deviation 
SEM standard error of the mean 
sfRNA subgenomic flavivirus RNA 
SG stress granule 
SINV sindbis virus 
siRNA small-inderfering RNAs 
SL stem-loop 
STAT signal transducer and activator of transcription  
TLR Toll-like receptors 
TNF tumor necrosis factor 
TRIF TIR domain-containing adaptor inducing IFNβ  
UTR untranslated region 
VEGF vascular endothelial growth factor 
VpG viral protein, genome-linked 
WNV West Nile virus 
XRN1 exoribonuclease 1 
XRN2 exoribonuclease 2 
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Appendix 2. Conservation of the amino acid sequences of XRN1. 
 
Amino acid sequences of XRN1 homologs in human, fruit fly, house mouse, mosquito, and two 
species of yeast were aligned using COBALT (Papadopoulos and Agarwala 2007). The full 
protein name, species, and NCBI or GenBank reference sequence are indicated below.  
 
Name Species ID 
5'-3' exoribonuclease 1 isoform a Homo sapiens NP_061874.3 
pacman, isoform a Drosophila melanogaster AAF48958.1 
5'-3' exoribonuclease 1 Mus musculus NP_036046.2 
5'-3' exoribonuclease 1 Culex quinquefasciatus EDS29953.1 














H. sap.  1     MGVPKFYRWISERYPCLSEVVKEHQIPEFDNLYLDMNGIIHQCSHPNDDDVHFRISDDKIFTDIFHYLEVLFRIIKPRKV  80 
D. mel.  1     MGVPKFFRYISERYPCLSELAREHCIPEFDNLYLDMNGIVHNCSHPDDNNIHFHLEEEQIFQEIFNYVDKLFYLIKPQRL  80 
M. mus.  1     MGVPKFYRWISERYPCLSEVVKEHQIPEFDNLYLDMNGIIHQCSHPNDDDVHFRISDDKIFTDIFHYLEVLFRIIKPRKV  80 
C. qui.  1     MGVPKFFRYMSERYPCLGELVRENQVPDFDNLYLDMNGIIHNCSHPNDSDVFFRITEEQIFSDIFHYLEFLFRMIRPQKL  80 
K. lac.  1     MGIPKFFHFISERWPQISQLIDGSQIPEFDNLYLDMNSILHNCTHGDGSEVNSRLSEEEVYSKIFSYIDHLFHTIKPKQT  80 
S. cer.  1     MGIPKFFRYISERWPMILQLIEGTQIPEFDNLYLDMNSILHNCTHGNDDDVTKRLTEEEVFAKICTYIDHLFQTIKPKKI  80 
 
H. sap.  81    FFMAVDGVAPRAKMNQQRGRRFRSAKEAEDKIKKAIEKGETLPTEARFDSNCITPGTEFMARLHEHLKYFVNMKISTDKS  160 
D. mel.  81    FFLSVDGVAPRAKMNQQRSRRFRTAREAEQQEAKAAQRGELRE-HERFDSNCITPGTEFMVRLQEGLRAFLKTKISTDPL  159 
M. mus.  81    FFMAVDGVAPRAKMNQQRGRRFRSAKEAEDKIKKAIEKGETLPTEARFDSNCITPGTEFMARLHEHLKYFVNMKISTDKS  160 
C. qui.  81    FFIAVDGVAPRAKMNQQRGRRFRSAREAQEQVEQAEKKGDVLPLEARFDSNCITPGTSFMVRLQRALEHFIKVKVSTNPL  160 
K. lac.  81    FYMAIDGVAPRAKMNQQRARRFRTAMDAEKALQKAIENGDELPKGEPFDSNAITPGTEFMAKLTENLKYFIHDKITNDTR  160 
S. cer.  81    FYMAIDGVAPRAKMNQQRARRFRTAMDAEKALKKAIENGDEIPKGEPFDSNSITPGTEFMAKLTKNLQYFIHDKISNDSK  160 
 
H. sap.  161   WQGVTIYFSGHETPGEGEHKIMEFIRSEKAKPDHDPNTRHCLYGLDADLIMLGLTSHEAHFSLLREEVRFgGKKTQRVCA  240 
D. mel.  160   WQRCTVILSGQEAPGEGEHKIMDYIRYMKTQPDYDPNTRHCLYGLDADLIILGLCTHELHFVVLREEVKF-GRNVKRTS-  237 
M. mus.  161   WQGVTIYFSGHETPGEGEHKIMEFIRSEKAKPDHDPNTRHCLYGLDADLIMLGLTSHEAHFSLLREEVRFgGKKTQRVCA  240 
C. qui.  161   WKHCKVVLSGHETPGEGEHKIMEYIRHAKASPGFDSNTRHCLYGLDADLIMLGLCTHERHFSLLREEVKF-GKNDKKSSI  239 
K. lac.  161   WQNVKVIFSGHEVPGEGEHKIMDYIRAIRAQEDYNPNTRHCIYGLDADLIILGLSTHDHHFCLLREEVTF-GKRSSSVKT  239 
S. cer.  161   WREVQIIFSGHEVPGEGEHKIMNFIRHLKSQKDFNQNTRHCIYGLDADLIMLGLSTHGPHFALLREEVTF-GRRNSEKKS  239 
 
H. sap.  241   PEETTFHLLHLSLMREYIDYEFSVLK-EKITFKYDIERIIDDWILMGFLVGNDFIPHLPHLHINHDALPLLYGTYVTILP  319 
D. mel.  238   VEETRFFLLHLGLLREYLELEFDALRtDEHKLDIA--QLIDDWVLMGFLVGNDFIPHLPCLHISSNALPLLYRTYIGIYP  315 
M. mus.  241   PEETTFHLLHLSLMREYIDYEFSALK-EKITFKYDIEKIIDDWILMGFLVGNDFIPHLPHLHINHDALPLLYGTYIAILP  319 
C. qui.  240   VEETRFYLLHLTLLREYLELEFAPVR-DKLKFEFNPYKLIDDWVLMGYMVGNDFIPHLPNLHINENALPTLFQAYMDVLP  318 
K. lac.  240   LETQNFFLLHLSILREYLALEFEEIT-DSVQFEYDFERVLDDFIFVLFTIGNDFLPNLPDLHLKKGAFPVLLQTFKEALQ  318 
S. cer.  240   LEHQNFYLLHLSLLREYMELEFKEIA-DEMQFEYNFERILDDFILVMFVIGNDFLPNLPDLHLNKGAFPVLLQTFKEALL  318 
 
H. sap.  320   ELGGYINESGHLNLPRFEKYLVKLSDFDREHFSEVFVDLKWFESKVG-NKYLNEAAGVAAEEARNYKEKKKLKGQE      394 
D. mel.  316   TLGGNINENGKLNLRRLQIFISALTEVELDHFKEHADDLKYMN-----NK--SEAFDMDVGEITESQNLDSDLGAL      384 
M. mus.  320   ELGGYINESGHLNLPRFERYLVKLSDFDREHFSEVFVDLKWFESKVG-NKYLNEAAGAAAEEAKNCKEKRKPKGQE      394 
C. qui.  319   GLDGYINEGGILNLERLEVLMERLARFDRDIFLENYTDLQYFKAKRG--ANDTEAFDVTLEEIK--ADMDMDLSAL      390 
K. lac.  319   HMDGYINEQGKINLARFSIWLKYLSDFEYLNFEKKDIDVEWFNQQLEnISLEGERKRTRMGKKLLMKQQKKLIGAV[51]  445 
S. cer.  319   HTDGYINEHGKINLKRLGVWLNYLSQFELLNFEKDDIDVEWFNKQLEnISLEGERKRQRVGKKLLVKQQKKLIGSI[51]  445 
 
H. sap.  395   NSLCWTAL    DKNEGEMITSKDNL    EDETEDDDLFETEFRQYKRTYYMTKMGVDVVSDDFLADQAACYVQAIQWI  466 
D. mel.  385   INKSMLLY    DDDSE---------    EDCSDENAVLLKEFQNYKRNFYRNKFKR-DPNDELIEELCHHYVNALQWV  446 
M. mus.  395   NSLSWAAL    DKSEGEGVASRDNF    EDETEDDDLFETEFRQYKRTYYMTKMGVDVVSDEFLANQAACYVQAIQWI  466 
C. qui.  391   IKASEDMF    LDDDEDGGGERYST    EDIENDPELFEKEFAAYKRNYYMTKMGYGDFNEETRAEQAECYIRALQWT  462 
K. lac.  446   HSKSKDLY[11]QETDEEHEARIHET[16]EELEEEREIYSERFVEWKDQYYKDKLDFSINDTDSLKEMTENYVGGLQWV  544 
S. cer.  446   HSKSKGSY[11]DETEEEFQNRVNSI[16]EELETEKTIYNERFERWKHEYYHDKLKFTTDSEEKVRDLAKDYVEGLQWV  544 
 
H. sap.  467   LHYYYHGVQSWSWYYPYHYAPFLSDIHNISTLKIHFELGKPFKPFEQLLAVLPAASKNLLPACYQHLMTNEDSPIIEYYP  546 
D. mel.  447   LDYYYRGVQSWDWYYPFHYTPFISDLKNIEQVEIAFHMGTPFLPFQQLLAVLPAASAKLLPVAYHDLMLLPTSPLAEFYP  526 
M. mus.  467   LHYYYHGVQSWSWYYPYHYAPFLSDIRSISTLKIHFELGKPFKPFEQLLAVLPSASKNLLPTCYQHLMTSEDSPIIEYYP  546 
C. qui.  463   LLYYYRGVSSWAWYYPHHYAPFISDVQNFKNIKLNFEMGKPFLPFQQLLSVLPAASKDHLPTAYHKLMTDPDSSVIDYYP  542 
K. lac.  545   LYYYYRGCPSWSWYYRYHYAPRISDVIKGIDQNIEFHKGQPFKPFQQLMAVLPERSKNLIPVVYRPLMYDEHSPILDFYP  624 
S. cer.  545   LYYYYRGCPSWSWYYPHHYAPRISDLAKGLDQDIEFDLSKPFTPFQQLMAVLPERSKNLIPPAFRPLMYDEQSPIHDFYP  624 
 
H. sap.  547   PDFKTDLNGKQQEWEAVVLIPFIDEKRLLEAMETCNHSLKKEERKRNQHSECLMCWYDRDTEFIYPSPWPEKFPAIER--  624 
D. mel.  527   LEFESDLNGKKHDWEAVVLIPFIDEGRLLAAMLPCEAQLSLEERERNRHGPMYVYKYSTVAQGPMPAYPPLRALPVLY--  604 
M. mus.  547   PDFKTDLNGKQQEWEAVVLIPFIDETRLLEAMETCNHSLKKEERKRNQHSECLMCWYDRDTEFTYSSPWPEKFPAIER--  624 
C. qui.  543   ENFGTDLNGKQQAWEAVVLIPFIDEKRLLKAMEPCDAFLTDEEKQRNVHGPMMLFQYDEQGSAFLGANYGLDDVAELK--  620 
K. lac.  625   NEVELDLNGKTADWEAVVKISFVDQKRLVEAMAPYDAKLSPDEKKRNSFGTDLIFIFNPQVDTVYKTPLAGLFNDIEHnh  704 
S. cer.  625   AEVQLDKNGKTADWEAVVLISFVDEKRLIEAMQPYLRKLSPEEKTRNQFGKDLIYSFNPQVDNLYKSPLGGIFSDIEHnh  704 
 
H. sap.  625   -CCTRYKIISLDAWRVDINKNKITRIDQKAL----YFCGFPTLKHIRHKFFLKKSGVQVFQQSSRGENMMLEILVDAESD  699 
D. mel.  605   -C----TEVAKWSHEIAVNLPYSVCIELPNAArtvFFPGFPTMQHLPFDFELRNDRVKVFEQVSRNQNIVLKP--RKRQL  677 
M. mus.  625   -CCTRYKMISLDAWRVDINKNKITRVDQKAL----YFCGFPTLKHIKHKFFLKKSGVQVFQQSSRGENLMLEISVNAEPD  699 
C. qui.  621   -----VKEIPIYRDDLYVPENKLVLGPSKGAIldgYIKGFPTMKHLKYHGILKEIRVKVFNFPSRNASMVVAI--DKEGD  693 
K. lac.  705   cIEREFIPESMENVKFLFGLPKGAKLGASSLA------GFPSLKTLPLTAELAYNSSVVFNFPSKQQSMVLHIQDLYKEN  778 
S. cer.  705   cVEKEYITIPLDSSEIRYGLLPNAKLGAEMLA------GFPTLLSLPFTSSLEYNETMVFQQPSKQQSMVLQITDIYKTN  778 
 
H. sap.  700   ELTVENVASSVLGKSVFVNWPHLEEARVVAVSDGETKFYLEEPpGTQKLYSGRTAPPSKVVHLGDKEQSNWAKeVQGISE  779 
D. mel.  678   EDTLTAVASQYLGKVIHVGWPHLVKAIVVRVATRDQRV------------------DSEGITLNDSRRFDSEC--KALQE  737 
M. mus.  700   ELRIENIASAVLGKAVFVNWPHLEEARVVAVSDGETKFYIEEPpGTQKVYLGKTAPPSKVIQLTDKEQSNWTKeIQGISE  779 
C. qui.  694   DKSTAQLAQELLGSIVYVSWPHLTEAKVVKVADAKTVYEKDRE------------------ERPNNEKFFGTC-VKAIVE  754 
K. lac.  779   GISLSDLAKRHMGKIVYSRWPFLRESKLLSLITEETVYEGVKS-GKLTKV--IERKPQDF----ERKEFRELK--MTLKS  849 
S. cer.  779   NVTLEDFSKRHLNKVIYTRWPYLRESKLVSLTDGKTIYEYQES-NDKKKFGFITKPAETQ----DKKLFNSLK--NSMLR  851 
 
H. sap.  780   HYLRRKGIIINETSAVVYAQLLTGRKYQINQNGEVRLEKQWSKQVVPFVYQTIVKDIRAFDSRFSNIKTL--DDLFPLRS  857 
D. mel.  738   HFINRMGIQFANYDVLVYVRTFAGNSTEFRDKGALMVRDSWSSSVTGYPAQGVVADLTVWERMRKNFLNV--EHYFPVGS  815 
M. mus.  780   QYLRRKGIIINETSAVVYAQLLTGRKYQISQNGEVRLEKQWSKQILPFVYQTIVKDIRAFDSRFSNIKTL--DDLFPPRT  857 
C. qui.  755   HHSNRLAIDLGEIRQLVHVKTCVGSEY-VLKDDRYVLNKLWNQGETMYPVQAIVTDLREALRTLKPYQEV--QEMFPENC  831 
K. lac.  850   NYQRTKAILLDDISALAKVVPVNG----LVRNSDGSYSKSFNETIEYYPLQLIVEDVKNKDERYIEKEPLpiNKEFPKGS  925 
S. cer.  852   MYAKQKAVKIGPMEAIATVFPVTG----LVRDSDGGYIKTFSPTPDYYPLQLVVESVVNEDERYKERGPIpiEEEFPLNS  927 
 
H. sap.  858   MVFMLGTPYYGCTGEVQDSGDVITEGRIRVIF---SIPCEPNLDALIQNQHKYSIKYNPGYVLASRLGVSGYLVSRFTGS  934 
D. mel.  816   TIFLITDPYYGSEGTVQDPRLAYTNGRIQVSI---MVRPEPKVNAARQLQEERDRDYLSTFQVCNLLRISGRTLGRLSGT  892 
M. mus.  858   MVFMLGTPYYGCTGEVQDSGDLITEGRIRVVF---SIPCEPNLDALIQNQHKYSIKYNPGYVLAGRLGVSGYLVSRFTGS  934 
C. qui.  832   VVFLRATQWYGSMGHVVDVT--AGHKRIKTRFE---IYEEPNLDTVLKIDDEARSHYLTTYDAASSIGISANLLSRLSST  906 
K. lac.  926   KVVFLGDYAYGGEATVDGYN---SETRLKLTVKkgSLRAEPNIGKVRAKLDSQALRFYPTQVFSKIARVHPLFLSKITSR  1002 










H. sap.  1     MGVPKFYRWISERYPCLSEVVKEHQIPEFDNLYLDMNGIIHQCSHPNDDDVHFRISDDKIFTDIFHYLEVLFRIIKPRKV  80 
D. mel.  1     MGVPKFFRYISERYPCLSELAREHCIPEFDNLYLDMNGIVHNCSHPDDNNIHFHLEEEQIFQEIFNYVDKLFYLIKPQRL  80 
M. mus.  1     MGVPKFYRWISERYPCLSEVVKEHQIPEFDNLYLDMNGIIHQCSHPNDDDVHFRISDDKIFTDIFHYLEVLFRIIKPRKV  80 
C. qui.  1     MGVPKFFRYMSERYPCLGELVRENQVPDFDNLYLDMNGIIHNCSHPNDSDVFFRITEEQIFSDIFHYLEFLFRMIRPQKL  80 
K. lac.  1     MGIPKFFHFISERWPQISQLIDGSQIPEFDNLYLDMNSILHNCTHGDGSEVNSRLSEEEVYSKIFSYIDHLFHTIKPKQT  80 
S. cer.  1     MGIPKFFRYISERWPMILQLIEGTQIPEFDNLYLDMNSILHNCTHGNDDDVTKRLTEEEVFAKICTYIDHLFQTIKPKKI  80 
 
H. sap.  81    FFMAVDGVAPRAKMNQQRGRRFRSAKEAEDKIKKAIEKGETLPTEARFDSNCITPGTEFMARLHEHLKYFVNMKISTDKS  160 
D. mel.  81    FFLSVDGVAPRAKMNQQRSRRFRTAREAEQQEAKAAQRGELRE-HERFDSNCITPGTEFMVRLQEGLRAFLKTKISTDPL  159 
M. mus.  81    FFMAVDGVAPRAKMNQQRGRRFRSAKEAEDKIKKAIEKGETLPTEARFDSNCITPGTEFMARLHEHLKYFVNMKISTDKS  160 
C. qui.  81    FFIAVDGVAPRAKMNQQRGRRFRSAREAQEQVEQAEKKGDVLPLEARFDSNCITPGTSFMVRLQRALEHFIKVKVSTNPL  160 
K. lac.  81    FYMAIDGVAPRAKMNQQRARRFRTAMDAEKALQKAIENGDELPKGEPFDSNAITPGTEFMAKLTENLKYFIHDKITNDTR  160 
S. cer.  81    FYMAIDGVAPRAKMNQQRARRFRTAMDAEKALKKAIENGDEIPKGEPFDSNSITPGTEFMAKLTKNLQYFIHDKISNDSK  160 
 
H. sap.  161   WQGVTIYFSGHETPGEGEHKIMEFIRSEKAKPDHDPNTRHCLYGLDADLIMLGLTSHEAHFSLLREEVRFgGKKTQRVCA  240 
D. mel.  160   WQRCTVILSGQEAPGEGEHKIMDYIRYMKTQPDYDPNTRHCLYGLDADLIILGLCTHELHFVVLREEVKF-GRNVKRTS-  237 
M. mus.  161   WQGVTIYFSGHETPGEGEHKIMEFIRSEKAKPDHDPNTRHCLYGLDADLIMLGLTSHEAHFSLLREEVRFgGKKTQRVCA  240 
C. qui.  161   WKHCKVVLSGHETPGEGEHKIMEYIRHAKASPGFDSNTRHCLYGLDADLIMLGLCTHERHFSLLREEVKF-GKNDKKSSI  239 
K. lac.  161   WQNVKVIFSGHEVPGEGEHKIMDYIRAIRAQEDYNPNTRHCIYGLDADLIILGLSTHDHHFCLLREEVTF-GKRSSSVKT  239 
S. cer.  161   WREVQIIFSGHEVPGEGEHKIMNFIRHLKSQKDFNQNTRHCIYGLDADLIMLGLSTHGPHFALLREEVTF-GRRNSEKKS  239 
 
H. sap.  241   PEETTFHLLHLSLMREYIDYEFSVLK-EKITFKYDIERIIDDWILMGFLVGNDFIPHLPHLHINHDALPLLYGTYVTILP  319 
D. mel.  238   VEETRFFLLHLGLLREYLELEFDALRtDEHKLDIA--QLIDDWVLMGFLVGNDFIPHLPCLHISSNALPLLYRTYIGIYP  315 
M. mus.  241   PEETTFHLLHLSLMREYIDYEFSALK-EKITFKYDIEKIIDDWILMGFLVGNDFIPHLPHLHINHDALPLLYGTYIAILP  319 
C. qui.  240   VEETRFYLLHLTLLREYLELEFAPVR-DKLKFEFNPYKLIDDWVLMGYMVGNDFIPHLPNLHINENALPTLFQAYMDVLP  318 
K. lac.  240   LETQNFFLLHLSILREYLALEFEEIT-DSVQFEYDFERVLDDFIFVLFTIGNDFLPNLPDLHLKKGAFPVLLQTFKEALQ  318 
S. cer.  240   LEHQNFYLLHLSLLREYMELEFKEIA-DEMQFEYNFERILDDFILVMFVIGNDFLPNLPDLHLNKGAFPVLLQTFKEALL  318 
 
H. sap.  320   ELGGYINESGHLNLPRFEKYLVKLSDFDREHFSEVFVDLKWFESKVG-NKYLNEAAGVAAEEARNYKEKKKLKGQE      394 
D. mel.  316   TLGGNINENGKLNLRRLQIFISALTEVELDHFKEHADDLKYMN-----NK--SEAFDMDVGEITESQNLDSDLGAL      384 
M. mus.  320   ELGGYINESGHLNLPRFERYLVKLSDFDREHFSEVFVDLKWFESKVG-NKYLNEAAGAAAEEAKNCKEKRKPKGQE      394 
C. qui.  319   GLDGYINEGGILNLERLEVLMERLARFDRDIFLENYTDLQYFKAKRG--ANDTEAFDVTLEEIK--ADMDMDLSAL      390 
K. lac.  319   HMDGYINEQGKINLARFSIWLKYLSDFEYLNFEKKDIDVEWFNQQLEnISLEGERKRTRMGKKLLMKQQKKLIGAV[51]  445 
S. cer.  319   HTDGYINEHGKINLKRLGVWLNYLSQFELLNFEKDDIDVEWFNKQLEnISLEGERKRQRVGKKLLVKQQKKLIGSI[51]  445 
 
H. sap.  395   NSLCWTAL    DKNEGEMITSKDNL    EDETEDDDLFETEFRQYKRTYYMTKMGVDVVSDDFLADQAACYVQAIQWI  466 
D. mel.  385   INKSMLLY    DDDSE---------    EDCSDENAVLLKEFQNYKRNFYRNKFKR-DPNDELIEELCHHYVNALQWV  446 
M. mus.  395   NSLSWAAL    DKSEGEGVASRDNF    EDETEDDDLFETEFRQYKRTYYMTKMGVDVVSDEFLANQAACYVQAIQWI  466 
C. qui.  391   IKASEDMF    LDDDEDGGGERYST    EDIENDPELFEKEFAAYKRNYYMTKMGYGDFNEETRAEQAECYIRALQWT  462 
K. lac.  446   HSKSKDLY[11]QETDEEHEARIHET[16]EELEEEREIYSERFVEWKDQYYKDKLDFSINDTDSLKEMTENYVGGLQWV  544 
S. cer.  446   HSKSKGSY[11]DETEEEFQNRVNSI[16]EELETEKTIYNERFERWKHEYYHDKLKFTTDSEEKVRDLAKDYVEGLQWV  544 
 
H. sap.  467   LHYYYHGVQSWSWYYPYHYAPFLSDIHNISTLKIHFELGKPFKPFEQLLAVLPAASKNLLPACYQHLMTNEDSPIIEYYP  546 
D. mel.  447   LDYYYRGVQSWDWYYPFHYTPFISDLKNIEQVEIAFHMGTPFLPFQQLLAVLPAASAKLLPVAYHDLMLLPTSPLAEFYP  526 
M. mus.  467   LHYYYHGVQSWSWYYPYHYAPFLSDIRSISTLKIHFELGKPFKPFEQLLAVLPSASKNLLPTCYQHLMTSEDSPIIEYYP  546 
C. qui.  463   LLYYYRGVSSWAWYYPHHYAPFISDVQNFKNIKLNFEMGKPFLPFQQLLSVLPAASKDHLPTAYHKLMTDPDSSVIDYYP  542 
K. lac.  545   LYYYYRGCPSWSWYYRYHYAPRISDVIKGIDQNIEFHKGQPFKPFQQLMAVLPERSKNLIPVVYRPLMYDEHSPILDFYP  624 
S. cer.  545   LYYYYRGCPSWSWYYPHHYAPRISDLAKGLDQDIEFDLSKPFTPFQQLMAVLPERSKNLIPPAFRPLMYDEQSPIHDFYP  624 
 
H. sap.  547   PDFKTDLNGKQQEWEAVVLIPFIDEKRLLEAMETCNHSLKKEERKRNQHSECLMCWYDRDTEFIYPSPWPEKFPAIER--  624 
D. mel.  527   LEFESDLNGKKHDWEAVVLIPFIDEGRLLAAMLPCEAQLSLEERERNRHGPMYVYKYSTVAQGPMPAYPPLRALPVLY--  604 
M. mus.  547   PDFKTDLNGKQQEWEAVVLIPFIDETRLLEAMETCNHSLKKEERKRNQHSECLMCWYDRDTEFTYSSPWPEKFPAIER--  624 
C. qui.  543   ENFGTDLNGKQQAWEAVVLIPFIDEKRLLKAMEPCDAFLTDEEKQRNVHGPMMLFQYDEQGSAFLGANYGLDDVAELK--  620 
K. lac.  625   NEVELDLNGKTADWEAVVKISFVDQKRLVEAMAPYDAKLSPDEKKRNSFGTDLIFIFNPQVDTVYKTPLAGLFNDIEHnh  704 
S. cer.  625   AEVQLDKNGKTADWEAVVLISFVDEKRLIEAMQPYLRKLSPEEKTRNQFGKDLIYSFNPQVDNLYKSPLGGIFSDIEHnh  704 
 
H. sap.  625   -CCTRYKIISLDAWRVDINKNKITRIDQKAL----YFCGFPTLKHIRHKFFLKKSGVQVFQQSSRGENMMLEILVDAESD  699 
D. mel.  605   -C----TEVAKWSHEIAVNLPYSVCIELPNAArtvFFPGFPTMQHLPFDFELRNDRVKVFEQVSRNQNIVLKP--RKRQL  677 
M. mus.  625   -CCTRYKMISLDAWRVDINKNKITRVDQKAL----YFCGFPTLKHIKHKFFLKKSGVQVFQQSSRGENLMLEISVNAEPD  699 
C. qui.  621   -----VKEIPIYRDDLYVPENKLVLGPSKGAIldgYIKGFPTMKHLKYHGILKEIRVKVFNFPSRNASMVVAI--DKEGD  693 
K. lac.  705   cIEREFIPESMENVKFLFGLPKGAKLGASSLA------GFPSLKTLPLTAELAYNSSVVFNFPSKQQSMVLHIQDLYKEN  778 
S. cer.  705   cVEKEYITIPLDSSEIRYGLLPNAKLGAEMLA------GFPTLLSLPFTSSLEYNETMVFQQPSKQQSMVLQITDIYKTN  778 
 
H. sap.  700   ELTVENVASSVLGKSVFVNWPHLEEARVVAVSDGETKFYLEEPpGTQKLYSGRTAPPSKVVHLGDKEQSNWAKeVQGISE  779 
D. mel.  678   EDTLTAVASQYLGKVIHVGWPHLVKAIVVRVATRDQRV------------------DSEGITLNDSRRFDSEC--KALQE  737 
M. mus.  700   ELRIENIASAVLGKAVFVNWPHLEEARVVAVSDGETKFYIEEPpGTQKVYLGKTAPPSKVIQLTDKEQSNWTKeIQGISE  779 
C. qui.  694   DKSTAQLAQELLGSIVYVSWPHLTEAKVVKVADAKTVYEKDRE------------------ERPNNEKFFGTC-VKAIVE  754 
K. lac.  779   GISLSDLAKRHMGKIVYSRWPFLRESKLLSLITEETVYEGVKS-GKLTKV--IERKPQDF----ERKEFRELK--MTLKS  849 
S. cer.  779   NVTLEDFSKRHLNKVIYTRWPYLRESKLVSLTDGKTIYEYQES-NDKKKFGFITKPAETQ----DKKLFNSLK--NSMLR  851 
 
H. sap.  780   HYLRRKGIIINETSAVVYAQLLTGRKYQINQNGEVRLEKQWSKQVVPFVYQTIVKDIRAFDSRFSNIKTL--DDLFPLRS  857 
D. mel.  738   HFINRMGIQFANYDVLVYVRTFAGNSTEFRDKGALMVRDSWSSSVTGYPAQGVVADLTVWERMRKNFLNV--EHYFPVGS  815 
M. mus.  780   QYLRRKGIIINETSAVVYAQLLTGRKYQISQNGEVRLEKQWSKQILPFVYQTIVKDIRAFDSRFSNIKTL--DDLFPPRT  857 
C. qui.  755   HHSNRLAIDLGEIRQLVHVKTCVGSEY-VLKDDRYVLNKLWNQGETMYPVQAIVTDLREALRTLKPYQEV--QEMFPENC  831 
K. lac.  850   NYQRTKAILLDDISALAKVVPVNG----LVRNSDGSYSKSFNETIEYYPLQLIVEDVKNKDERYIEKEPLpiNKEFPKGS  925 
S. cer.  852   MYAKQKAVKIGPMEAIATVFPVTG----LVRDSDGGYIKTFSPTPDYYPLQLVVESVVNEDERYKERGPIpiEEEFPLNS  927 
 
H. sap.  858   MVFMLGTPYYGCTGEVQDSGDVITEGRIRVIF---SIPCEPNLDALIQNQHKYSIKYNPGYVLASRLGVSGYLVSRFTGS  934 
D. mel.  816   TIFLITDPYYGSEGTVQDPRLAYTNGRIQVSI---MVRPEPKVNAARQLQEERDRDYLSTFQVCNLLRISGRTLGRLSGT  892 
M. mus.  858   MVFMLGTPYYGCTGEVQDSGDLITEGRIRVVF---SIPCEPNLDALIQNQHKYSIKYNPGYVLAGRLGVSGYLVSRFTGS  934 
C. qui.  832   VVFLRATQWYGSMGHVVDVT--AGHKRIKTRFE---IYEEPNLDTVLKIDDEARSHYLTTYDAASSIGISANLLSRLSST  906 
K. lac.  926   KVVFLGDYAYGGEATVDGYN---SETRLKLTVKkgSLRAEPNIGKVRAKLDSQALRFYPTQVFSKIARVHPLFLSKITSR  1002 
S. cer.  928   KVIFLGDYAYGGETTIDGYS---SDRRLKITVEkkFLDSEPTIGKERLQMDHQAVKYYPSYIVSKNMHLHPLFLSKITSK  1004 
 
H. sap.  935   IFIGRGSRRNPHGDH--KANVGLNLKFNKKNEEVPGYTKKVGSEWMYSSAAEQLLAEYLERAPELFSYIAKNSQE-DVFY  1011 
D. mel.  893   VWVVLGPRRQ-KMENvtKHNIGLQLKYPRQNEERAGYCFRTNNQWYYSSLAVDLMRNYCQRYPDVIDFFGDSNDRaEFVF  971 
M. mus.  935   IFIGRGSRRNPHGDH--KANVGLNLKFNKKNEEVPGYTKKVGNEWMYSSAAEQLLAEYIERAPELFSYIAKNSQE-DVFY  1011 
C. qui.  907   IYMVTGGRRSLNVDEkgKMNIGLQLRLVSQDIETVGYTRKMAKNWMYSDKAIELVKAYYDKVPQVFEKLESFGNR-DVLF  985 
K. lac.  1003  YLVNDSKKKS--------HNVGLMIKFKARNQKVLGYARCSSNKWEYSDVALGLLEQFRSTFPEFFAKLSNSKEQ-AIPS  1073 
S. cer.  1005  FMITDATGKH--------INVGIPVKFEARHQKVLGYARRNPRGWEYSNLTLNLLKEYRQTFPDFFFRLSKVGND--IPV  1074 
 
H. sap.  1012  EDDIWP---GENENGAEKVQEIITWLKGHPVSTLSRSSCDLQILDAAIVEKIEEEVEKCKQRKNNKKVRVTVK-PHLLYR  1087 
D. mel.  972   EQDVFPNAvGHRRVE-----ELANWVRQQPHMKVERISCGSKTVCRETIELLIAA-VDDLRSLPVKHVKLQVK-PHLLIK  1044 
M. mus.  1012  EDDIWP---GENENGAEKVQEIITWLKGHPVSTLSRSSCDLHILDAAIVEKIEEEVEKCKQRKSNKKVRVTVK-PHLLYR  1087 
C. qui.  986   EDEIFGEK----REEGSGLKELVAWIKAQDHAKAEKRSCGTKILEPAAVEELVKIRAESVRQLPTMQT-MFVH-PKDLYK  1059 
K. lac.  1074  ITDLFPNK--SSAEADSILKTVADWLS-EARKPFVVVSLESDSLTKASMAAVESEIIKYVSLPDSSEQKKLAKvPREAIL  1150 
S. cer.  1075  LEDLFPDT--STKDAMNLLDGIKQWLK-YVSSKFIAVSLESDSLTKTSIAAVEDHIMKYAANIEGHERKQLAKvPREAVL  1151 
 
H. sap.  1088  PLEQQHGVIpDRDAEFCLFDRVVNVRENFSVPVGLRGTIIGIKGAN    READVLFEVLFDEEFPGGLTIRCSPG---R  1160 
D. mel.  1045  PNVTLPDVY-RSKRPVRLFDRVVIVRTIYMVPVGTKGTVIGIHPVT[10]HAVDTFCKVLFDSPVPNCNNIHGIAE--DR  1127 
M. mus.  1088  PLEQQHGVIpDRDAEFRLFDRVVNVRESFSVPVGLRGTVIGIKGAS    READVLFEVLFDEEFPGGLTIRCSPG---R  1160 
C. qui.  1060  PGMKQARSI-DYMANYELLDRVIIARETEVVPLGYRGTIIGIHLAK[10]SKEDKYFDILFDKQFPNGTHIFGIEQTrNR  1144 
K. lac.  1151  NAESSYVLL--RSQRFHLGDRVMYIQDSGKVPLHSKGTVVGYTSIG    --KNVSIQVLFDNEIIAGNNFGGRLQT-RR  1221 
S. cer.  1152  NPRSSFALL--RSQKFDLGDRVVYIQDSGKVPIFSKGTVVGYTTLS    --SSLSIQVLFDHEIVAGNNFGGRLRT-NR  1222 
 
H. sap.  1161  GYRLPTSALVNLSHGSRSETGNQKLTAIVKPQPAVHQhSSSSSVSSGHLGALNHSPQSLfVPTQVPTKDDDEFCNIWQSL  1240 
D. mel.  1128  VYKVPEIALVIIKTDEEGKKQNDCELPVRDPQPNQAQdEPVRATSSRYVTAAGSTSV----PITMKTQISDEFVKTR-S-  1201 
M. mus.  1161  GYRLPTSALVNLSHGSRCETGNQKLTAIVKPQPSV---SHCSAAPSGHLGGLNHSPQSPfLPTQVPTKGDDEFCNIWQSL  1237 
C. qui.  1145  VVRVAEGAILNISFGVADFEYKQ----VDPAQPIMLP-------AEEFCPGGLASKQ----PSTVRSV---ETIRVKPS-  1205 
K. lac.  1222  GLGLDSSFLLNLSDRQL----------------------------------VYHSKASK-SADKKPKAVPNDKQVAL---  1263 
S. cer.  1223  GLGLDASFLLNITNRQF----------------------------------IYHSKASK-KALEKKKQSNNRNNNTKTAH  1267 
 
H. sap.  1241  QGSGKMQYFQPTIQEKGAVLPQEISQVNQHHKSGFNDNSVKYQQRKHDPHRKFKEECKSPKAECWS-QKMSNKQ------  1313 
D. mel.  1202  DPIARTDSYKPSSEPKPVPVPEQITNWRERVSTPTN-KPQPAPNNWRINRSSSRQQGGSIF------VAPPTKTPDAAAS  1274 
M. mus.  1238  QGAGKIQHLQPTVQEKGAVLPQEISQVTEGHKSGFTDHSVRHQQRKHDSQRKFKEEYKSPKAECQS-QKLSSKQTSGGSA  1316 
C. qui.  1206  KPTAKSESIKKRLNERIEKNPNPMKAFVMANRKPLEENGA-------------NSQAGCDFEKVWNkLREPNQTTTTTLD  1272 
K. lac.  1264  ---AKKKRVEELKKKQAHELLNHIKKDNAESNTES-----------------------------------------GSAP  1299 
S. cer.  1268  KTPSKQQSEEKLRKERAHDLLNFIKKDTNEKNSESVD----------------NKSMGSQKDSKPAkKVLLKRPAQKSSE  1331 
 
H. sap.  1314  -------------------------------PNSGIENFLASLNISKENEVQSSHHGEPPSEEHL-SPQSFAM-GTRmlK  1360 
D. mel.  1275  TASTAFTAASSATLTPLDQTLALM-SVLGVGEDQSSPPLQEAVQQQRPPLLQQQRAPFPGQMPNLPKPPLFWQ------Q  1347 
M. mus.  1317  RCSIKLLKRNESPGTSEAQKVVTSyPNAVHKPPSGIENFLASLNLSKENEAQLPHHGEPPDEADL-SPQSFAMkGTRmlK  1395 
C. qui.  1273  ERDIKSFLANAAPAAQESAPVPTN-PLAPSSDPTDMLKKMLKISADQEPAVQTPPQLNIPMPKNLPKPPSSWRsDHK---  1348 
K. lac.  1300  QIAVNTLN--------PSAANNVF------------------------NAVLNQIKPG--SQQQIQPPP-----------  1334 
S. cer.  1332  NVQVDLANFEKAPLDNPTVAGSIF------------------------NAVANQYSDGIGSNLNIPTPPHPMN-------  1380 
 
H. sap.  1361  EILKIDGSNTVDHKNEIKQIANEIPVSSNRRDEYGLPSQPKQNKKLASYMNKP----HSANEYHNVQSMDNMCWPAPSQI  1436 
D. mel.  1348  EAQKQEALQQEAQQQEAQKKQQQAHAQME--PERINSQHFYRSGQTGAALNQPplgAPSKRQWHE--------WVHPRMQ  1417 
M. mus.  1396  EILKIDSPDTRDSKNDMKKSDNEATVSS-RRDERGVSAHPKPSKKLTCHMNKP----HGTNEFQNVASVDSVCWPG--QM  1468 
C. qui.  1349  -----SAKDTVKQQHPADKPQQKQNHQMPMPPQPFAQFQPYQLAHQQNRYQPPp-gQFLPNQYQ----------PMPRYQ  1412 
K. lac.  1335  -----------------------------------------------------------ANS-----LPYNFTVPPHMV-  1349 
S. cer.  1381  ------------------------------------------------VVGGP---IPGANDVADVGLPYN--IPPGFMT  1407 
 
H. sap.  1437  PPVSTP[13]PQPDFSFLRMPQTMTVCQVKLSNGLLVHGPQCHS   ENE--AKEKAALFALQQLGSLGMNFPLPSQVFA  1520 
D. mel.  1418  HANAFH    AGVNNGYQMRPKKNIAAQSTFNNNVHMHLQQPYY   PNQqqQQQQQQPLQLTEINNAPPRYSTIQD---  1487 
M. mus.  1469  PPVSTP[13]PQPDFSFLRTTQTMTVCQVKLSNGLLVHGPQCHS   ESE--AKERAALFALQQLGSLGVSFPLPPPIFT  1552 
C. qui.  1413  PQMPMP    PQKNNNHSAYQQF---------NQHHQQLQQQLY[7]NGPqnNNNNNQHHLRQRGPNGPQNLSFNRNTPA  1483 
K. lac.  1350  -PGGIP    ----------------------HPLMMQ-PPFIP   NNE------------------HIAYAAPPQ---  1377 
S. cer.  1408  HPNGL-    ----------------------HPLHPH-QMPYP   NMN------------------GMSIPPPAPHGF  1438 
 
H. sap.  1521  NYPSAVPPGTIPPAFPPPTG[6]NYA[10]SHLFGSMPWGPSVPVPGKPFHHTLYSGTMP[16]QVTKKRVANKKNFENK  1621 
D. mel.  1488  ----FVPIQAYRPKKL----   NRV    -----QPAGRQDVDAT----KNPSRSPVLQ    QPTNETIDTKAS----  1535 
M. mus.  1553  NYPPAVPPGAVPPVFTQPT-   ---[ 7]SHLFGSVSWRPPVPVAGNAFHYPSYPGTMP[16]QVTKKRVANRKNFENK  1640 
C. qui.  1484  GTGAFVPLQAIIKSKTRPNG[2]NKS    -----NKAGSSNANSTGFAQKNAELRQKVE    QKQQENKQDFASFLGG  1549 
K. lac.  1378  SQPVQNPP-------LDKEA   SRN[ 1]KNLLIRDENGRTANVE--------------    ---NKDSDDTKRSSHS  1423 
S. cer.  1439  GQPISFPP-------PPPMT   N--    ----VSDQGSRIV-VN--------------    ---EKESQDLKKFING  1476 
 
H. sap.  1622  EAQSSQATPVQTSQPDSSNIVKVSPRESSSASLKSSPIAQPASS[4]TASQGHSISHHKSTPiSSSRRKSRKLAVNFGVS  1702 
D. mel.  1536  SSLPVQSAGEQVIGLMQTLEIKPAASQSESDGVSTGSANAPTAT   TSSQAVNRRKHRVPRiGAKFDLEYILPDSPHPT  1612 
M. mus.  1641  EAQSSQATPLQTNKPGSSEATKMTPQESPPASSSSSQAAQPVSS[3]TASQGHVGSQPRSAP-SSSKRKSRKLAVNFSVS  1719 
C. qui.  1550  AGKSVEAAAAAVVTTADEKCDKPERKKDDG-----GDGVQKTAS   TSPK---------PP----KVRQMRIAANFSQA  1608 
K. lac.  1424  RGGRRGRSNRGRGASGRGGHFKNSP-------------------   ------------------KKTET----------  1453 
S. cer.  1477  KQHSNGSTIGGETKNSRKGEIKPSSGTNSTECQSPKSQSNAADR   ----------------DNKKDEST---------  1528 
 
H. sap.  1703  Kpse  1706 
D. mel.        ----   
M. mus.  1720  Kpse  1723 
C. qui.  1609  D---  1609 
K. lac.        ----   
S. cer.        ----   
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H. sap.  935   IFIGRGSRRNPHGDH--KANVGLNLKFNKKNEEVPGYTKKVGSEWMYSSAAEQLLAEYLERAPELFSYIAKNSQE-DVFY  1011 
D. mel.  893   VWVVLGPRRQ-KMENvtKHNIGLQLKYPRQNEERAGYCFRTNNQWYYSSLAVDLMRNYCQRYPDVIDFFGDSNDRaEFVF  971 
M. mus.  935   IFIGRGSRRNPHGDH--KANVGLNLKFNKKNEEVPGYTKKVGNEWMYSSAAEQLLAEYIERAPELFSYIAKNSQE-DVFY  1011 
C. qui.  907   IYMVTGGRRSLNVDEkgKMNIGLQLRLVSQDIETVGYTRKMAKNWMYSDKAIELVKAYYDKVPQVFEKLESFGNR-DVLF  985 
K. lac.  1003  YLVNDSKKKS--------HNVGLMIKFKARNQKVLGYARCSSNKWEYSDVALGLLEQFRSTFPEFFAKLSNSKEQ-AIPS  1073 
S. cer.  1005  FMITDATGKH--------INVGIPVKFEARHQKVLGYARRNPRGWEYSNLTLNLLKEYRQTFPDFFFRLSKVGND--IPV  1074 
 
H. sap.  1012  EDDIWP---GENENGAEKVQEIITWLKGHPVSTLSRSSCDLQILDAAIVEKIEEEVEKCKQRKNNKKVRVTVK-PHLLYR  1087 
D. mel.  972   EQDVFPNAvGHRRVE-----ELANWVRQQPHMKVERISCGSKTVCRETIELLIAA-VDDLRSLPVKHVKLQVK-PHLLIK  1044 
M. mus.  1012  EDDIWP---GENENGAEKVQEIITWLKGHPVSTLSRSSCDLHILDAAIVEKIEEEVEKCKQRKSNKKVRVTVK-PHLLYR  1087 
C. qui.  986   EDEIFGEK----REEGSGLKELVAWIKAQDHAKAEKRSCGTKILEPAAVEELVKIRAESVRQLPTMQT-MFVH-PKDLYK  1059 
K. lac.  1074  ITDLFPNK--SSAEADSILKTVADWLS-EARKPFVVVSLESDSLTKASMAAVESEIIKYVSLPDSSEQKKLAKvPREAIL  1150 
S. cer.  1075  LEDLFPDT--STKDAMNLLDGIKQWLK-YVSSKFIAVSLESDSLTKTSIAAVEDHIMKYAANIEGHERKQLAKvPREAVL  1151 
 
H. sap.  1088  PLEQQHGVIpDRDAEFCLFDRVVNVRENFSVPVGLRGTIIGIKGAN    READVLFEVLFDEEFPGGLTIRCSPG---R  1160 
D. mel.  1045  PNVTLPDVY-RSKRPVRLFDRVVIVRTIYMVPVGTKGTVIGIHPVT[10]HAVDTFCKVLFDSPVPNCNNIHGIAE--DR  1127 
M. mus.  1088  PLEQQHGVIpDRDAEFRLFDRVVNVRESFSVPVGLRGTVIGIKGAS    READVLFEVLFDEEFPGGLTIRCSPG---R  1160 
C. qui.  1060  PGMKQARSI-DYMANYELLDRVIIARETEVVPLGYRGTIIGIHLAK[10]SKEDKYFDILFDKQFPNGTHIFGIEQTrNR  1144 
K. lac.  1151  NAESSYVLL--RSQRFHLGDRVMYIQDSGKVPLHSKGTVVGYTSIG    --KNVSIQVLFDNEIIAGNNFGGRLQT-RR  1221 
S. cer.  1152  NPRSSFALL--RSQKFDLGDRVVYIQDSGKVPIFSKGTVVGYTTLS    --SSLSIQVLFDHEIVAGNNFGGRLRT-NR  1222 
 
H. sap.  1161  GYRLPTSALVNLSHGSRSETGNQKLTAIVKPQPAVHQhSSSSSVSSGHLGALNHSPQSLfVPTQVPTKDDDEFCNIWQSL  1240 
D. mel.  1128  VYKVPEIALVIIKTDEEGKKQNDCELPVRDPQPNQAQdEPVRATSSRYVTAAGSTSV----PITMKTQISDEFVKTR-S-  1201 
M. mus.  1161  GYRLPTSALVNLSHGSRCETGNQKLTAIVKPQPSV---SHCSAAPSGHLGGLNHSPQSPfLPTQVPTKGDDEFCNIWQSL  1237 
C. qui.  1145  VVRVAEGAILNISFGVADFEYKQ----VDPAQPIMLP-------AEEFCPGGLASKQ----PSTVRSV---ETIRVKPS-  1205 
K. lac.  1222  GLGLDSSFLLNLSDRQL----------------------------------VYHSKASK-SADKKPKAVPNDKQVAL---  1263 
S. cer.  1223  GLGLDASFLLNITNRQF----------------------------------IYHSKASK-KALEKKKQSNNRNNNTKTAH  1267 
 
H. sap.  1241  QGSGKMQYFQPTIQEKGAVLPQEISQVNQHHKSGFNDNSVKYQQRKHDPHRKFKEECKSPKAECWS-QKMSNKQ------  1313 
D. mel.  1202  DPIARTDSYKPSSEPKPVPVPEQITNWRERVSTPTN-KPQPAPNNWRINRSSSRQQGGSIF------VAPPTKTPDAAAS  1274 
M. mus.  1238  QGAGKIQHLQPTVQEKGAVLPQEISQVTEGHKSGFTDHSVRHQQRKHDSQRKFKEEYKSPKAECQS-QKLSSKQTSGGSA  1316 
C. qui.  1206  KPTAKSESIKKRLNERIEKNPNPMKAFVMANRKPLEENGA-------------NSQAGCDFEKVWNkLREPNQTTTTTLD  1272 
K. lac.  1264  ---AKKKRVEELKKKQAHELLNHIKKDNAESNTES-----------------------------------------GSAP  1299 
S. cer.  1268  KTPSKQQSEEKLRKERAHDLLNFIKKDTNEKNSESVD----------------NKSMGSQKDSKPAkKVLLKRPAQKSSE  1331 
 
H. sap.  1314  -------------------------------PNSGIENFLASLNISKENEVQSSHHGEPPSEEHL-SPQSFAM-GTRmlK  1360 
D. mel.  1275  TASTAFTAASSATLTPLDQTLALM-SVLGVGEDQSSPPLQEAVQQQRPPLLQQQRAPFPGQMPNLPKPPLFWQ------Q  1347 
M. mus.  1317  RCSIKLLKRNESPGTSEAQKVVTSyPNAVHKPPSGIENFLASLNLSKENEAQLPHHGEPPDEADL-SPQSFAMkGTRmlK  1395 
C. qui.  1273  ERDIKSFLANAAPAAQESAPVPTN-PLAPSSDPTDMLKKMLKISADQEPAVQTPPQLNIPMPKNLPKPPSSWRsDHK---  1348 
K. lac.  1300  QIAVNTLN--------PSAANNVF------------------------NAVLNQIKPG--SQQQIQPPP-----------  1334 
S. cer.  1332  NVQVDLANFEKAPLDNPTVAGSIF------------------------NAVANQYSDGIGSNLNIPTPPHPMN-------  1380 
 
H. sap.  1361  EILKIDGSNTVDHKNEIKQIANEIPVSSNRRDEYGLPSQPKQNKKLASYMNKP----HSANEYHNVQSMDNMCWPAPSQI  1436 
D. mel.  1348  EAQKQEALQQEAQQQEAQKKQQQAHAQME--PERINSQHFYRSGQTGAALNQPplgAPSKRQWHE--------WVHPRMQ  1417 
M. mus.  1396  EILKIDSPDTRDSKNDMKKSDNEATVSS-RRDERGVSAHPKPSKKLTCHMNKP----HGTNEFQNVASVDSVCWPG--QM  1468 
C. qui.  1349  -----SAKDTVKQQHPADKPQQKQNHQMPMPPQPFAQFQPYQLAHQQNRYQPPp-gQFLPNQYQ----------PMPRYQ  1412 
K. lac.  1335  -----------------------------------------------------------ANS-----LPYNFTVPPHMV-  1349 
S. cer.  1381  ------------------------------------------------VVGGP---IPGANDVADVGLPYN--IPPGFMT  1407 
 
H. sap.  1437  PPVSTP[13]PQPDFSFLRMPQTMTVCQVKLSNGLLVHGPQCHS   ENE--AKEKAALFALQQLGSLGMNFPLPSQVFA  1520 
D. mel.  1418  HANAFH    AGVNNGYQMRPKKNIAAQSTFNNNVHMHLQQPYY   PNQqqQQQQQQPLQLTEINNAPPRYSTIQD---  1487 
M. mus.  1469  PPVSTP[13]PQPDFSFLRTTQTMTVCQVKLSNGLLVHGPQCHS   ESE--AKERAALFALQQLGSLGVSFPLPPPIFT  1552 
C. qui.  1413  PQMPMP    PQKNNNHSAYQQF---------NQHHQQLQQQLY[7]NGPqnNNNNNQHHLRQRGPNGPQNLSFNRNTPA  1483 
K. lac.  1350  -PGGIP    ----------------------HPLMMQ-PPFIP   NNE------------------HIAYAAPPQ---  1377 
S. cer.  1408  HPNGL-    ----------------------HPLHPH-QMPYP   NMN------------------GMSIPPPAPHGF  1438 
 
H. sap.  1521  NYPSAVPPGTIPPAFPPPTG[6]NYA[10]SHLFGSMPWGPSVPVPGKPFHHTLYSGTMP[16]QVTKKRVANKKNFENK  1621 
D. mel.  1488  ----FVPIQAYRPKKL----   NRV    -----QPAGRQDVDAT----KNPSRSPVLQ    QPTNETIDTKAS----  1535 
M. mus.  1553  NYPPAVPPGAVPPVFTQPT-   ---[ 7]SHLFGSVSWRPPVPVAGNAFHYPSYPGTMP[16]QVTKKRVANRKNFENK  1640 
C. qui.  1484  GTGAFVPLQAIIKSKTRPNG[2]NKS    -----NKAGSSNANSTGFAQKNAELRQKVE    QKQQENKQDFASFLGG  1549 
K. lac.  1378  SQPVQNPP-------LDKEA   SRN[ 1]KNLLIRDENGRTANVE--------------    ---NKDSDDTKRSSHS  1423 
S. cer.  1439  GQPISFPP-------PPPMT   N--    ----VSDQGSRIV-VN--------------    ---EKESQDLKKFING  1476 
 
H. sap.  1622  EAQSSQATPVQTSQPDSSNIVKVSPRESSSASLKSSPIAQPASS[4]TASQGHSISHHKSTPiSSSRRKSRKLAVNFGVS  1702 
D. mel.  1536  SSLPVQSAGEQVIGLMQTLEIKPAASQSESDGVSTGSANAPTAT   TSSQAVNRRKHRVPRiGAKFDLEYILPDSPHPT  1612 
M. mus.  1641  EAQSSQATPLQTNKPGSSEATKMTPQESPPASSSSSQAAQPVSS[3]TASQGHVGSQPRSAP-SSSKRKSRKLAVNFSVS  1719 
C. qui.  1550  AGKSVEAAAAAVVTTADEKCDKPERKKDDG-----GDGVQKTAS   TSPK---------PP----KVRQMRIAANFSQA  1608 
K. lac.  1424  RGGRRGRSNRGRGASGRGGHFKNSP-------------------   ------------------KKTET----------  1453 
S. cer.  1477  KQHSNGSTIGGETKNSRKGEIKPSSGTNSTECQSPKSQSNAADR   ----------------DNKKDEST---------  1528 
 
H. sap.  1703  Kpse  1706 
D. mel.        ----   
M. mus.  1720  Kpse  1723 
C. qui.  1609  D---  1609 
K. lac.        ----   
S. cer.        ----   
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Appendix 3. Fold change in RNA abundances in 293T cells infected with SINV, the 
sfRNA(-) KUNV, or the wild-type KUNV as determined by RNA-seq analysis.  
 
Gene symbol, GenBank ID numbers, and fold-change in RNA abundance are indicated below. 
 
Appendix 3A. The twenty most elevated transcripts in wild-type KUNV infected 293T 
































Transcripts elevated in wild-type KUNV infected 293T 
cells relative to sfRNA(-) KUNV infected 293T cells 
Gene symbol ID Fold change 
SPSB2 NM_032641 11.94 
RIC3 NR_045405 10.61 
SPATA25 NM_080608 10.61 
TPPP3 NM_016140 9.29 
PLIN5 NM_001013706 7.96 
UCP3 NM_003356 7.30 
NCAM2 NM_004540 6.63 
C2orf81 NM_001145054 6.63 
FILIP1L NM_001042459 6.34 
GRIP2 NM_001080423 6.19 
FXYD6-FXYD2 NM_001204268 5.97 
ADSSL1 NM_199165 5.31 
CRLF1 NM_004750 5.31 
TRIM7 NM_203297 5.31 
FGF5 NM_004464 5.31 
OLFM2 NM_058164 4.64 
VWCE NM_152718 4.64 
SYTL5 NM_001163335 4.64 
FOXB1 NM_012182 4.64 
DENND2A NM_015689 4.42 
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Appendix 3. Continued. 
 
Appendix 3B. The twenty most reduced transcripts in wild-type KUNV infected 293T 
cells compared to 293T cells infected with the sfRNA(-) KUNV.  
 
Transcripts reduced in wild-type KUNV infected 293T 
cells relative to sfRNA(-) KUNV infected 293T cells 
Gene symbol ID Fold change 
SLC2A3 NM_006931 -12.81 
FILIP1 NM_015687 -8.29 
RBM24 NM_001143942 -6.03 
TGFB2 NM_001135599 -6.03 
PTGES NM_004878 -5.28 
ACOT11 NM_147161 -4.90 
GPRC5C NM_022036 -4.52 
C10orf55 NM_001001791 -4.52 
SPATA24 NM_194296 -4.52 
DENND1C NM_024898 -4.52 
CEBPD NM_005195 -4.52 
FRMPD1 NM_014907 -4.15 
HTR6 NM_000871 -3.77 
TOX3 NM_001146188 -3.77 
XKRX NM_212559 -3.77 
RBFOX3 NM_001082575 -3.77 
SNCG NM_003087 -3.77 
LPPR4 NM_014839 -3.77 
FAM150A NM_207413 -3.77 


















Appendix 3. Continued. 
 
Appendix 3C. The twenty most elevated transcripts in wild-type KUNV infected 293T 












































Transcripts elevated in wild-type KUNV infected 
293T cells relative to mock infected 293T cells 
Gene symbol ID Fold change 
IFIT2 NM_001547 54.59 
FILIP1L NM_001042459 39.13 
ATF3 NM_001040619 22.02 
FUT1 NM_000148 18.20 
TAC1 NM_003182 15.47 
OAZ3 NM_016178 13.65 
SH2D3C NM_170600 12.74 
C1QTNF3 NM_181435 11.83 
ANKRD1 NM_014391 11.28 
SPAG4 NM_003116 10.01 
PCDP1 NR_073132 10.01 
TRPM6 NM_017662 9.10 
DUSP8 NM_004420 7.73 
CHAC1 NM_024111 7.73 
HSPB8 NM_014365 7.28 
IKZF2 NM_001079526 7.28 
SPATA25 NM_080608 7.28 
NUDT13 NM_015901 6.73 
FBXL13 NM_145032 6.55 
RASGRP1 NM_005739 6.37 
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Appendix 3. Continued. 
 
Appendix 3D. The twenty most down-regulated transcripts in wild-type KUNV infected 













































Transcripts reduced in wild-type KUNV infected 
293T cells relative to mock infected 293T cells 
Gene symbol ID Fold change 
UNC5A NM_133369 -8.79 
GPRC5C NM_022036 -7.14 
SLC2A3 NM_006931 -6.59 
FAM43B NM_207334 -6.59 
PSD4 NM_012455 -6.04 
KIAA1984 NM_001039374 -5.50 
SPATA24 NM_194296 -5.50 
CYP27A1 NM_000784 -5.50 
S1PR1 NM_001400 -4.95 
CEBPD NM_005195 -4.95 
C17orf67 NM_001085430 -4.95 
JAKMIP1 NM_001099433 -4.67 
FILIP1 NM_015687 -4.40 
CSPG4 NM_001897 -4.40 
ACOT11 NM_147161 -4.40 
NECAB2 NM_019065 -4.40 
FAM131C NM_182623 -4.40 
RASGEF1C NM_175062 -4.40 
RBFOX3 NM_001082575 -4.40 
C8orf73 NM_001100878 -4.40 
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Appendix 3. Continued. 
 
Appendix 3E. The twenty most up-regulated transcripts in sfRNA(-) KUNV infected 
293T cells relative to mock infected cells. 
 
Transcripts elevated in sfRNA(-) KUNV infected 
293T cells relative to mock infected 293T cells 
Gene symbol ID Fold change 
IFIT2 NM_001547 17.83 
FUT1 NM_000148 11.66 
ATF3 NM_001040619 11.08 
TRPM6 NM_017662 10.97 
C11orf96 NM_001145033 8.92 
CD207 NM_015717 8.23 
TAC1 NM_003182 8.23 
PPAPDC1B NM_001102559 7.37 
ANKRD1 NM_014391 6.72 
FILIP1L NM_001042459 6.17 
SH2D3C NM_170600 6.17 
SPAG4 NM_003116 6.17 
AKNA NM_030767 5.90 
CHAC1 NM_024111 5.83 
HSPB8 NM_014365 5.83 
NUDT13 NM_015901 5.76 
SNAP91 NM_001256717 5.49 
OAZ3 NM_016178 5.49 
ADM2 NM_024866 5.21 



















Appendix 3. Continued. 
 
Appendix 3F. The twenty most down-regulated transcripts in sfRNA(-) KUNV infected 
293T cells relative to mock infected cells. 
 
Transcripts reduced in sfRNA(-) KUNV infected 
293T cells relative to mock infected 293T cells 
Gene symbol ID Fold change 
C2orf81 NM_001145054 -10.21 
CEL NM_001807 -10.21 
UCP3 NM_003356 -8.02 
RPRML NM_203400 -7.29 
SPSB2 NM_032641 -7.29 
S1PR1 NM_001400 -6.56 
DMRT3 NM_021240 -6.32 
VWCE NM_152718 -5.83 
CRLF1 NM_004750 -5.83 
NPIPL3 NM_130464 -5.83 
UNC5A NM_133369 -5.83 
PSD4 NM_012455 -5.35 
ADSSL1 NM_199165 -5.10 
NKX1-2 NM_001146340 -5.10 
GTF2IRD2B NM_001003795 -5.10 
CTXN1 NM_206833 -5.00 
KIAA1984 NM_001039374 -4.86 
SEPT1 NM_052838 -4.86 
RCN3 NM_020650 -4.62 


















Appendix 3. Continued. 
 
Appendix 3G. The twenty most up-regulated transcripts in SINV infected 293T cells 
relative to mock infected cells. 
 
Transcripts elevated in SINV infected 293T 
cells relative to mock infected 293T cells 
Gene symbol ID Fold change 
TRPM6 NM_017662 11.8 
TAS2R20 NM_176889 10.3 
C1QTNF3 NM_181435 7.4 
FCGR2A NM_001136219 7.4 
C10orf111 NM_153244 5.9 
SPAG4 NM_003116 5.9 
NUPR1 NM_001042483 5.9 
C11orf96 NM_001145033 5.9 
HIST1H4B NM_003544 4.4 
EGFLAM NM_001205301 4.4 
OAZ3 NM_016178 4.4 
COL23A1 NM_173465 4.4 
PRSS27 NM_031948 4.4 
SNAP91 NM_001256717 4.4 
SMAGP NM_001031628 4.0 
C17orf108 NM_001076680 3.9 
MTMR8 NM_017677 3.8 
HEATR7A NM_032450 3.8 
CDA NM_001785 3.7 












Appendix 3. Continued. 
 
Appendix 3H. The twenty most down-regulated transcripts in SINV infected 293T cells 



































Transcripts reduced in SINV infected 293T cells 
relative to mock infected 293T cells 
Gene symbol ID Fold change 
RGS20 NM_170587 -8.8 
OLFML2B NM_015441 -6.1 
C17orf67 NM_001085430 -6.1 
HOMER3 NR_027297 -5.4 
ZNF222 NM_001129996 -5.4 
TTC39B NM_152574 -5.4 
HOPX NM_001145460 -5.4 
DMRTA2 NM_032110 -4.8 
NKX1-2 NM_001146340 -4.8 
GAL3ST1 NM_004861 -4.8 
SUSD4 NM_017982 -4.8 
ALOXE3 NM_001165960 -4.8 
PAX7 NM_001135254 -4.8 
DENND6B NM_001001794 -4.8 
IL6R NM_000565 -4.4 
MYLK2 NM_033118 -4.1 
PLAC8L1 NM_001029869 -4.1 
UBE2QL1 NM_001145161 -4.1 
KCNK5 NM_003740 -3.9 
DDIT3 NM_001195056 -3.8 
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Appendix 4. Functional annotation of stabilized RNAs in wild-type KUNV infections 
compared to sfRNA(-) KUNV infections. 
 
Significantly enriched (p<0.001) annotated functions of transcripts that were 2-fold or more 
increased in stability in KUNV infected cells relative to sfRNA(-) KUNV infected cells by RNA-
seq were determined using the DAVID GOTERM_BP_FAT tool (Huang et al. 2009(a), Huang et 
al. 2009(b)) and are listed below from most to least significant. 
Term p-value 
RNA processing 5.90E-15 
RNA splicing 6.30E-14 
ubiquitin-dependent protein catabolic process 1.60E-11 
mRNA processing 1.70E-11 
mRNA metabolic process 1.20E-10 
mitotic cell cycle 1.20E-10 
cell cycle 1.90E-10 
cellular macromolecule catabolic process 3.50E-09 
cell cycle process 6.10E-09 
macromolecule catabolic process 1.00E-08 
ncRNA metabolic process 2.20E-08 
protein catabolic process 5.80E-08 
proteolysis involved in cellular protein catabolic process 1.10E-07 
ribonucleoprotein complex biogenesis 1.30E-07 
cellular protein catabolic process 1.40E-07 
anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein 
catabolic process 
1.50E-07 
modification-dependent protein catabolic process 1.80E-07 
modification-dependent macromolecule catabolic process 1.80E-07 
regulation of ubiquitin-protein ligase activity during mitotic cell cycle 4.80E-07 
macromolecular complex subunit organization 7.40E-07 
negative regulation of ubiquitin-protein ligase activity during mitotic cell cycle 1.00E-06 
microtubule cytoskeleton organization 1.00E-06 
macromolecular complex assembly 1.10E-06 
negative regulation of ubiquitin-protein ligase activity 1.50E-06 
negative regulation of ligase activity 1.50E-06 
regulation of ubiquitin-protein ligase activity 1.60E-06 
proteasomal protein catabolic process 1.90E-06 
proteasomal ubiquitin-dependent protein catabolic process 1.90E-06 
cell cycle phase 2.10E-06 
regulation of ligase activity 2.50E-06 
organelle fission 3.10E-06 
response to DNA damage stimulus 3.60E-06 
negative regulation of protein ubiquitination 4.80E-06 
M phase 4.90E-06 
mitosis 5.00E-06 
nuclear division 5.00E-06 
M phase of mitotic cell cycle 6.80E-06 
regulation of protein ubiquitination 6.90E-06 
nuclear mRNA splicing, via spliceosome 7.60E-06 
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RNA splicing, via transesterification reactions 7.60E-06 
RNA splicing, via transesterification reactions with bulged adenosine as nucleophile 7.60E-06 
cellular macromolecular complex subunit organization 9.80E-06 
positive regulation of ubiquitin-protein ligase activity during mitotic cell cycle 1.10E-05 
tRNA metabolic process 1.30E-05 
chromosome segregation 1.30E-05 
chromosome organization 1.40E-05 
positive regulation of ubiquitin-protein ligase activity 1.40E-05 
protein complex assembly 1.50E-05 
protein complex biogenesis 1.50E-05 
cellular macromolecular complex assembly 1.80E-05 
regulation of cellular protein metabolic process 1.90E-05 
positive regulation of protein ubiquitination 2.00E-05 
positive regulation of ligase activity 2.20E-05 
cell division 3.40E-05 
microtubule-based process 5.20E-05 
ribosome biogenesis 7.60E-05 
DNA metabolic process 8.00E-05 
protein localization 1.00E-04 
ncRNA processing 1.30E-04 
negative regulation of protein modification process 2.10E-04 
negative regulation of cellular protein metabolic process 2.30E-04 
RNA biosynthetic process 2.30E-04 
ribonucleoprotein complex assembly 3.10E-04 
rRNA metabolic process 3.40E-04 
protein transport 3.50E-04 
tRNA aminoacylation for protein translation 3.50E-04 
amino acid activation 3.50E-04 
tRNA aminoacylation 3.50E-04 
negative regulation of protein metabolic process 3.70E-04 
RNA transport 3.70E-04 
establishment of RNA localization 3.70E-04 
nucleic acid transport 3.70E-04 
cytoskeleton organization 4.30E-04 
establishment of protein localization 4.40E-04 
transcription, DNA-dependent 4.60E-04 
RNA localization 4.90E-04 
protein folding 5.40E-04 
translation 5.40E-04 
cellular response to stress 7.40E-04 
DNA repair 7.40E-04 
positive regulation of cellular protein metabolic process 7.80E-04 
rRNA processing 8.60E-04 
regulation of translational initiation 9.20E-04 






Appendix 5. Nucleotide sequences of the 3’ UTRs of sfRNA-deficient Kunjin viruses. 
  
 
Below is a ClustalOmega sequencing alignment of the 3’ UTRs of sequenced Kunjin 
virus mutants generated to assess the importance of the three-helix junction in the sfRNA in 
XRN1 resistance (related to Figure 29). Mutated nucleotides are in red. Abbreviations: FLSDX = 
wild-type Kunjin virus; all other names indicate mutated nucleotides and the position in the full-


































FLSDX             ATAGTGTTTAGTGTGTTTAGAGTTAGAAAAATTTTAGTGAGGAAGTCAGGCCGGAAAATT 
UCA10498_ACA10658 ATAGTGTTTAGTGTGTTTAGAGTTAGAAAAATTTTAGTGAGGATCACAGGCCGGAAAATT 
ACA10658          ATAGTGTTTAGTGTGTTTAGAGTTAGAAAAATTTTAGTGAGGAAGTCAGGCCGGAAAATT  
UCA10498          ATAGTGTTTAGTGTGTTTAGAGTTAGAAAAATTTTAGTGAGGATCACAGGCCGGAAAATT  
G10519_G10680     ATAGTGTTTAGTGTGTTTAGAGTTAGAAAAATTTTAGTGAGGAAGTCAGGCCGGAAAATT  
G10680            ATAGTGTTTAGTGTGTTTAGAGTTAGAAAAATTTTAGTGAGGAAGTCAGGCCGGAAAATT 
G10519            ATAGTGTTTAGTGTGTTTAGAGTTAGAAAAATTTTAGTGAGGAAGTCAGGCCGGAAAATT  
                  *******************************************: :**************  
FLSDX             CCCGCCACCGGAAGTTGAGTAGACGGTGCTGCCTGCGACTCAACCCCAGGAGGACTGGGT 
UCA10498_ACA10658 CCCGCCACCGGAAGTTGAGTAGACGGTGCTGCCTGCGACTCAACCCCAGGAGGACTGGGT  
ACA10658          CCCGCCACCGGAAGTTGAGTAGACGGTGCTGCCTGCGACTCAACCCCAGGAGGACTGGGT  
UCA10498          CCCGCCACCGGAAGTTGAGTAGACGGTGCTGCCTGCGACTCAACCCCAGGAGGACTGGGT  
G10519_G10680     CCCGGCACCGGAAGTTGAGTAGACGGTGCTGCCTGCGACTCAACCCCAGGAGGACTGGGT  
G10680            CCCGCCACCGGAAGTTGAGTAGACGGTGCTGCCTGCGACTCAACCCCAGGAGGACTGGGT  
G10519            CCCGGCACCGGAAGTTGAGTAGACGGTGCTGCCTGCGACTCAACCCCAGGAGGACTGGGT  
                  **** ******************************************************* 
FLSDX             GAACAAAGCTGCGAAGTGATCCATGTAAGCCCTCAGAACCGTCTCGGAAAGAGGACCCCA 
UCA10498_ACA10658 GAACAAAGCTGCGAAGTGATCCATGTAAGCCCTCAGAACCGTCTCGGAAAGAGGACCCCA 
ACA10658          GAACAAAGCTGCGAAGTGATCCATGTAAGCCCTCAGAACCGTCTCGGAAAGAGGACCCCA 
UCA10498          GAACAAAGCTGCGAAGTGATCCATGTAAGCCCTCAGAACCGTCTCGGAAAGAGGACCCCA  
G10519_G10680     GAACAAAGCTGCGAAGTGATCCATGTAAGCCCTCAGAACCGTCTCGGAAAGAGGACCCCA  
G10680            GAACAAAGCTGCGAAGTGATCCATGTAAGCCCTCAGAACCGTCTCGGAAAGAGGACCCCA  
G10519            GAACAAAGCTGCGAAGTGATCCATGTAAGCCCTCAGAACCGTCTCGGAAAGAGGACCCCA  
                  ************************************************************  
FLSDX             CATGTTGTAGCTTCAAGGCCCAATGTCAGACCACGCCATGGCGTGCCACTCTGCGGAGAG  
UCA10498_ACA10658 CATGTTGTAGCTTCAAGGCCCAAACACAGACCACGCCATGGCGTGCCACTCTGCGGAGAG  
ACA10658          CATGTTGTAGCTTCAAGGCCCAAACACAGACCACGCCATGGCGTGCCACTCTGCGGAGAG  
UCA10498          CATGTTGTAGCTTCAAGGCCCAATGTCAGACCACGCCATGGCGTGCCACTCTGCGGAGAG  
G10519_G10680     CATGTTGTAGCTTCAAGGCCCAATGTCAGACCACGCCATGGCGTGGCACTCTGCGGAGAG  
G10680            CATGTTGTAGCTTCAAGGCCCAATGTCAGACCACGCCATGGCGTGGCACTCTGCGGAGAG  
G10519            CATGTTGTAGCTTCAAGGCCCAATGTCAGACCACGCCATGGCGTGCCACTCTGCGGAGAG  
                  ***********************: :******************* **************  
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Appendix 6. Sindbis virus perturbs cellular mRNA stability due to sequestration of HuR. 
 
 
 Our findings that sfRNA formation during flavivirus infections was strongly associated 
with dramatic changes in cellular mRNA stability prompted us to determine if other viruses may 
similarly alter post-transcriptional regulation of gene expression. The Wilusz laboratory had 
previously demonstrated that Alphaviruses contained U-rich elements in their 3’ UTRs that were 
high affinity binding sites for the host HuR protein (Sokoloski et al. 2010) as discussed in the 
Introduction. We therefore hypothesized that (1) the high affinity binding sites in the SINV 3’ 
UTR could effectively act as a ‘sponge’ for the HuR protein, leading to the sequestration of HuR 
in the cytoplasm, and (2) the sequestration of the HuR protein by Sindbis virus (the prototypical 
Alphavirus) could influence post-transcriptional gene regulation in the cell as HuR was no longer 
available to perform its normal functions in stabilizing RNAs and influencing the nuclear 
processes of alternative polyadenylation and splicing. We found that transfection of GFP 
expression vectors or in vitro transcribed RNAs containing the SINV 3’ UTR alone was enough 
to cause the re-localization of the HuR protein from the nucleus to the cytoplasm. Furthermore, 
we used deletion constructs to demonstrate the essential ~60nt U-rich region in the SINV 3’ 
UTR required for this effect. To test the hypothesis that the commandeering of HuR by SINV 
caused changes in post-transcriptional regulation of cellular transcripts, we first analyzed the 
stability of several cellular mRNAs using actinomycin D transcriptional shut-off assays in 293T 
cells infected with SINV (or mock infected). Several transcripts were destabilized upon SINV 
infection, and RNA-protein co-immunoprecipitation analyses demonstrated that these mRNAs 
were less associated with HuR protein during SINV infection. Furthermore, we determined that 
alternative splicing and polyadenylation were disrupted in SINV infected cells. Major aspects of 
this project were reported in Michael Barnhart’s thesis (towards a master’s degree); however, I 
contributed to the publication of this work by performing all experiments necessary to address 
reviewer’s comments for re-submission to the journal Cell Reports. I was therefore co-first 
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author of the manuscript published in 2013 and my contributions to this manuscript were as 
follows.  
 Figure 1D: analysis of the region of the 3’ UTR necessary for re-localization of the HuR 
protein from the nucleus to the cytoplasm. 
 Figure 2B and 2D: analysis of the changes in mRNA stability in cells transfected with 
the 3’ UTR of SINV compared to a control RNA. 
 Figure 3B: qRT-PCR analysis of HuR-RNA co-immunoprecipitations from SINV and 
mock infected cells. 
 Figure 4C and 4D: analysis of alternative splicing of two transcripts in SINV infected 
and mock infected cells; analysis of alternative polyadenylation/splicing of CALCA in 
cells transfected with an RNA containing the SINV 3’ UTR or a control RNA. 
 Finally, I also determined that the minimum amount of in vitro transcribed RNA 
containing the SINV 3’ UTR that caused a re-distribution of the HuR protein from the 
nucleus to the cytoplasm was similar to the amount of SINV 3’ UTR RNA present in 
the cell during an infection. 
This study further contributed to our understanding of how RNA viruses can cause dramatic 
changes in the post-transcriptional regulation of gene expression by interacting with host RNA 
binding proteins during infection. Furthermore, although several studies had demonstrated that 
viral RNAs can sponge host microRNAs (as discussed in the Introduction), this study 
demonstrated that RNA binding proteins can be similarly ‘sponged up’ by viral RNAs. The 
citation for this manuscript is as follows and the article is available from Cell Reports: 
Barnhart MD, Moon SL, Emch AW, Wilusz CJ, Wilusz J. Changes in cellular mRNA stability, 
splicing, and polyadenylation through HuR protein sequestration by a cytoplasmic RNA virus. 
Cell Rep. 2013 Nov 27;5(4):909-17.  
 
 
